Annotation Detail for CYP1A2
Basic Information Top
| Gene Symbol: | CYP1A2 ( CP12,P3-450,P450(PA) ) |
|---|---|
| Gene Full Name: | cytochrome P450, family 1, subfamily A, polypeptide 2 |
| Band: | 15q24.1 |
| Quick Links | Entrez ID:1544; OMIM: 124060; Uniprot ID:CP1A2_HUMAN; ENSEMBL ID: ENSG00000140505; HGNC ID: 2596 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa00830 | Retinol metabolism |
| hsa00380 | Tryptophan metabolism |
| hsa00980 | Metabolism of xenobiotics by cytochrome P450 |
| hsa00982 | Drug metabolism - cytochrome P450 |
| hsa01100 | Metabolic pathways |
| hsa00591 | Linoleic acid metabolism |
| hsa00232 | Caffeine metabolism |
| Pathway ID | Pathway Name |
|---|---|
| Biological oxidations |
| No data |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 500198 | Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 |
| 500215 | Methylation |
| No data |
| Desease ID | Desease Name |
|---|---|
| 1990 | Skin disease, Genetic |
| 1804 | Chronic obstructive airway disease |
| 1811 | Drug-Induced dyskinesia |
| 1934 | Cancer |
| 2069 | Schizophrenia |
| Desease Name |
|---|
| ovarian cancer |
| Diastolic blood pressure |
| QT intervals |
| colorectal cancer |
| CARDIOVASCULAR |
| myocardial infarct |
| liver cancer |
| CANCER |
| PSYCH |
| liver disease |
| PHARMACOGENOMIC |
| breast cancer |
| cholesterol glucose insulin triglycerides |
| urinary mutagenicity |
| schizophrenia |
| METABOLIC |
| lung cancer |
| 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine |
| Plasma caffeine metabolite ratio |
| No data |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C495657 | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | CYP1A2 protein results in increased chemical synthesis of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | increases chemical synthesis | 9733665 |
| C495657 | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | CYP1A2 protein results in increased hydroxylation of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | increases hydroxylation | 9047321 |
| C018673 | 1,2,4,5-tetrachlorobenzene | 1,2,4,5-tetrachlorobenzene results in increased expression of CYP1A2 protein | increases expression | 10696772 |
| C009947 | 1,2,4-trichlorobenzene | CYP1A2 protein results in increased oxidation of 1,2,4-trichlorobenzene | increases oxidation | 7747284 |
| C410870 | 1,2,4-trihydroxy-9,10-anthracenedione | 1,2,4-trihydroxy-9,10-anthracenedione results in decreased activity of CYP1A2 protein | decreases activity | 12379470 |
| C026486 | 1,2,5,6-dibenzanthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944 |
| C035384 | 1,2-dichloroethylene | 1,2-dichloroethylene affects the expression of CYP1A2 protein | affects expression | 9493318 |
| C035384 | 1,2-dichloroethylene | 1,2-dichloroethylene results in decreased activity of CYP1A2 protein | decreases activity | 9671540 |
| C117619 | 1,2-dimethylnaphthalene | 1,2-dimethylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C439392 | 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline | 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline results in decreased activity of CYP1A2 protein | decreases activity | 15585365 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA | increases expression | 15764585 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | NCOA6 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 15764585 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA | increases expression | 16109766 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | MED1 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16109766 |
| C031969 | 1,4-dimethylnaphthalene | 1,4-dimethylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C035342 | 1,4-naphthoquinone | CYP1A2 protein results in increased abundance of 1,4-naphthoquinone | increases abundance | 16243959 |
| C466921 | 1,6-dimethylnaphthalene | 1,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C021183 | 1,7-dimethylxanthine | CYP1A2 protein results in increased hydroxylation of 1,7-dimethylxanthine | increases hydroxylation | 15980104 |
| C053486 | 1,7-phenanthroline | 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein] | affects cotreatment|decreases expression|decreases reaction | 17967931 |
| C053486 | 1,7-phenanthroline | 1,7-phenanthroline results in increased expression of CYP1A2 protein | increases expression | 17967931 |
| C033020 | 1-aminobenzotriazole | 1-aminobenzotriazole results in decreased activity of CYP1A2 protein | decreases activity | 15618748 |
| C004482 | 1-aminopyrene | CYP1A2 protein results in increased activity of 1-aminopyrene | increases activity | 15728263 |
| C031337 | 1-chloronaphthalene | 1-chloronaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C025968 | 1-methylnaphthalene | 1-methylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C053085 | 1-methylxanthine | 1-methylxanthine results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| C029350 | 1-naphthol | 1-naphthol results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C029350 | 1-naphthol | CYP1A2 protein results in increased abundance of 1-naphthol | increases abundance | 16243959 |
| C032668 | 1-nitropyrene | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C032668 | 1-nitropyrene | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C024336 | 1-phenylazo-2-naphthol | CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] | increases oxidation|increases reaction | 17159775 |
| C024336 | 1-phenylazo-2-naphthol | CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol | increases oxidation | 17159775 |
| C541980 | 2,2',4,6'-tetramethoxystilbene | 2,2',4,6'-tetramethoxystilbene results in decreased activity of CYP1A2 protein | decreases activity | 19463925 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester results in decreased activity of CYP1A2 protein | decreases activity | 19276279 |
| C094210 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein | decreases activity | 15542068 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | 2,3,3',4,4',5-hexachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | 2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | 2,3,3',4,4',5-hexachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 10986007 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | 2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | 2,3,3',4,4'-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | 2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | 2,3,3',4,4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 10986007 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | 2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 10986007 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17342196 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | CYP1A2 protein affects the abundance of 2,3,4,7,8-pentachlorodibenzofuran | affects abundance | 9240455 10448125 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | 2,3,4,7,8-pentachlorodibenzofuran results in increased activity of CYP1A2 protein | increases activity | 17160103 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17342195 |
| C100420 | 2,3-diaminotoluene | 2,3-diaminotoluene results in increased expression of CYP1A2 protein | increases expression | 8685904 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 16835634 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 16835634 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 protein | increases expression | 3302669 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17160104 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of CYP1A2 protein | increases expression | 8685904 |
| C028519 | 2,6-dimethylnaphthalene | 2,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C085049 | 2,7-dinitrofluorene | 2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C085049 | 2,7-dinitrofluorene | 2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | CYP1A2 protein polymorphism results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases activity | 15110095 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases activity | 12949046 15110095 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases hydroxylation | 15944213 14725854 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | CYP1A2 protein results in increased hydroxylation of and results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases hydroxylation|increases metabolic processing | 15310245 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein | increases expression | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases activity | 15598703 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | CYP1A2 protein affects the metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | affects metabolic processing | 2655891 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | CYP1A2 protein results in increased hydroxylation of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | increases hydroxylation | 14725854 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | CYP1A2 protein affects the metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | affects metabolic processing | 2655891 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | CYP1A2 protein results in increased activity of and results in increased hydroxylation of 2-amino-3-methyl-9H-pyrido(2,3-b)indole | increases activity|increases hydroxylation | 14729582 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | CYP1A2 protein affects the metabolism of 2-amino-3-methylimidazo(4,5-f)quinoline | affects metabolic processing | 2655891 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | CYP1A2 protein results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline | increases activity | 15728263 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | CYP1A2 protein results in increased hydroxylation of and results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline | increases activity|increases hydroxylation | 14725854 |
| C035208 | 2-amino-4,6-dinitrotoluene | 2-amino-4,6-dinitrotoluene affects the expression of CYP1A2 mRNA | affects expression | 21346803 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | CYP1A2 protein affects the metabolism of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | affects metabolic processing | 2655891 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | CYP1A2 protein results in increased hydroxylation of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | increases hydroxylation | 14725854 |
| C012177 | 2-aminofluorene | CYP1A2 protein affects the metabolism of 2-aminofluorene | affects metabolic processing | 2655891 |
| C003898 | 2-anisidine | CYP1A2 protein results in increased oxidation of 2-anisidine | increases oxidation | 15828049 |
| C003898 | 2-anisidine | CYP1A2 protein results in increased oxidation of 2-anisidine | increases oxidation | 16601807 |
| C003898 | 2-anisidine | 2-anisidine results in increased expression of CYP1A2 | increases expression | 11409192 |
| C006593 | 2-anthramine | CYB5 protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] | increases activity|increases reaction | 15728263 |
| C006593 | 2-anthramine | CYP1A2 protein affects the metabolism of 2-anthramine | affects metabolic processing | 2655891 |
| C006593 | 2-anthramine | CYP1A2 protein results in increased activity of 2-anthramine | increases activity | 15728263 |
| C055142 | 2-chlorobiphenyl | 2-chlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C004726 | 2-dichlorobenzene | CYP1A2 protein results in increased oxidation of 2-dichlorobenzene | increases oxidation | 7747284 |
| C001390 | 2-hydroxyestradiol | Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| C001390 | 2-hydroxyestradiol | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| C001390 | 2-hydroxyestradiol | CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol | increases chemical synthesis | 16790556 |
| C001390 | 2-hydroxyestradiol | Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| C001390 | 2-hydroxyestradiol | naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| C053767 | 2-methoxy-4-aminoazobenzene | 2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA | increases expression | 7553614 |
| C053767 | 2-methoxy-4-aminoazobenzene | 2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein | increases expression | 7553614 |
| C082155 | 2-methoxynaphthalene | 2-methoxynaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C027384 | 2-methylnaphthalene | 2-methylnaphthalene results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C037073 | 2-methylquinoline | 2-methylquinoline results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C028405 | 2-naphthol | 2-naphthol results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C028405 | 2-naphthol | CYP1A2 protein results in increased abundance of 2-naphthol | increases abundance | 16243959 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of CYP1A2 | increases expression | 11409192 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of CYP1A2 protein | increases expression | 16601807 |
| C109602 | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate results in decreased activity of CYP1A2 protein | decreases activity | 16049129 |
| C472365 | 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine | 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine results in decreased activity of CYP1A2 protein | decreases activity | 15193955 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | CYP1A2 protein affects the chemical synthesis of 3,3',4,5'-tetrahydroxystilbene | affects chemical synthesis | 15276085 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA | increases expression | 15672752 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane results in increased expression of CYP1A2 protein | increases expression | 15672752 |
| C016392 | 3,3'-diindolylmethane | CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane | increases oxidation | 16544949 |
| C016392 | 3,3'-diindolylmethane | Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | decreases reaction|increases oxidation | 16544949 |
| C016392 | 3,3'-diindolylmethane | resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | decreases reaction|increases oxidation | 16544949 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17183067 |
| C013279 | 3,4,3',4'-tetrachloroazobenzene | 3,4,3',4'-tetrachloroazobenzene results in increased activity of CYP1A2 protein | increases activity | 2315923 |
| C013279 | 3,4,3',4'-tetrachloroazobenzene | 3,4,3',4'-tetrachloroazobenzene results in increased expression of CYP1A2 protein | increases expression | 2315923 |
| C013280 | 3,4,3',4'-tetrachloroazoxybenzene | 3,4,3',4'-tetrachloroazoxybenzene results in increased activity of CYP1A2 protein | increases activity | 2315923 |
| C013280 | 3,4,3',4'-tetrachloroazoxybenzene | 3,4,3',4'-tetrachloroazoxybenzene results in increased expression of CYP1A2 protein | increases expression | 2315923 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | 3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | 3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | increases expression | 16049271 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | increases expression | 16049271 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 10986007 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 16835634 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17342196 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17160104 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein | increases activity | 16628245 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | increases expression | 16049271 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17342195 |
| C497286 | 3,4',5-trimethoxystilbene | 3,4',5-trimethoxystilbene results in decreased activity of CYP1A2 protein | decreases activity | 16684708 |
| C475568 | 3-aminobenzanthrone | CYP1A2 protein results in increased oxidation of and results in increased activity of 3-aminobenzanthrone | increases activity|increases oxidation | 15885895 |
| C482258 | 3'-hydroxy-genistein | CYP1A2 protein results in increased chemical synthesis of 3'-hydroxy-genistein | increases chemical synthesis | 12814970 |
| C081194 | 3-methylquinoline | 3-methylquinoline results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C031285 | 3-xylene | CYP1A2 protein results in increased metabolism of 3-xylene | increases metabolic processing | 8558417 |
| C031285 | 3-xylene | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] | decreases reaction|increases metabolic processing | 8558417 |
| C031285 | 3-xylene | 3-xylene results in decreased activity of CYP1A2 protein | decreases activity | 8598570 |
| C006757 | 4-biphenylamine | CYP1A2 protein affects the metabolism of 4-biphenylamine | affects metabolic processing | 2655891 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased activity of 4-biphenylamine | increases activity | 15450435 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine | increases activity|increases hydroxylation | 16988941 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased metabolism of 4-biphenylamine | increases metabolic processing | 11376689 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased oxidation of 4-biphenylamine | increases oxidation | 2908851 |
| C006983 | 4-chlorobiphenyl | 4-chlorobiphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C032171 | 4-coumaric acid | 4-coumaric acid results in decreased activity of CYP1A2 protein | decreases activity | 15841493 |
| C018511 | 4-dichlorobenzene | CYP1A2 protein results in increased oxidation of 4-dichlorobenzene | increases oxidation | 7747284 |
| C082137 | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide results in increased expression of CYP1A2 mRNA | increases expression | 15681896 |
| C451019 | 4-hydroxychalcone | CYP1A2 protein affects the chemical synthesis of 4-hydroxychalcone | affects chemical synthesis | 15863696 |
| C001470 | 4-ipomeanol | CYP1A2 protein results in increased activity of 4-ipomeanol | increases activity | 15892579 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased activity of CYP1A2 protein | increases activity | 9545601 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased expression of CYP1A2 mRNA | increases expression | 9545601 7553614 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased expression of CYP1A2 protein | increases expression | 7553614 9545601 |
| C024836 | 4-nitrophenol | CYP1A2 protein results in increased hydroxylation of 4-nitrophenol | increases hydroxylation | 11911841 |
| C120195 | 4-nitroquinolone-1-oxide | 4-nitroquinolone-1-oxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | affects metabolic processing|increases activity | 11774366 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | increases activity | 15728263 |
| C483032 | 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | CYP1A2 protein mutant form results in decreased metabolism of 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | decreases metabolic processing | 15564884 |
| C483032 | 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | CYP1A2 protein results in increased hydroxylation of 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | increases hydroxylation | 15564884 |
| C066668 | 5,6-dimethylxanthenoneacetic acid | Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of 5,6-dimethylxanthenoneacetic acid] | decreases reaction|increases oxidation | 16120190 |
| C066668 | 5,6-dimethylxanthenoneacetic acid | CYP1A2 protein results in increased oxidation of 5,6-dimethylxanthenoneacetic acid | increases oxidation | 16120190 |
| C100101 | 6-chrysenamine | CYP1A2 protein results in increased activity of 6-chrysenamine | increases activity | 15728263 |
| C054923 | 6-methyl-1,3,8-trichlorodibenzofuran | 6-methyl-1,3,8-trichlorodibenzofuran results in increased expression of CYP1A2 mRNA | increases expression | 19828881 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine results in decreased activity of CYP1A2 protein | decreases activity | 15193955 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | CYP1A2 protein results in increased activity of 7-(deoxyadenosin-N(6)-yl)aristolactam I | increases activity | 15386410 |
| C056033 | 7-ethoxy-4-trifluoromethylcoumarin | CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin | decreases ethylation | 9241656 |
| C056033 | 7-ethoxy-4-trifluoromethylcoumarin | Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] | decreases ethylation|decreases reaction | 9241656 |
| C013478 | 7H-dibenzo(c,g)carbazole | CYP1A2 protein affects the metabolism of and results in increased activity of 7H-dibenzo(c,g)carbazole | affects metabolic processing|increases activity | 15534862 |
| C084236 | 7-hydroxy-4-trifluoromethylcoumarin | CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin | increases chemical synthesis | 9241656 |
| C084236 | 7-hydroxy-4-trifluoromethylcoumarin | Orphenadrine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] | decreases reaction|increases chemical synthesis | 9241656 |
| C076580 | 7-methoxyresorufin | CYB5 protein inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | decreases methylation|decreases reaction | 15728263 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein binds to and affects the metabolism of 7-methoxyresorufin | affects binding|affects metabolic processing | 15659567 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein results in decreased methylation of 7-methoxyresorufin | decreases methylation | 15728263 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein binds to and affects the metabolism of 7-methoxyresorufin | affects binding|affects metabolic processing | 15659567 |
| C028322 | 8-phenyltheophylline | 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | decreases ethylation|decreases reaction | 11465391 |
| C028322 | 8-phenyltheophylline | 8-phenyltheophylline results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| C119737 | 8-prenylnaringenin | 8-prenylnaringenin results in increased expression of CYP1A2 mRNA | increases expression | 15672752 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | CYP1A2 protein affects the metabolism of 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | affects metabolic processing | 17067997 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | CYP1A2 protein results in increased chemical synthesis of 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | increases chemical synthesis | 15279827 |
| C042552 | acenaphthene | acenaphthene results in increased activity of CYP1A2 protein | increases activity | 8001243 |
| C042553 | acenaphthylene | acenaphthylene results in increased activity of CYP1A2 protein | increases activity | 8001243 10977129 |
| C042553 | acenaphthylene | acenaphthylene results in increased expression of CYP1A2 mRNA | increases expression | 8001243 |
| C042553 | acenaphthylene | acenaphthylene results in increased expression of CYP1A2 protein | increases expression | 8001243 |
| D000074 | Acenocoumarol | CYP1A2 protein affects the metabolism of Acenocoumarol | affects metabolic processing | 11918509 |
| C001969 | acephate | [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| C001969 | acephate | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | increases chemical synthesis | 17097115 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | increases chemical synthesis | 15155557 12401345 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased oxidation of Acetaminophen | increases oxidation | 10811468 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP1A2 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 mRNA | decreases expression | 16611625 15576447 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 protein | decreases expression | 15576447 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 mRNA | increases expression | 14978233 12958197 16141365 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 protein | increases expression | 19002106 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased metabolism of Acetaminophen | increases metabolic processing | 10977129 19002106 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased metabolism of and affects the susceptibility to Acetaminophen | affects response to substance|increases metabolic processing | 11376689 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased susceptibility to Acetaminophen | increases response to substance | 16141365 16557553 |
| D000082 | Acetaminophen | IL1A protein inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 19002106 |
| D000082 | Acetaminophen | NR1I2 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 16141365 |
| D000082 | Acetaminophen | PPARA protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 12958197 |
| D000082 | Acetaminophen | RXRA protein promotes the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 14978233 |
| D000082 | Acetaminophen | SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 16729303 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP1A2 mRNA | affects expression | 11245408 17366322 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 mRNA | decreases expression | 12969438 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 protein | increases expression | 18798224 |
| D000082 | Acetaminophen | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18798224 |
| D000082 | Acetaminophen | [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA] | affects cotreatment|decreases expression|increases reaction | 12969438 |
| D000096 | Acetone | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 8996725 |
| D000166 | Acridines | Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of 5,6-dimethylxanthenoneacetic acid] | decreases reaction|increases oxidation | 16120190 |
| D000166 | Acridines | Acridines analog results in decreased activity of CYP1A2 protein | decreases activity | 16120190 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased activity of Aflatoxin B1 | increases activity | 15988000 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased susceptibility to Aflatoxin B1 | increases response to substance | 11189750 |
| C027955 | aflatoxin G1 | CYP1A2 protein results in increased susceptibility to aflatoxin G1 | increases response to substance | 11189750 |
| C000188 | alachlor | alachlor results in increased expression of CYP1A2 protein | increases expression | 11850968 |
| D015766 | Albendazole | Albendazole results in increased expression of CYP1A2 mRNA | increases expression | 12451431 |
| D015766 | Albendazole | CYP1A2 protein affects the metabolism of Albendazole | affects metabolic processing | 12920490 |
| D015766 | Albendazole | Albendazole results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 15766946 |
| D015766 | Albendazole | CYP1A2 protein affects the metabolism of and results in decreased activity of Albendazole | affects metabolic processing|decreases activity | 15766946 |
| C010078 | alizarin | alizarin results in decreased activity of CYP1A2 protein | decreases activity | 12379470 |
| C006463 | allyl alcohol | allyl alcohol results in decreased expression of CYP1A2 protein | decreases expression | 10547960 |
| C077207 | allyl methyl sulfide | allyl methyl sulfide results in increased expression of CYP1A2 protein | increases expression | 16000231 |
| C010177 | alpha-hederin | alpha-hederin results in decreased activity of CYP1A2 protein | decreases activity | 9861456 |
| C010177 | alpha-hederin | alpha-hederin results in decreased expression of CYP1A2 mRNA | decreases expression | 9861456 |
| D017962 | alpha-Linolenic Acid | alpha-Linolenic Acid results in decreased activity of CYP1A2 protein | decreases activity | 16978661 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | decreases activity | 15306208 15860655 15766918 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of CYP1A2 mRNA | increases expression | 19828881 |
| C011512 | alpha-naphthoflavone | CYP1A2 protein results in increased metabolism of alpha-naphthoflavone | increases metabolic processing | 17702393 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | decreases activity | 15766918 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | decreases activity | 15766918 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | decreases activity | 15507517 10828259 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol results in increased activity of CYP1A2 protein | increases activity | 15665910 |
| C100057 | ametryne | CYP1A2 protein results in increased metabolism of ametryne | increases metabolic processing | 8971136 |
| C100057 | ametryne | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] | increases metabolic processing|increases reaction | 8971136 |
| D000588 | Amines | CYP1A2 protein affects the metabolism of and results in increased activity of Amines | affects metabolic processing|increases activity | 12505289 |
| D000588 | Amines | CYP1A2 protein results in increased hydroxylation of and affects the metabolism of Amines | affects metabolic processing|increases hydroxylation | 15613766 |
| D009762 | o-Aminoazotoluene | o-Aminoazotoluene results in increased activity of CYP1A2 protein | increases activity | 15863256 |
| D009762 | o-Aminoazotoluene | o-Aminoazotoluene results in increased expression of CYP1A2 mRNA | increases expression | 10887293 14562683 |
| D015081 | 2-Naphthylamine | CYP1A2 protein results in increased activity of 2-Naphthylamine | increases activity | 15450435 |
| D000634 | Aminoquinolines | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D000634 | Aminoquinolines | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D000655 | Amodiaquine | Amodiaquine results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| D000661 | Amphetamine | CYP1A2 protein affects the chemical synthesis of Amphetamine | affects chemical synthesis | 15294457 |
| C030419 | andrographolide | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 17825862 |
| C030419 | andrographolide | andrographolide results in increased expression of CYP1A2 mRNA | increases expression | 17825862 |
| C011659 | angelicin | angelicin results in increased expression of CYP1A2 protein | increases expression | 18692084 |
| C023650 | aniline | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | affects cotreatment|affects metabolic processing | 15279827 |
| C023650 | aniline | aniline analog results in increased activity of CYP1A2 protein | increases activity | 16639589 |
| C023650 | aniline | aniline analog results in increased expression of CYP1A2 mRNA | increases expression | 16639589 |
| C023650 | aniline | aniline analog results in increased expression of CYP1A2 protein | increases expression | 16639589 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17959153 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA | increases expression | 17959153 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17959153 |
| C034020 | anthracene | anthracene results in increased activity of CYP1A2 protein | increases activity | 8001243 |
| D018943 | Anthracyclines | Anthracyclines results in decreased activity of CYP1A2 protein | decreases activity | 15588138 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in decreased activity of CYP1A2 protein | decreases activity | 16978661 |
| C059427 | aranidipine | aranidipine results in decreased activity of CYP1A2 protein | decreases activity | 10805063 |
| C075875 | artemisin | artemisin results in decreased activity of CYP1A2 protein | decreases activity | 16261361 |
| C031327 | artemisinine | artemisinine results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| C031327 | artemisinine | artemisinine results in increased expression of CYP1A2 mRNA | increases expression | 16919048 |
| D001218 | Aspartame | Aspartame results in increased activity of CYP1A2 protein | increases activity | 16937917 |
| C050701 | atipamezole | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity|increases expression|increases reaction | 16510159 |
| C050701 | atipamezole | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| C050701 | atipamezole | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| C050701 | atipamezole | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D053626 | Atovaquone | Atovaquone results in increased activity of CYP1A2 protein | increases activity | 11124226 |
| D001280 | Atrazine | Atrazine results in increased activity of CYP1A2 protein | increases activity | 9711812 |
| C423185 | avasimibe | avasimibe results in decreased activity of CYP1A2 protein | decreases activity | 15333513 |
| D001374 | Azacitidine | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 12927368 |
| D001374 | Azacitidine | Azacitidine results in increased expression of CYP1A2 mRNA | increases expression | 12927368 |
| D001397 | Azoxymethane | Azoxymethane results in decreased expression of CYP1A2 mRNA | decreases expression | 18038451 |
| C030935 | benz(a)anthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | affects cotreatment|increases metabolic processing | 8961944 |
| C030935 | benz(a)anthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944 |
| C030935 | benz(a)anthracene | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 17825862 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of CYP1A2 mRNA | increases expression | 17825862 |
| C030935 | benz(a)anthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | affects cotreatment|increases metabolic processing | 8961944 |
| C030935 | benz(a)anthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944 |
| C002615 | benzo(c)phenanthrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | affects cotreatment|increases metabolic processing | 8961944 |
| C002615 | benzo(c)phenanthrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944 |
| C002615 | benzo(c)phenanthrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | affects cotreatment|increases metabolic processing | 8961944 |
| C002615 | benzo(c)phenanthrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | affects metabolic processing|increases reaction | 10936227 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of CYP1A2 protein | increases activity | 15893423 14722322 10923861 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | increases expression | 12623754 14722322 15629189 15855724 16985168 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 protein | increases expression | 15629189 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | affects metabolic processing|increases reaction | 10936227 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of CYP1A2 protein | increases activity | 16054776 10463385 15466162 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | increases expression | 15466162 15607757 16354159 10463385 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 protein | increases expression | 10463385 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20045035 18164116 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 | increases expression | 15507517 |
| C105430 | benzofuran | benzofuran analog results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D001572 | Benzofurans | Benzofurans analog results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| D001572 | Benzofurans | Benzofurans analog results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | increases expression | 20106945 15056799 20553787 20542099 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 protein | increases expression | 20542099 11849738 |
| D001564 | Benzo(a)pyrene | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 20553787 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | affects metabolic processing | 20542099 |
| D001564 | Benzo(a)pyrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | affects cotreatment|increases metabolic processing | 8961944 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene | increases hydrolysis | 19919601 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein results in increased metabolism of Benzo(a)pyrene | increases metabolic processing | 2791199 |
| D001564 | Benzo(a)pyrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944 |
| D001564 | Benzo(a)pyrene | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | decreases reaction|increases hydrolysis | 19919601 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CYP1A2 protein | increases activity | 15863256 18321868 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | increases expression | 19961161 20371670 18321868 19896525 14562683 19406224 17997381 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 protein | increases expression | 18321868 17997381 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18321868 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 18321868 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18321868 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | affects metabolic processing | 16256281 |
| D001564 | Benzo(a)pyrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | affects cotreatment|increases metabolic processing | 8961944 |
| D001564 | Benzo(a)pyrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944 |
| D001564 | Benzo(a)pyrene | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 16510159 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | increases expression | 19497421 16510159 |
| D001564 | Benzo(a)pyrene | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | increases activity|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 16510159 |
| D001564 | Benzo(a)pyrene | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | increases activity|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | decreases abundance|increases activity|increases expression|increases reaction | 16510159 |
| D001564 | Benzo(a)pyrene | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases abundance|increases expression|increases reaction | 16510159 |
| C017057 | benzoxazolone | benzoxazolone results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C025383 | benzylideneacetone | CYP1A2 protein results in increased oxidation of benzylideneacetone | increases oxidation | 15863696 |
| C057754 | benzyloxyresorufin | CYP1A2 protein results in decreased alkylation of benzyloxyresorufin | decreases alkylation | 11911841 |
| C068337 | bergamottin | bergamottin results in increased expression of CYP1A2 protein | increases expression | 18692084 |
| C095105 | bexarotene | bexarotene results in decreased expression of CYP1A2 mRNA | decreases expression | 16648578 |
| D001663 | Bilirubin | Bilirubin results in decreased activity of CYP1A2 protein | decreases activity | 16183037 |
| C073710 | bilobalide | bilobalide results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 18421621 |
| C073710 | bilobalide | bilobalide results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| C004541 | biochanin A | CYP1A2 protein results in increased metabolism of biochanin A | increases metabolic processing | 12814970 |
| C400082 | bortezomib | CYP1A2 protein affects the metabolism of bortezomib | affects metabolic processing | 15764713 |
| C032036 | bromobenzene | bromobenzene results in decreased expression of CYP1A2 protein | decreases expression | 10547960 |
| C025191 | bromodichloromethane | CYP1A2 protein results in increased metabolism of bromodichloromethane | increases metabolic processing | 12076521 |
| C025191 | bromodichloromethane | bromodichloromethane results in decreased expression of CYP1A2 protein | decreases expression | 11295256 |
| C025191 | bromodichloromethane | bromodichloromethane results in increased expression of CYP1A2 protein | increases expression | 11295256 |
| C025191 | bromodichloromethane | CYP1A2 protein affects the metabolism of bromodichloromethane | affects metabolic processing | 12062927 |
| C025191 | bromodichloromethane | CYP1A2 protein results in increased metabolism of bromodichloromethane | increases metabolic processing | 12076521 11295256 |
| C025191 | bromodichloromethane | isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | affects metabolic processing|decreases reaction | 12062927 |
| C025191 | bromodichloromethane | Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | affects metabolic processing|increases reaction | 12062927 |
| C010831 | bufuralol | CYP1A2 protein results in increased hydroxylation of bufuralol | increases hydroxylation | 9429232 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in decreased activity of CYP1A2 protein | decreases activity | 18177683 |
| C474480 | butylcyclohexane | butylcyclohexane results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D002087 | Butyrates | Butyrates results in increased expression of CYP1A2 mRNA | increases expression | 15252868 |
| D002087 | Butyrates | Tetrachlorodibenzodioxin inhibits the reaction [Butyrates results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 15252868 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of CYP1A2 mRNA | increases expression | 17481689 |
| C055494 | caffeic acid phenethyl ester | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 20360939 |
| D002110 | Caffeine | Caffeine results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| D002110 | Caffeine | CYP1A2 protein affects the metabolism of Caffeine | affects metabolic processing | 14586387 15327588 15199075 15980104 15022032 15286053 14586384 |
| D002110 | Caffeine | CYP1A2 protein binds to and affects the metabolism of Caffeine | affects binding|affects metabolic processing | 15659567 15856409 |
| D002110 | Caffeine | CYP1A2 protein results in decreased methylation of Caffeine | decreases methylation | 12433797 |
| D002110 | Caffeine | CYP1A2 protein results in increased metabolism of Caffeine | increases metabolic processing | 11907490 |
| D002110 | Caffeine | GH1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | increases metabolic processing|increases reaction | 11907490 |
| D002110 | Caffeine | CYP1A2 protein results in decreased methylation of Caffeine | decreases methylation | 11376689 |
| D002110 | Caffeine | Caffeine results in increased activity of CYP1A2 protein | increases activity | 15822860 |
| D002110 | Caffeine | CYP1A2 protein affects the metabolism of Caffeine | affects metabolic processing | 15619608 |
| D002110 | Caffeine | CYP1A2 protein binds to and affects the metabolism of Caffeine | affects binding|affects metabolic processing | 15659567 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of CYP1A2 mRNA | increases expression | 17112801 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D012721 | Carbaryl | Carbaryl results in decreased activity of CYP1A2 protein | decreases activity | 16790556 |
| D012721 | Carbaryl | Carbaryl results in increased expression of CYP1A2 protein | increases expression | 9858662 |
| D002235 | Carbofuran | CYP1A2 protein results in increased hydroxylation of Carbofuran | increases hydroxylation | 15560889 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | decreases expression | 17084009 18038451 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | decreases expression | 16445600 |
| D002251 | Carbon Tetrachloride | CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA] | decreases expression|decreases reaction | 17084009 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of CYP1A2 mRNA | affects expression | 15963342 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased activity of CYP1A2 protein | decreases activity | 14706259 16288784 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | decreases expression | 16239168 14706259 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | decreases expression | 17606319 |
| D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 16288784 |
| D002251 | Carbon Tetrachloride | CYP1A2 protein results in increased metabolism of Carbon Tetrachloride | increases metabolic processing | 15988118 |
| D002338 | Carotenoids | CYP1A2 protein polymorphism affects the susceptibility to Carotenoids | affects response to substance | 15095308 |
| D002395 | Catecholamines | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | decreases abundance|increases activity|increases expression|increases reaction | 16510159 |
| D002395 | Catecholamines | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases abundance|increases expression|increases reaction | 16510159 |
| C105934 | celecoxib | celecoxib results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| C088453 | Celsior | [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 15448115 |
| C088453 | Celsior | Celsior results in decreased activity of CYP1A2 protein | decreases activity | 15448115 |
| C088453 | Celsior | Celsior results in decreased expression of CYP1A2 mRNA | decreases expression | 15448115 |
| D002599 | Chalcone | CYP1A2 protein results in increased hydroxylation of Chalcone | increases hydroxylation | 15863696 |
| C023386 | chlorinated dibenzofurans | [Polychlorinated Biphenyls co-treated with chlorinated dibenzofurans] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17051818 |
| C023386 | chlorinated dibenzofurans | [polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 17850846 |
| D002719 | Chlormethiazole | Chlormethiazole results in decreased expression of CYP1A2 mRNA | decreases expression | 10751552 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | increases expression | 16049271 16934159 17851650 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | increases expression | 17851650 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | increases expression | 16049271 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein | increases activity | 8471063 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | increases expression | 8471063 16049271 18178546 11163329 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | increases expression | 8471063 |
| D002746 | Chlorpromazine | Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D002746 | Chlorpromazine | CYP1A2 protein results in increased metabolism of and results in increased activity of Chlorpromazine | increases activity|increases metabolic processing | 19482014 |
| D002746 | Chlorpromazine | Chlorpromazine affects the expression of CYP1A2 mRNA | affects expression | 18246545 |
| D004390 | Chlorpyrifos | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| D004390 | Chlorpyrifos | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased activity of CYP1A2 protein | decreases activity | 16790556 |
| D004390 | Chlorpyrifos | CYP1A2 protein affects the metabolism of Chlorpyrifos | affects metabolic processing | 17079358 15557345 |
| D002753 | Chlorzoxazone | CYP1A2 protein affects the metabolism of Chlorzoxazone | affects metabolic processing | 14586387 |
| D002753 | Chlorzoxazone | CYP1A2 protein affects the metabolism of Chlorzoxazone | affects metabolic processing | 15879494 |
| D002753 | Chlorzoxazone | CYP1A2 protein results in increased hydroxylation of Chlorzoxazone | increases hydroxylation | 11911841 |
| D002794 | Choline | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18798224 |
| D002794 | Choline | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 18798224 |
| C031180 | chrysene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | affects cotreatment|increases metabolic processing | 8961944 |
| C031180 | chrysene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944 |
| C031180 | chrysene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | affects cotreatment|increases metabolic processing | 8961944 |
| C031180 | chrysene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944 |
| C007054 | chrysoeriol | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 20553787 |
| C019304 | ciprofibrate | ciprofibrate results in decreased expression of CYP1A2 mRNA | decreases expression | 7676460 |
| D002939 | Ciprofloxacin | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | affects metabolic processing|decreases reaction | 15592331 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased activity of CYP1A2 protein | decreases activity | 18816299 15592331 |
| D002939 | Ciprofloxacin | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine | decreases activity|increases abundance | 11151749 |
| D002939 | Ciprofloxacin | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine | decreases activity|increases abundance | 11151749 |
| D002976 | Clenbuterol | Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| D002976 | Clenbuterol | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CYP1A2 protein | decreases expression | 17967931 |
| D002995 | Clofibric Acid | Clofibric Acid affects the expression of CYP1A2 mRNA | affects expression | 17602206 |
| C055162 | clopidogrel | CYP1A2 protein results in increased oxidation of clopidogrel | increases oxidation | 19812348 |
| C055162 | clopidogrel | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of clopidogrel] | decreases reaction|increases oxidation | 19812348 |
| D003022 | Clotrimazole | Clotrimazole results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| D003024 | Clozapine | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine | decreases activity|increases abundance | 11151749 |
| D003024 | Clozapine | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D003024 | Clozapine | CYP1A2 gene polymorphism affects the metabolism of Clozapine | affects metabolic processing | 16044115 |
| D003024 | Clozapine | CYP1A2 gene SNP affects the susceptibility to Clozapine | affects response to substance | 15206669 |
| D003024 | Clozapine | CYP1A2 gene SNP results in decreased metabolism of Clozapine | decreases metabolic processing | 12919186 |
| D003024 | Clozapine | CYP1A2 gene SNP results in decreased susceptibility to Clozapine | decreases response to substance | 11763009 |
| D003024 | Clozapine | CYP1A2 gene SNP results in increased metabolism of Clozapine | increases metabolic processing | 15206669 11763009 |
| D003024 | Clozapine | CYP1A2 protein affects the metabolism of Clozapine | affects metabolic processing | 15286053 15883149 15949157 |
| D003024 | Clozapine | CYP1A2 protein affects the susceptibility to Clozapine | affects response to substance | 12919186 |
| D003024 | Clozapine | CYP1A2 protein polymorphism affects the metabolism of Clozapine | affects metabolic processing | 15949157 |
| D003024 | Clozapine | CYP1A2 protein results in increased metabolism of Clozapine | increases metabolic processing | 16044115 |
| D003024 | Clozapine | Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine] | affects metabolic processing|affects reaction | 16044115 |
| D003024 | Clozapine | Smoke promotes the reaction [CYP1A2 protein results in increased metabolism of Clozapine] | increases metabolic processing|increases reaction | 16044115 |
| D003024 | Clozapine | Clozapine results in increased expression of CYP1A2 mRNA | increases expression | 12969762 |
| D003024 | Clozapine | CYP1A2 protein results in increased metabolism of Clozapine | increases metabolic processing | 12969762 |
| D003024 | Clozapine | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D003033 | Coal Tar | Coal Tar results in increased expression of CYP1A2 mRNA | increases expression | 16882163 |
| D003069 | Coffee | Coffee results in increased expression of CYP1A2 mRNA | increases expression | 18028974 |
| D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 18028974 |
| D003276 | Contraceptives, Oral | Contraceptives, Oral results in decreased activity of CYP1A2 protein | decreases activity | 17089110 |
| D003367 | Cotinine | Cotinine results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D003367 | Cotinine | Cotinine results in increased activity of CYP1A2 protein | increases activity | 16203240 |
| C043168 | coumaran | coumaran results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C030123 | coumarin | coumarin affects the expression of CYP1A2 mRNA | affects expression | 16963487 |
| C030123 | coumarin | coumarin results in decreased expression of CYP1A2 mRNA | decreases expression | 18480146 |
| D003474 | Curcumin | Curcumin results in decreased activity of CYP1A2 protein | decreases activity | 15841493 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 16288784 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CYP1A2 mRNA | increases expression | 17383702 |
| C084639 | cyclobarbital | cyclobarbital results in increased expression of CYP1A2 mRNA | increases expression | 10064569 |
| D003505 | Cyclodextrins | Cyclodextrins analog results in decreased activity of CYP1A2 protein | decreases activity | 15665498 |
| D015084 | 2,4-Dichlorophenoxyacetic Acid | 2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA | increases expression | 10910964 |
| D003606 | Dacarbazine | CYP1A2 protein results in increased metabolism of Dacarbazine metabolite | increases metabolic processing | 11751525 |
| D003606 | Dacarbazine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] | decreases reaction|increases metabolic processing | 11751525 |
| D003620 | Dantrolene | Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D003630 | Daunorubicin | [pyridoxal isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| D003630 | Daunorubicin | [salicylaldehyde isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased activity of CYP1A2 protein | increases activity | 18495385 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CYP1A2 mRNA | increases expression | 18495385 |
| C017180 | decamethrin | decamethrin results in increased expression of CYP1A2 mRNA | increases expression | 16859670 16952383 16494911 |
| C017180 | decamethrin | decamethrin results in increased expression of CYP1A2 protein | increases expression | 16859670 |
| C109757 | decan-4-olide | decan-4-olide results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D003671 | DEET | CYP1A2 protein results in increased metabolism of DEET | increases metabolic processing | 11854147 |
| C047386 | desethylamodiaquine | desethylamodiaquine results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| D017135 | Desogestrel | Desogestrel results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | affects cotreatment|increases activity|increases reaction | 19022236 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 19022236 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 19022236 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 19022236 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 19022236 |
| D003907 | Dexamethasone | Dexamethasone results in decreased activity of CYP1A2 protein | decreases activity | 19022236 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of CYP1A2 protein | decreases expression | 19022236 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of CYP1A2 mRNA | affects expression | 15102944 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 17690134 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CYP1A2 mRNA | increases expression | 15607757 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D020927 | Dexmedetomidine | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity|increases expression|increases reaction | 16510159 |
| D020927 | Dexmedetomidine | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| D020927 | Dexmedetomidine | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | increases activity|increases expression|increases reaction | 16510159 |
| D020927 | Dexmedetomidine | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| C028009 | diallyl disulfide | diallyl disulfide results in increased expression of CYP1A2 protein | increases expression | 16000231 |
| D003976 | Diazinon | CYP1A2 protein affects the metabolism of Diazinon | affects metabolic processing | 15557345 15764407 |
| D003976 | Diazinon | CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon | decreases sulfation|increases activity | 15764407 |
| D003976 | Diazinon | CYP1A2 protein results in increased metabolism of and results in increased activity of Diazinon | increases activity|increases metabolic processing | 11708902 |
| D003976 | Diazinon | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | increases expression|increases metabolic processing | 17442507 |
| C041517 | dibenzo(a,l)pyrene | CYP1A2 protein results in increased activity of dibenzo(a,l)pyrene | increases activity | 15606143 |
| C023614 | dibenzofuran | dibenzofuran results in increased activity of CYP1A2 protein | increases activity | 8001243 |
| C004354 | dichloran | CYP1A2 protein results in decreased nitrosation of dichloran | decreases nitrosation | 3137698 |
| D002945 | Cisplatin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D002945 | Cisplatin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C121718 | dicyclanil | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20118626 |
| C121718 | dicyclanil | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | affects cotreatment|increases abundance|increases expression | 20118626 |
| C121718 | dicyclanil | dicyclanil results in increased expression of CYP1A2 mRNA | increases expression | 15664270 |
| D004026 | Dieldrin | Dieldrin results in increased expression of CYP1A2 mRNA | increases expression | 10910964 |
| D004041 | Dietary Fats | 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein] | affects cotreatment|decreases expression|decreases reaction | 17967931 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 17967931 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 17967931 |
| D019422 | Dietary Sucrose | 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein] | affects cotreatment|decreases expression|decreases reaction | 17967931 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 17967931 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 17967931 |
| D004052 | Diethylnitrosamine | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20118626 |
| D004052 | Diethylnitrosamine | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | affects cotreatment|increases abundance|increases expression | 20118626 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20045035 18164116 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 20360939 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CYP1A2 mRNA | decreases expression | 19638242 20360939 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 18253720 |
| D004052 | Diethylnitrosamine | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 18754104 |
| D004054 | Diethylstilbestrol | CYP1A2 protein affects the susceptibility to Diethylstilbestrol | affects response to substance | 8242868 |
| D004075 | Diglycerides | Diglycerides results in increased stability of and results in increased activity of CYP1A2 protein | increases activity|increases stability | 15966743 |
| C039060 | dihydroquinghaosu | dihydroquinghaosu results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein | increases activity | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA | increases expression | 17183067 19276279 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene | increases activity | 15606143 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein | increases activity | 16054776 |
| D004126 | Dimethylformamide | Dimethylformamide results in decreased expression of CYP1A2 protein | decreases expression | 10547960 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CYP1A2 mRNA | decreases expression | 17072980 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CYP1A2 protein | decreases expression | 16997515 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of CYP1A2 mRNA | affects expression | 12843640 |
| D004147 | Dioxins | Dioxins results in increased expression of CYP1A2 mRNA | increases expression | 15977188 |
| D004147 | Dioxins | Dioxins results in increased expression of CYP1A2 protein | increases expression | 15977188 |
| C010574 | diphenyl | diphenyl results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D019297 | 2,4-Dinitrophenol | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D019297 | 2,4-Dinitrophenol | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased activity of CYP1A2 protein | decreases activity | 16978661 |
| D004294 | Domperidone | CYP1A2 protein results in increased hydroxylation of Domperidone | increases hydroxylation | 15327587 |
| D007980 | Levodopa | Levodopa inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D004317 | Doxorubicin | [pyridoxal isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| D004317 | Doxorubicin | [salicylaldehyde isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16901605 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased expression of CYP1A2 mRNA | increases expression | 16901605 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased activity of CYP1A2 protein | decreases activity | 16978661 |
| C034192 | ellipticine | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C034192 | ellipticine | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C105196 | enfuvirtide | enfuvirtide affects the activity of CYP1A2 protein | affects activity | 15656696 |
| D015365 | Enoxacin | Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] | affects metabolic processing|decreases reaction | 15905806 |
| D015365 | Enoxacin | Enoxacin results in decreased activity of CYP1A2 protein | decreases activity | 15905806 |
| D015365 | Enoxacin | Enoxacin binds to CYP1A2 protein | affects binding | 8905919 |
| D015365 | Enoxacin | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 8905919 |
| C091891 | epsilon-viniferin | epsilon-viniferin results in decreased activity of CYP1A2 protein | decreases activity | 12818727 |
| D004958 | Estradiol | Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004958 | Estradiol | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004958 | Estradiol | CYP1A2 protein results in increased hydroxylation of Estradiol | increases hydroxylation | 15961252 |
| D004958 | Estradiol | CYP1A2 protein results in increased metabolism of Estradiol | increases metabolic processing | 16790556 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 19619570 |
| D004958 | Estradiol | Estradiol results in increased expression of CYP1A2 mRNA | increases expression | 19619570 |
| D004958 | Estradiol | Fonofos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004958 | Estradiol | naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004958 | Estradiol | CYP1A2 protein results in increased hydroxylation of Estradiol | increases hydroxylation | 10910964 |
| D004967 | Estrogens | CYP1A2 protein results in increased hydroxylation of Estrogens | increases hydroxylation | 15734958 |
| D004997 | Ethinyl Estradiol | CYP1A2 protein results in increased hydroxylation of Ethinyl Estradiol | increases hydroxylation | 15304426 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein | affects cotreatment|decreases activity | 16198659 |
| D004997 | Ethinyl Estradiol | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | affects cotreatment|decreases activity|decreases metabolic processing | 16198659 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | affects cotreatment|decreases activity | 16291717 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride results in decreased activity of CYP1A2 protein | decreases activity | 15081870 |
| D017308 | Etodolac | Etodolac results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| C422649 | etoricoxib | etoricoxib results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| D005204 | Farnesol | Farnesol results in increased activity of CYP1A2 protein | increases activity | 15840382 |
| C033789 | fenarimol | [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| C033789 | fenarimol | [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| C033789 | fenarimol | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | affects cotreatment|decreases expression | 18253720 |
| C026013 | fenproporex | CYP1A2 protein results in decreased alkylation of fenproporex | decreases alkylation | 15294457 |
| C004999 | ferulic acid | ferulic acid results in decreased activity of CYP1A2 protein | decreases activity | 15841493 |
| C043562 | flavone | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| D005421 | Flavoring Agents | Flavoring Agents results in decreased activity of CYP1A2 protein | decreases activity | 15529323 |
| D015725 | Fluconazole | Fluconazole results in increased expression of CYP1A2 mRNA | increases expression | 16730040 |
| C041509 | fluorene | fluorene results in increased activity of CYP1A2 protein | increases activity | 8001243 |
| D015073 | 2-Acetylaminofluorene | CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene | affects metabolic processing | 2655891 |
| D015073 | 2-Acetylaminofluorene | CYP1A2 protein results in increased activity of 2-Acetylaminofluorene | increases activity | 15450435 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA | increases expression | 16381673 |
| D015073 | 2-Acetylaminofluorene | NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 16381673 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein | decreases expression | 15916741 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in decreased expression of CYP1A2 protein | decreases expression | 15916741 |
| D016666 | Fluvoxamine | CYP1A2 protein binds to and affects the metabolism of Fluvoxamine | affects binding|affects metabolic processing | 15905806 |
| D016666 | Fluvoxamine | Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] | affects metabolic processing|decreases reaction | 15905806 |
| D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | affects metabolic processing|decreases reaction | 15545309 |
| D016666 | Fluvoxamine | Fluvoxamine results in decreased activity of CYP1A2 protein | decreases activity | 18816299 15845683 15545309 11763009 |
| D004397 | Fonofos | Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| D004397 | Fonofos | Fonofos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| D004397 | Fonofos | Fonofos results in decreased activity of CYP1A2 protein | decreases activity | 16790556 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| C050131 | furafylline | furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] | affects reaction|increases metabolic processing | 10215755 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] | decreases reaction|increases metabolic processing | 8558417 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 16049126 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of clopidogrel] | decreases reaction|increases oxidation | 19812348 |
| C050131 | furafylline | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | decreases activity | 16035375 15766918 12814958 16049126 15155557 15860655 12467917 15279827 15333513 15306208 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | decreases activity | 15766918 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | decreases activity | 15766918 |
| C050131 | furafylline | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | decreases activity | 15879494 12814958 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | decreases activity | 15507517 15799453 |
| C038958 | gadolinium chloride | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18202523 |
| C037032 | galangin | galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| C037556 | gamma-valerolactone | gamma-valerolactone results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D019833 | Genistein | CYP1A2 protein results in increased chemical synthesis of Genistein | increases chemical synthesis | 12814970 |
| D019833 | Genistein | CYP1A2 protein results in increased metabolism of Genistein | increases metabolic processing | 12814970 |
| D019833 | Genistein | CYP1A2 protein results in increased hydroxylation of Genistein | increases hydroxylation | 15587933 |
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein | affects cotreatment|decreases activity | 16198659 |
| C033273 | Gestodene | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | affects cotreatment|decreases activity|decreases metabolic processing | 16198659 |
| C033273 | Gestodene | Gestodene inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 results in decreased activity of CYP1A2 protein | decreases activity | 15147983 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 results in increased expression of CYP1A2 mRNA | increases expression | 19034627 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 18421621 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| C477042 | ginkgolide A | ginkgolide A results in increased activity of CYP1A2 protein | increases activity | 18421621 |
| C477042 | ginkgolide A | ginkgolide A results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| C045856 | ginkgolide B | ginkgolide B results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 18421621 |
| C045856 | ginkgolide B | ginkgolide B results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| C023847 | Glu-P-2 | CYP1A2 protein affects the metabolism of Glu-P-2 | affects metabolic processing | 2655891 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [FOS protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [JUND protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [JUN protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D006145 | Guanethidine | Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 16510159 |
| D006202 | Hair Dyes | CYP1A2 protein polymorphism affects the susceptibility to Hair Dyes | affects response to substance | 12663508 |
| D006571 | Heterocyclic Compounds | CYP1A2 protein affects the metabolism of and results in increased activity of Heterocyclic Compounds | affects metabolic processing|increases activity | 12505289 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CYP1A2 mRNA | increases expression | 2856071 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CYP1A2 protein | increases expression | 10696772 2856071 2539049 2845946 9630449 |
| C050426 | huperzine A | CYP1A2 protein results in increased metabolism of huperzine A | increases metabolic processing | 12586202 |
| D006830 | Hydralazine | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D006830 | Hydralazine | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D047348 | Hydrolyzable Tannins | Hydrolyzable Tannins results in decreased activity of CYP1A2 protein | decreases activity | 12749824 |
| D007099 | Imipramine | CYP1A2 protein affects the metabolism of Imipramine | affects metabolic processing | 15286053 |
| D007099 | Imipramine | CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine | decreases methylation|increases activity | 15922009 |
| D007099 | Imipramine | Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine] | decreases methylation|decreases reaction|increases activity | 15922009 |
| C031534 | imperatorin | imperatorin results in increased expression of CYP1A2 protein | increases expression | 18692084 |
| C093582 | indan | indan results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C013352 | indanone | indanone analog results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C027185 | indirubin | indirubin results in increased expression of CYP1A2 mRNA | increases expression | 15056799 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CYP1A2 | increases expression | 9806166 |
| C075954 | indolo(3,2-b)carbazole | indolo(3,2-b)carbazole results in increased expression of CYP1A2 mRNA | increases expression | 12419834 |
| D007213 | Indomethacin | TLR4 protein affects the reaction [Indomethacin results in decreased activity of CYP1A2 protein] | affects reaction|decreases activity | 12927920 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of CYP1A2 mRNA | decreases expression | 16771604 |
| D015056 | 1-Methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| C015304 | isopimpinellin | isopimpinellin results in increased expression of CYP1A2 protein | increases expression | 18692084 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| D007545 | Isoproterenol | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| C016527 | isoquercitrin | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| C015959 | isosafrole | isosafrole results in increased expression of CYP1A2 mRNA | increases expression | 8722114 |
| C015959 | isosafrole | isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | affects metabolic processing|decreases reaction | 12062927 |
| C015959 | isosafrole | isosafrole results in decreased activity of CYP1A2 protein | decreases activity | 12062927 |
| C015959 | isosafrole | isosafrole results in increased expression of CYP1A2 mRNA | increases expression | 11285323 |
| C512910 | isoxanthohumol | isoxanthohumol results in increased expression of CYP1A2 mRNA | increases expression | 15672752 |
| C006552 | kaempferol | kaempferol results in increased expression of CYP1A2 mRNA | increases expression | 19034627 |
| C006552 | kaempferol | kaempferol results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 18421621 |
| C006552 | kaempferol | kaempferol results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP1A2 protein | decreases activity | 15916432 15618748 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP1A2 protein | decreases activity | 12814958 15879494 |
| C099406 | L 742694 | L 742694 affects the expression of CYP1A2 mRNA | affects expression | 15102944 |
| C058687 | lansoprazole | lansoprazole results in increased expression of CYP1A2 mRNA | increases expression | 12623754 |
| D007912 | Lentinan | Lentinan results in decreased expression of CYP1A2 | decreases expression | 15630237 |
| D008012 | Lidocaine | CYP1A2 protein affects the metabolism of Lidocaine | affects metabolic processing | 15447735 |
| D001556 | Lindane | Lindane results in increased activity of CYP1A2 protein | increases activity | 16641539 12842176 |
| D001556 | Lindane | Lindane results in increased expression of CYP1A2 protein | increases expression | 12842176 |
| D008070 | Lipopolysaccharides | Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| D008070 | Lipopolysaccharides | Forskolin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| D008070 | Lipopolysaccharides | Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15710352 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased activity of CYP1A2 protein | decreases activity | 15710352 15542068 |
| D008070 | Lipopolysaccharides | N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15542068 |
| D008070 | Lipopolysaccharides | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| D008070 | Lipopolysaccharides | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| D008294 | Malathion | CYP1A2 protein affects the metabolism of Malathion | affects metabolic processing | 15557345 |
| C501277 | Mangifera indica extract | Mangifera indica extract results in decreased activity of CYP1A2 protein | decreases activity | 18053976 |
| C013592 | mangiferin | mangiferin results in decreased activity of CYP1A2 protein | decreases activity | 18053976 |
| D008463 | Mebendazole | Mebendazole results in increased expression of CYP1A2 protein | increases expression | 12841937 |
| D008463 | Mebendazole | Mebendazole results in increased expression of CYP1A2 protein | increases expression | 12841937 |
| D008468 | Meclizine | Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] | decreases reaction|increases activity|increases expression | 15272053 |
| D008468 | Meclizine | [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA | affects binding|increases activity|increases expression | 15272053 |
| D008528 | Mefenamic Acid | Mefenamic Acid results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| D008550 | Melatonin | CYP1A2 protein affects the metabolism of Melatonin | affects metabolic processing | 15626586 15824912 |
| D008550 | Melatonin | CYP1A2 protein results in decreased methylation of Melatonin | decreases methylation | 15616152 |
| D008550 | Melatonin | CYP1A2 protein results in increased hydroxylation of Melatonin | increases hydroxylation | 15616152 |
| D008550 | Melatonin | CYP1A2 protein results in increased metabolism of Melatonin | increases metabolic processing | 17565714 |
| D008550 | Melatonin | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | decreases reaction|increases hydrolysis | 19919601 |
| D008550 | Melatonin | Melatonin results in decreased activity of CYP1A2 protein | decreases activity | 19919601 |
| D008550 | Melatonin | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| D008558 | Melphalan | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D008558 | Melphalan | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D008694 | Methamphetamine | CYP1A2 protein affects the metabolism of Methamphetamine metabolite | affects metabolic processing | 16038959 |
| D003915 | Dextromethorphan | CYP1A2 protein affects the metabolism of Dextromethorphan | affects metabolic processing | 15199075 |
| D008727 | Methotrexate | Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of CYP1A2 mRNA | decreases expression | 15120968 |
| D008731 | Methoxychlor | CYP1A2 protein results in decreased methylation of Methoxychlor | decreases methylation | 9733665 |
| D008731 | Methoxychlor | CYP1A2 protein results in increased hydroxylation of Methoxychlor | increases hydroxylation | 9047321 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 12919727 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP1A2 protein | decreases activity | 8819299 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP1A2 protein | decreases activity | 12814958 15879494 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | increases activity | 16639589 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | increases expression | 16639589 |
| D008748 | Methylcholanthrene | AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 15155550 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | increases expression | 15155550 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | increases expression | 15155550 |
| D008748 | Methylcholanthrene | [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 15448115 |
| D008748 | Methylcholanthrene | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | affects cotreatment|increases activity|increases reaction | 19022236 |
| D008748 | Methylcholanthrene | Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 19022236 |
| D008748 | Methylcholanthrene | Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 19022236 |
| D008748 | Methylcholanthrene | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | increases activity | 19022236 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | increases expression | 19022236 15769886 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | increases expression | 15769886 |
| D008748 | Methylcholanthrene | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | increases activity | 16639589 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | increases expression | 19525444 11549291 16639589 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | increases expression | 16639589 |
| D008748 | Methylcholanthrene | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | increases activity | 15590115 16639589 15302093 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 15946133 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | increases expression | 15144902 16639589 20226384 11285323 7493548 10772642 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | increases expression | 11285323 16639589 |
| D008748 | Methylcholanthrene | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 15302093 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 | increases expression | 15890479 |
| C051786 | metolachlor | metolachlor results in increased activity of CYP1A2 protein | increases activity | 10813365 |
| D015735 | Mifepristone | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | affects cotreatment|increases activity|increases reaction | 19022236 |
| D015735 | Mifepristone | [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D016685 | Mitomycin | Mitomycin results in decreased activity of CYP1A2 protein | decreases activity | 15696929 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of CYP1A2 mRNA | increases expression | 17481689 |
| C031448 | musk ketone | musk ketone results in increased expression of CYP1A2 mRNA | increases expression | 9441723 |
| C031448 | musk ketone | musk ketone results in increased activity of CYP1A2 protein | increases activity | 10630706 |
| C031448 | musk ketone | musk ketone results in increased expression of CYP1A2 protein | increases expression | 10630706 |
| C031447 | musk xylene | musk xylene metabolite results in increased expression of CYP1A2 mRNA | increases expression | 9397191 |
| C031447 | musk xylene | musk xylene results in increased expression of CYP1A2 mRNA | increases expression | 9397191 |
| C031447 | musk xylene | musk xylene results in increased activity of CYP1A2 protein | increases activity | 10630706 |
| C031447 | musk xylene | musk xylene results in increased expression of CYP1A2 protein | increases expression | 10630706 |
| C104820 | N-(3-(aminomethyl)benzyl)acetamidine | N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 15542068 |
| C507425 | N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine | CYP1A2 protein results in increased hydroxylation of N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine | increases hydroxylation | 16857327 |
| C031721 | naphthalene | naphthalene analog results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C031721 | naphthalene | naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | decreases reaction|increases chemical synthesis | 16790556 |
| C031721 | naphthalene | naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | decreases reaction|increases metabolic processing | 16790556 |
| C031721 | naphthalene | naphthalene results in decreased activity of CYP1A2 protein | decreases activity | 16790556 15916432 |
| D015058 | 1-Naphthylisothiocyanate | [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 15598703 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein | decreases expression | 15598703 |
| D015058 | 1-Naphthylisothiocyanate | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein | affects cotreatment|decreases expression | 15598703 |
| C498045 | NCX 4040 | NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19542225 |
| C498045 | NCX 4040 | NCX 4040 results in decreased activity of CYP1A2 protein | decreases activity | 19542225 |
| C026385 | n-hexane | CYP1A2 protein results in increased hydroxylation of n-hexane | increases hydroxylation | 16484137 |
| D009529 | Nicardipine | Nicardipine results in decreased activity of CYP1A2 protein | decreases activity | 15863898 |
| D009534 | Niclosamide | Niclosamide results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| D009538 | Nicotine | Nicotine results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D009538 | Nicotine | Nicotine results in increased expression of CYP1A2 protein | increases expression | 11849738 |
| D009543 | Nifedipine | Nifedipine results in decreased activity of CYP1A2 protein | decreases activity | 10805063 |
| D015737 | Nisoldipine | Nisoldipine results in decreased activity of CYP1A2 protein | decreases activity | 10805063 |
| C008625 | nitroaniline | nitroaniline analog results in increased activity of CYP1A2 protein | increases activity | 9545601 |
| C008625 | nitroaniline | nitroaniline analog results in increased expression of CYP1A2 mRNA | increases expression | 9545601 |
| C008625 | nitroaniline | nitroaniline analog results in increased expression of CYP1A2 protein | increases expression | 9545601 |
| D009582 | Nitrofurantoin | Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C041150 | N-methyl-7H-dibenzo(c,g)carbazole | CYP1A2 protein affects the metabolism of and results in increased activity of N-methyl-7H-dibenzo(c,g)carbazole | affects metabolic processing|increases activity | 15534862 |
| C062567 | N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | CYP1A2 protein results in increased activity of N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | increases activity | 15725615 |
| C468271 | N-methyl-N-benzylnitrosamine | N-methyl-N-benzylnitrosamine results in decreased activity of CYP1A2 protein | decreases activity | 12222751 |
| C454677 | N,N-diethyl-3-hydroxymethylbenzamide | CYP1A2 protein results in increased chemical synthesis of N,N-diethyl-3-hydroxymethylbenzamide | increases chemical synthesis | 11854147 |
| C058272 | norclozapine | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine | decreases activity|increases abundance | 11151749 |
| C058272 | norclozapine | CYP1A2 protein results in increased metabolism of norclozapine | increases metabolic processing | 12969762 |
| D009643 | Norfloxacin | Norfloxacin binds to CYP1A2 protein | affects binding | 8905919 |
| D009643 | Norfloxacin | Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 8905919 |
| C017576 | norgestimate | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | affects cotreatment|decreases activity | 16291717 |
| C010262 | norharman | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | affects cotreatment|affects metabolic processing | 15279827 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin] | affects metabolic processing|decreases reaction | 11751525 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] | decreases reaction|increases metabolic processing | 11751525 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine results in decreased activity of CYP1A2 protein | decreases activity | 11751525 |
| C064976 | O(6)-benzylguanine | CYP1A2 protein affects the oxidation of O(6)-benzylguanine | affects oxidation | 11751525 |
| C025589 | ochratoxin A | CYP1A2 protein results in increased susceptibility to ochratoxin A | increases response to substance | 11189750 |
| C014138 | octachlorostyrene | octachlorostyrene results in increased activity of CYP1A2 protein | increases activity | 19525444 |
| C014138 | octachlorostyrene | octachlorostyrene results in increased expression of CYP1A2 mRNA | increases expression | 19525444 |
| D019787 | Linoleic Acid | Linoleic Acid results in decreased activity of CYP1A2 protein | decreases activity | 16978661 |
| C076029 | olanzapine | CYP1A2 protein affects the metabolism of olanzapine | affects metabolic processing | 15883149 15545309 |
| C076029 | olanzapine | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | affects metabolic processing|decreases reaction | 15545309 |
| D009828 | Oleanolic Acid | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 15043991 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in decreased activity of CYP1A2 protein | decreases activity | 15043991 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in decreased expression of CYP1A2 mRNA | decreases expression | 18706400 |
| C011521 | olivacine | CYP1A2 protein affects the metabolism of olivacine analog | affects metabolic processing | 14709624 |
| C011521 | olivacine | olivacine analog results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 14709624 |
| C026209 | oltipraz | CYP1A2 protein affects the metabolism of oltipraz | affects metabolic processing | 15920769 15831204 |
| C026209 | oltipraz | oltipraz results in increased activity of CYP1A2 protein | increases activity | 8625305 |
| C026209 | oltipraz | oltipraz results in increased expression of CYP1A2 mRNA | increases expression | 8625305 |
| D009853 | Omeprazole | Omeprazole results in decreased activity of CYP1A2 protein | decreases activity | 16035375 |
| D009853 | Omeprazole | Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 15802389 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 mRNA | increases expression | 12623754 17954527 15681896 15802389 12040753 18332078 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 protein | increases expression | 12841937 |
| D017294 | Ondansetron | CYP1A2 protein affects the metabolism of Ondansetron | affects metabolic processing | 15286053 |
| D009943 | Organophosphorus Compounds | Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine] | decreases methylation|decreases reaction|increases activity | 15922009 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] | decreases ethylation|decreases reaction | 9241656 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] | decreases reaction|increases chemical synthesis | 9241656 |
| D009966 | Orphenadrine | Orphenadrine results in decreased activity of CYP1A2 protein | decreases activity | 9241656 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 18754104 |
| D010126 | Ozone | AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 19536146 |
| D010126 | Ozone | AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 protein] | affects reaction|increases expression | 19536146 |
| D010126 | Ozone | Ozone results in increased expression of CYP1A2 mRNA | increases expression | 19536146 |
| D010126 | Ozone | Ozone results in increased expression of CYP1A2 protein | increases expression | 19536146 |
| D010126 | Ozone | Ozone results in decreased expression of CYP1A2 mRNA | decreases expression | 16183385 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of CYP1A2 mRNA | increases expression | 15585946 |
| D010208 | Papaverine | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D010278 | Parathion | CYP1A2 protein affects the metabolism of Parathion | affects metabolic processing | 17079358 15557345 12669189 |
| C003060 | pentachlorobenzene | pentachlorobenzene results in increased expression of CYP1A2 protein | increases expression | 10696772 |
| D010424 | Pentobarbital | Pentobarbital results in increased expression of CYP1A2 mRNA | increases expression | 10064569 |
| D010431 | Pentoxifylline | Pentoxifylline results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of CYP1A2 mRNA | affects expression | 18281256 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | decreases expression | 16221955 |
| D010480 | Perhexiline | Perhexiline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 15801540 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | increases oxidation | 17097115 |
| D010615 | Phenacetin | 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | decreases ethylation|decreases reaction | 11465391 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 3577206 15801540 11751525 |
| D010615 | Phenacetin | CYP1A2 protein results in decreased ethylation of Phenacetin | decreases ethylation | 11303964 14725854 12433797 15618748 14563787 |
| D010615 | Phenacetin | CYP1A2 protein results in increased metabolism of Phenacetin | increases metabolic processing | 17267297 16124035 15043991 17702393 16049126 15370959 12401345 15155557 17418993 12467917 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | increases oxidation | 10985777 11284709 18032064 9195021 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin analog | increases oxidation | 11284709 |
| D010615 | Phenacetin | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 16049126 |
| D010615 | Phenacetin | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin] | affects metabolic processing|decreases reaction | 11751525 |
| D010615 | Phenacetin | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 15043991 |
| D010615 | Phenacetin | Phenacetin results in increased activity of CYP1A2 protein | increases activity | 15802386 |
| D010615 | Phenacetin | zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 14570767 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | increases oxidation | 9195021 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 15766918 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 15766918 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 15742976 |
| D010615 | Phenacetin | Phenacetin results in increased expression of CYP1A2 protein | increases expression | 15742976 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | affects metabolic processing | 15801540 15879494 15231049 |
| D010615 | Phenacetin | CYP1A2 protein results in decreased ethylation of Phenacetin | decreases ethylation | 12064368 11911841 |
| D010615 | Phenacetin | CYP1A2 protein results in increased metabolism of Phenacetin | increases metabolic processing | 17651725 8905919 12222751 |
| D010615 | Phenacetin | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 8905919 |
| D010615 | Phenacetin | Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 8905919 |
| C031181 | phenanthrene | phenanthrene results in increased activity of CYP1A2 protein | increases activity | 8001243 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | increases expression | 15672752 |
| D010634 | Phenobarbital | Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] | decreases reaction|increases activity|increases expression | 15272053 |
| D010634 | Phenobarbital | [Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA | increases activity|increases expression | 15272053 |
| D010634 | Phenobarbital | MED1 protein promotes the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16109766 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of CYP1A2 protein | increases activity | 10064569 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 mRNA | increases expression | 16109766 10064569 9397191 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 protein | increases expression | 18692084 10064569 |
| D010634 | Phenobarbital | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 18798224 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of CYP1A2 mRNA | decreases expression | 15596064 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 mRNA | increases expression | 20226384 |
| D019800 | Phenol | CYP1A2 protein affects the susceptibility to Phenol | affects response to substance | 8242868 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| D010713 | Phosphatidylcholines | Phosphatidylcholines affects the activity of CYP1A2 protein | affects activity | 15966743 |
| C483858 | phosphatidylethanolamine | phosphatidylethanolamine results in increased stability of and results in increased activity of CYP1A2 protein | increases activity|increases stability | 15966743 |
| C121565 | pifithrin | pifithrin results in decreased activity of CYP1A2 protein | decreases activity | 16258175 |
| C121565 | pifithrin | pifithrin results in increased expression of CYP1A2 mRNA | increases expression | 16258175 |
| C121565 | pifithrin | pifithrin results in increased expression of CYP1A2 protein | increases expression | 16258175 |
| C041648 | pimobendan | CYP1A2 protein results in decreased methylation of pimobendan | decreases methylation | 10611143 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | increases expression | 8722114 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | increases expression | 18544911 |
| D010882 | Piperonyl Butoxide | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 18544911 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP1A2 mRNA | affects binding|increases activity|increases expression | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CYP1A2 mRNA | decreases expression | 18467677 20059764 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP1A2 mRNA] | decreases expression|increases reaction | 20059764 18467677 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 11064004 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of CYP1A2 protein | increases activity | 15025748 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CYP1A2 mRNA | increases expression | 15629189 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CYP1A2 mRNA | decreases expression | 18158835 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP1A2 protein | decreases activity | 15831081 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 15598702 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 15807986 |
| D011078 | Polychlorinated Biphenyls | [Polychlorinated Biphenyls co-treated with chlorinated dibenzofurans] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17051818 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased activity of CYP1A2 protein | increases activity | 15743714 |
| C008954 | polychlorodibenzo-4-dioxin | [polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 17850846 |
| C008954 | polychlorodibenzo-4-dioxin | polychlorodibenzo-4-dioxin results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| C008954 | polychlorodibenzo-4-dioxin | polychlorodibenzo-4-dioxin results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of CYP1A2 protein | increases expression | 15824912 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased activity of CYP1A2 protein | increases activity | 7750161 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of CYP1A2 mRNA | increases expression | 7750161 |
| C025299 | polyphenols | polyphenols results in decreased expression of CYP1A2 mRNA | decreases expression | 19370779 |
| C025299 | polyphenols | polyphenols results in decreased expression of CYP1A2 protein | decreases expression | 19370779 |
| C025299 | polyphenols | polyphenols results in decreased activity of CYP1A2 protein | decreases activity | 15831081 |
| D011134 | Polysaccharides | Polysaccharides results in decreased activity of CYP1A2 protein | decreases activity | 17827724 |
| D011223 | Praziquantel | CYP1A2 protein affects the metabolism of Praziquantel | affects metabolic processing | 12920490 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 16510159 |
| D011224 | Prazosin | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D011224 | Prazosin | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 16510159 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA | decreases expression | 15596064 |
| D011319 | Primaquine | CYP1A2 protein affects the metabolism of Primaquine | affects metabolic processing | 12920490 |
| D011319 | Primaquine | Primaquine results in increased expression of CYP1A2 mRNA | increases expression | 12451431 17954527 12623754 |
| D011335 | Proadifen | Proadifen results in decreased activity of CYP1A2 protein | decreases activity | 15618748 |
| C011088 | propachlor | propachlor results in increased activity of CYP1A2 protein | increases activity | 10813365 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | increases expression | 19409404 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | increases expression | 19010342 16730040 |
| C045950 | propiconazole | propiconazole results in increased activity of CYP1A2 protein | increases activity | 3190755 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | increases expression | 15603923 16643972 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| D011433 | Propranolol | CYP1A2 protein affects the metabolism of Propranolol | affects metabolic processing | 15286053 |
| D011433 | Propranolol | Propranolol results in increased expression of CYP1A2 protein | increases expression | 15618653 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | decreases activity|decreases reaction | 15710352 |
| C009091 | protocatechuic acid | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 15302093 |
| C107773 | pterostilbene | pterostilbene results in decreased activity of CYP1A2 protein | decreases activity | 16684708 |
| C030984 | pyrene | CYP1A2 protein results in increased hydroxylation of pyrene | increases hydroxylation | 15016593 |
| C023666 | pyridine | pyridine results in increased activity of CYP1A2 protein | increases activity | 1857340 10463385 10413312 |
| C023666 | pyridine | pyridine results in increased expression of CYP1A2 mRNA | increases expression | 10463385 7493548 1857340 |
| C023666 | pyridine | pyridine results in increased expression of CYP1A2 protein | increases expression | 10413312 1857340 10463385 |
| C021079 | pyridoxal isonicotinoyl hydrazone | [pyridoxal isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| C021079 | pyridoxal isonicotinoyl hydrazone | [pyridoxal isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| C021079 | pyridoxal isonicotinoyl hydrazone | pyridoxal isonicotinoyl hydrazone results in decreased activity of CYP1A2 protein | decreases activity | 15588138 |
| D011794 | Quercetin | Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | decreases reaction|increases oxidation | 16544949 |
| D011794 | Quercetin | Quercetin promotes the reaction [JUND protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D011794 | Quercetin | Quercetin promotes the reaction [JUN protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D011794 | Quercetin | Quercetin results in decreased activity of CYP1A2 protein | decreases activity | 12949046 15916432 |
| D011794 | Quercetin | Quercetin results in increased expression of CYP1A2 mRNA | increases expression | 19034627 |
| D011794 | Quercetin | Quercetin results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 18421621 |
| D011794 | Quercetin | Quercetin results in increased expression of CYP1A2 mRNA | increases expression | 18421621 |
| D011802 | Quinidine | Quinidine results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D011803 | Quinine | Quinine results in increased expression of CYP1A2 mRNA | increases expression | 12451431 |
| C037219 | quinoline | quinoline analog results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C063129 | rabeprazole | rabeprazole results in increased expression of CYP1A2 mRNA | increases expression | 12623754 |
| C495910 | ramelteon | CYP1A2 protein results in increased metabolism of ramelteon | increases metabolic processing | 17069551 |
| D017382 | Reactive Oxygen Species | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | affects cotreatment|increases abundance|increases expression | 20118626 |
| D012110 | Reserpine | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | increases activity|increases expression|increases reaction | 16510159 |
| D012110 | Reserpine | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16510159 |
| D012110 | Reserpine | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | decreases abundance|increases activity|increases expression|increases reaction | 16510159 |
| D012110 | Reserpine | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | decreases abundance|increases expression|increases reaction | 16510159 |
| C059514 | resveratrol | CYP1A2 protein affects the metabolism of resveratrol | affects metabolic processing | 15276085 |
| C059514 | resveratrol | resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17959153 |
| C059514 | resveratrol | resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | decreases reaction|increases oxidation | 16544949 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19376845 |
| C059514 | resveratrol | resveratrol analog results in decreased activity of CYP1A2 protein | decreases activity | 16684708 |
| D012293 | Rifampin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP1A2 mRNA | increases expression | 15977188 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP1A2 protein | increases expression | 17590308 15977188 |
| D012293 | Rifampin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CYP1A2 mRNA | increases expression | 11918509 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| C028632 | rutecarpine | rutecarpine analog binds to and results in decreased activity of CYP1A2 protein | affects binding|decreases activity | 12852960 |
| C028632 | rutecarpine | rutecarpine binds to and results in decreased activity of CYP1A2 protein | affects binding|decreases activity | 12852960 |
| C028632 | rutecarpine | rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | affects metabolic processing|increases reaction | 15720787 |
| C028632 | rutecarpine | rutecarpine results in increased activity of CYP1A2 protein | increases activity | 15720787 |
| D012451 | Safrole | Safrole results in decreased activity of CYP1A2 protein | decreases activity | 15778010 |
| D012451 | Safrole | Safrole results in increased expression of CYP1A2 mRNA | increases expression | 8722114 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | [salicylaldehyde isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | [salicylaldehyde isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 15588138 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | salicylaldehyde isonicotinoyl hydrazone results in decreased activity of CYP1A2 protein | decreases activity | 15588138 |
| C031060 | salicylamide | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 14729655 |
| D012631 | Secobarbital | Secobarbital results in increased expression of CYP1A2 mRNA | increases expression | 10064569 |
| D012642 | Selegiline | CYP1A2 protein affects the metabolism of Selegiline | affects metabolic processing | 16198659 |
| C100180 | sesamex | sesamex results in increased expression of CYP1A2 mRNA | increases expression | 8722114 |
| C120148 | SIB 1893 | SIB 1893 results in decreased activity of CYP1A2 protein | decreases activity | 15193955 |
| D012839 | Simazine | Simazine results in increased activity of CYP1A2 protein | increases activity | 9711812 |
| D012839 | Simazine | Simazine results in increased expression of CYP1A2 protein | increases expression | 9711812 |
| D012906 | Smoke | Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine] | affects metabolic processing|affects reaction | 16044115 |
| D012906 | Smoke | Smoke promotes the reaction [CYP1A2 protein results in increased metabolism of Clozapine] | increases metabolic processing|increases reaction | 16044115 |
| D012906 | Smoke | Smoke results in increased activity of CYP1A2 protein | increases activity | 16044115 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 20188822 |
| C017947 | sodium arsenite | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity | 20188822 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CYP1A2 mRNA | decreases expression | 17451858 |
| C539817 | S-sulindac | S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| C539817 | S-sulindac | S-sulindac inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| C539817 | S-sulindac | S-sulindac results in decreased activity of CYP1A2 protein | decreases activity | 19276279 |
| C021092 | stiripentol | stiripentol results in decreased activity of CYP1A2 protein | decreases activity | 16022579 |
| D013311 | Streptozocin | Streptozocin results in decreased expression of CYP1A2 protein | decreases expression | 12700423 |
| D013311 | Streptozocin | Streptozocin results in increased expression of CYP1A2 protein | increases expression | 17442507 |
| D013311 | Streptozocin | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | increases expression|increases metabolic processing | 17442507 |
| D020058 | Styrene | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | decreases reaction|increases expression | 18202523 |
| D020058 | Styrene | Styrene results in increased expression of CYP1A2 mRNA | increases expression | 18202523 16418063 |
| D020058 | Styrene | Styrene results in increased expression of CYP1A2 protein | increases expression | 16418063 18202523 |
| C033006 | sudan III | sudan III results in increased expression of CYP1A2 protein | increases expression | 20308224 |
| D013426 | Sulfaphenazole | Sulfaphenazole results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| C016766 | sulforafan | sulforafan results in increased expression of CYP1A2 protein | increases expression | 15906351 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in decreased activity of CYP1A2 protein | decreases activity | 16023800 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in decreased expression of CYP1A2 mRNA | decreases expression | 16023800 |
| D013467 | Sulindac | Sulindac results in increased expression of CYP1A2 mRNA | increases expression | 17985343 |
| D013467 | Sulindac | Sulindac results in increased expression of CYP1A2 mRNA | increases expression | 16531450 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of CYP1A2 mRNA | increases expression | 17985343 |
| D013498 | Suramin | Suramin results in decreased activity of CYP1A2 protein | decreases activity | 11124226 |
| C446685 | systhane | systhane results in increased expression of CYP1A2 mRNA | increases expression | 19409404 |
| D013619 | Tacrine | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013619 | Tacrine | CYP1A2 protein affects the metabolism of Tacrine | affects metabolic processing | 15258105 |
| D013619 | Tacrine | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013619 | Tacrine | Tacrine results in decreased activity of CYP1A2 protein | decreases activity | 15258105 |
| C508967 | tamarixetin | tamarixetin results in increased expression of CYP1A2 mRNA | increases expression | 19034627 |
| D013629 | Tamoxifen | CYP1A2 protein results in increased hydroxylation of Tamoxifen | increases hydroxylation | 15587933 |
| C059006 | tangeretin | tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| D013662 | Tea | Tea results in decreased expression of CYP1A2 mRNA | decreases expression | 19370779 |
| D013662 | Tea | Tea results in decreased expression of CYP1A2 protein | decreases expression | 19370779 |
| C105050 | tegaserod | tegaserod results in decreased activity of CYP1A2 protein | decreases activity | 11560869 |
| C010347 | terbutryne | CYP1A2 protein results in increased metabolism of terbutryne | increases metabolic processing | 8971136 |
| C010347 | terbutryne | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] | increases metabolic processing|increases reaction | 8971136 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | increases expression | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | increases expression | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| D013749 | Tetrachlorodibenzodioxin | 2,3,3',4,4',5-hexachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,3,3',4,4'-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 17183067 |
| D013749 | Tetrachlorodibenzodioxin | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17183067 |
| D013749 | Tetrachlorodibenzodioxin | 4-nitroquinolone-1-oxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17959153 |
| D013749 | Tetrachlorodibenzodioxin | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 12927368 |
| D013749 | Tetrachlorodibenzodioxin | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 16636061 |
| D013749 | Tetrachlorodibenzodioxin | Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 19022236 |
| D013749 | Tetrachlorodibenzodioxin | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | affects cotreatment|increases expression | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 19022236 |
| D013749 | Tetrachlorodibenzodioxin | NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19542225 |
| D013749 | Tetrachlorodibenzodioxin | Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Perhexiline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Plant Extracts inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 11064004 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19376845 |
| D013749 | Tetrachlorodibenzodioxin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 14729655 |
| D013749 | Tetrachlorodibenzodioxin | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 20188822 |
| D013749 | Tetrachlorodibenzodioxin | S-sulindac inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 19276279 |
| D013749 | Tetrachlorodibenzodioxin | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA | affects binding|increases activity|increases expression | 14729655 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 17785579 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | increases activity | 20188822 17183067 16426572 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 14709624 16426572 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | increases expression | 11064004 11368318 17785579 19276279 16985168 16697128 15056799 16426572 12451431 14729655 16258175 19619570 16527260 17183067 20106945 19542225 17959153 12927368 19022236 19376845 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | increases expression | 16426572 16258175 |
| D013749 | Tetrachlorodibenzodioxin | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity | 20188822 |
| D013749 | Tetrachlorodibenzodioxin | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 12927368 |
| D013749 | Tetrachlorodibenzodioxin | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | affects reaction|increases expression | 16214954 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the abundance of and affects the susceptibility to Tetrachlorodibenzodioxin | affects abundance|affects response to substance | 15003330 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | affects abundance | 10448125 19695277 9240455 |
| D013749 | Tetrachlorodibenzodioxin | [CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin] inhibits the reaction [CYP1A1 protein results in increased metabolism of Tetrachlorodibenzodioxin] | affects abundance|decreases reaction|increases metabolic processing | 19695277 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 16636061 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Butyrates results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 15252868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 15252868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | increases activity | 10986007 16636061 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | increases expression | 15722456 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | increases expression | 18372398 16214954 20007409 16636061 18295293 18163543 18434241 17997381 18796159 15902423 16929009 17949056 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | increases expression | 17997381 9875294 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | increases expression | 15993909 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | increases expression | 15664428 |
| D013749 | Tetrachlorodibenzodioxin | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | 2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Acetaminophen inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein binds to and affects the abundance of Tetrachlorodibenzodioxin | affects abundance|affects binding | 16966094 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Drugs, Chinese Herbal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 16901605 |
| D013749 | Tetrachlorodibenzodioxin | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Levodopa inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | affects cotreatment|increases activity | 17342195 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | affects metabolic processing|increases reaction | 12062927 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | decreases activity | 15659567 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | increases activity | 12062927 2315923 16835633 18493746 16781091 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | increases activity|increases expression | 11585058 9707506 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | increases expression | 18796159 19497421 17690134 18178546 17656490 16054898 18465118 10910964 16901605 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | increases expression | 16966094 9144388 12606150 2315923 12361703 |
| D013749 | Tetrachlorodibenzodioxin | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which binds to CYP1A2 enhancer | affects binding | 9169078 |
| D013750 | Tetrachloroethylene | CYP1A2 protein results in increased metabolism of Tetrachloroethylene | increases metabolic processing | 11684365 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [JUND protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [JUN protein binds to CYP1A2 enhancer] | affects binding|increases reaction | 10620351 |
| D013805 | Theobromine | CYP1A2 protein results in increased metabolism of Theobromine | increases metabolic processing | 10215755 |
| D013805 | Theobromine | furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] | affects reaction|increases metabolic processing | 10215755 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | affects metabolic processing | 15692829 15948934 15970798 |
| D013806 | Theophylline | CYP1A2 protein results in increased metabolism of Theophylline | increases metabolic processing | 9701106 |
| D013806 | Theophylline | Theophylline results in decreased activity of CYP1A2 protein | decreases activity | 11465391 |
| D013806 | Theophylline | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | decreases reaction|increases metabolic processing | 9701106 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | affects metabolic processing | 15970798 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | affects metabolic processing | 15720787 15985363 |
| D013806 | Theophylline | rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | affects metabolic processing|increases reaction | 15720787 |
| D013827 | Thiabendazole | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | affects metabolic processing|increases reaction | 10936227 |
| D013827 | Thiabendazole | CYP1A2 protein affects the metabolism of Thiabendazole | affects metabolic processing | 10936227 12920490 |
| D013827 | Thiabendazole | Thiabendazole results in decreased activity of CYP1A2 protein | decreases activity | 11124226 16261361 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 mRNA | increases expression | 18570159 |
| D013827 | Thiabendazole | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | affects metabolic processing|increases reaction | 10936227 |
| D013827 | Thiabendazole | CYP1A2 protein affects the metabolism of Thiabendazole | affects metabolic processing | 10936227 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 mRNA | increases expression | 18539377 15110098 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 protein | increases expression | 15110098 |
| D013875 | Thiophanate | Thiophanate results in increased expression of CYP1A2 protein | increases expression | 10096430 |
| D013881 | Thioridazine | CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine | increases activity|increases metabolic processing | 19482014 |
| D013988 | Ticlopidine | Ticlopidine results in decreased activity of CYP1A2 protein | decreases activity | 10759690 |
| C055421 | tin mesoporphyrin | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | decreases reaction|increases activity | 20188822 |
| C023754 | tizanidine | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | affects metabolic processing|decreases reaction | 15592331 |
| C023754 | tizanidine | CYP1A2 protein affects the metabolism of tizanidine | affects metabolic processing | 15592331 16198659 |
| C023754 | tizanidine | CYP1A2 protein results in increased metabolism of tizanidine | increases metabolic processing | 17618427 |
| C023754 | tizanidine | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | affects cotreatment|decreases activity|decreases metabolic processing | 16198659 |
| C024746 | tobacco tar | tobacco tar results in increased activity of CYP1A2 protein | increases activity | 17089110 |
| C066340 | tolcapone | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C066340 | tolcapone | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| C009500 | tolfenamic acid | ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein] | decreases activity|decreases reaction | 17618427 |
| C009500 | tolfenamic acid | tolfenamic acid results in decreased activity of CYP1A2 protein | decreases activity | 18816299 17618427 |
| D014050 | Toluene | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | increases expression|increases reaction | 8996725 |
| D014050 | Toluene | Toluene results in increased expression of CYP1A2 protein | increases expression | 8996725 |
| C507866 | trans-1,2-dihydro-1,2-naphthalenediol | CYP1A2 protein results in increased abundance of trans-1,2-dihydro-1,2-naphthalenediol | increases abundance | 16243959 |
| D014191 | Tranylcypromine | Tranylcypromine results in decreased activity of CYP1A2 protein | decreases activity | 15916432 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CYP1A2 mRNA | decreases expression | 16882163 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CYP1A2 mRNA | increases expression | 16985168 |
| D014223 | Triamterene | CYP1A2 protein results in increased hydroxylation of Triamterene | increases hydroxylation | 16035375 |
| D014227 | Triazines | alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| D014227 | Triazines | CYP1A2 protein results in increased metabolism of Triazines | increases metabolic processing | 9305587 |
| D014227 | Triazines | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| D014227 | Triazines | Gestodene inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| D014227 | Triazines | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | decreases reaction|increases metabolic processing | 9305587 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | affects cotreatment|increases metabolic processing | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | affects cotreatment|increases metabolic processing | 8961944 |
| C012589 | trichostatin A | trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 12927368 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CYP1A2 mRNA | increases expression | 12927368 |
| C012589 | trichostatin A | Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] | decreases reaction|increases expression | 15252868 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CYP1A2 mRNA | increases expression | 15252868 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of CYP1A2 mRNA | increases expression | 17481689 |
| D014315 | Triterpenes | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 18544911 |
| C019133 | Trp-P-2 | CYP1A2 protein affects the metabolism of Trp-P-2 | affects metabolic processing | 2655891 |
| D014577 | Uroporphyrinogens | CYP1A2 protein affects the metabolism of Uroporphyrinogens | affects metabolic processing | 9224771 |
| D014577 | Uroporphyrinogens | CYP1A2 protein affects the metabolism of Uroporphyrinogens | affects metabolic processing | 9972481 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| C025643 | vinclozolin | [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| C025643 | vinclozolin | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | affects cotreatment|affects expression | 17686559 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CYP1A2 protein | increases expression | 7986207 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of CYP1A2 protein | decreases expression | 10547960 |
| D024483 | Vitamin K 3 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D024483 | Vitamin K 3 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | decreases reaction|increases activity | 18493746 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased activity of CYP1A2 protein | increases activity | 15603920 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of CYP1A2 mRNA | increases expression | 15603920 |
| D014859 | Warfarin | CYP1A2 protein affects the metabolism of Warfarin | affects metabolic processing | 15280511 14676821 |
| C062735 | zafirlukast | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | decreases reaction|increases metabolic processing | 9701106 |
| C063449 | zileuton | zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | decreases reaction|increases metabolic processing | 14570767 |
| C063449 | zileuton | zileuton results in decreased activity of CYP1A2 protein | decreases activity | 14570767 |
| C089750 | zolmitriptan | zolmitriptan results in decreased activity of CYP1A2 protein | decreases activity | 18816299 |
| D015049 | Zoxazolamine | CYP1A2 protein results in increased metabolism of and results in decreased activity of Zoxazolamine | decreases activity|increases metabolic processing | 16109766 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 7.58 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 7.58 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 1,2-dichloroethylene | 13.14 | 8449394 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 2-amino-4,6-dinitrotoluene | 13.14 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 13.14 | 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 13.14 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 13.14 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 13.14 | 14514962 11752688 15322242 | |
| MESH:D000022 | Abortion, Spontaneous | bromodichloromethane | 5.24 | 14691210 12970577 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.66 | 15043669 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 11.16 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | norgestimate | 11.16 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 11.16 | 20436887 | |
| MESH:D054058 | Acute Coronary Syndrome | clopidogrel | 4.38 | 19106084 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 8.50 | 17670903 15814532 12690470 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 8.50 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 8.50 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 8.50 | 7897758 | |
| MESH:D055371 | Acute Lung Injury | 3-xylene | 9.53 | 15204773 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 9.53 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 9.53 | 18653653 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 9.53 | 17118201 | |
| MESH:D000230 | Adenocarcinoma | 9,10-Dimethyl-1,2-benzanthracene | 14.22 | 12844480 10697514 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 14.22 | 20464547 20127859 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 14.22 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 14.22 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 14.22 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 14.22 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 14.22 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 14.22 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 14.22 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 14.22 | 11910360 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 31.78 | 10737359 | |
| MESH:D000236 | Adenoma | 4-dichlorobenzene | 31.78 | 12748734 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 31.78 | 16176798 | |
| MESH:D000236 | Adenoma | 9,10-Dimethyl-1,2-benzanthracene | 31.78 | 11376689 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 31.78 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 31.78 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 31.78 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 31.78 | 19555203 | |
| MESH:D000236 | Adenoma | Indomethacin | 31.78 | 11497255 | |
| MESH:D000236 | Adenoma | Melatonin | 31.78 | 17195641 | |
| MESH:D000236 | Adenoma | Methylcholanthrene | 31.78 | 10545420 6695378 | |
| MESH:D000236 | Adenoma | resveratrol | 31.78 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 31.78 | 10223192 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.35 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | 2-aminofluorene | 25.18 | 19052882 | |
| MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 25.18 | 16628245 | |
| MESH:D018248 | Adenoma, Liver Cell | dicyclanil | 25.18 | 17162532 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 25.18 | 19061943 17162532 17620307 16434500 19052882 18056438 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 25.18 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 25.18 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 25.18 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 7.99 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 7.99 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 7.99 | 11874996 15623613 11535846 16460482 12394442 19003578 17611924 | |
| MESH:D000303 | Adrenal Cortex Diseases | Catecholamines | 5.66 | 6895166 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.05 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.25 | 17306315 16712894 | |
| MESH:D000380 | Agranulocytosis | Clozapine | 3.46 | 12649775 14617031 16160616 | |
| MESH:D000382 | Agricultural Workers' Diseases | 2,4-Dichlorophenoxyacetic Acid | 26.50 | 16132792 | |
| MESH:D000382 | Agricultural Workers' Diseases | alachlor | 26.50 | 11874814 14769641 | |
| MESH:D000382 | Agricultural Workers' Diseases | Atrazine | 26.50 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Chlorpyrifos | 26.50 | 16611668 11874814 17119214 | |
| MESH:D000382 | Agricultural Workers' Diseases | Diazinon | 26.50 | 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Fonofos | 26.50 | 16611668 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 26.50 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Malathion | 26.50 | 17119214 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Parathion | 26.50 | 11874814 17119214 | |
| MESH:D000382 | Agricultural Workers' Diseases | Simazine | 26.50 | 12661182 | |
| MESH:D017109 | Akathisia, Drug-Induced | tolcapone | 4.64 | 11080934 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 2.98 | 21441931 | |
| MESH:D000437 | Alcoholism | Ondansetron | 4.84 | 19032576 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.44 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | Etodolac | 6.26 | 16979129 | |
| OMIM:607154 | ALLERGIC RHINITIS | zafirlukast | 6.26 | 16527031 | |
| MESH:D000505 | Alopecia | Tretinoin | 2.23 | 15955085 | |
| MESH:D016301 | Alveolar Bone Loss | etoricoxib | 9.34 | 17225004 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 9.34 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 12.89 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | huperzine A | 12.89 | 12586202 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 12.89 | 17627676 15579461 | |
| MESH:D000544 | Alzheimer Disease | Nicotine | 12.89 | 16627626 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 12.89 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 12.89 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 12.89 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 12.89 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Tacrine | 12.89 | 12725862 | |
| MESH:D000544 | Alzheimer Disease | tolcapone | 12.89 | 20150427 | |
| MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 4.42 | 18475255 16916582 16459022 15010207 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 2.92 | 15469931 | |
| MESH:D000707 | Anaphylaxis | Mangifera indica extract | 7.15 | 14669257 16536907 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 7.15 | 16536907 14669257 | |
| MESH:D000740 | Anemia | 4-nitroaniline | 9.37 | 3710033 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 9.37 | 17963324 15504547 | |
| MESH:D000740 | Anemia | Phenacetin | 9.37 | 2444515 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 9.37 | 11748828 | |
| MESH:D000743 | Anemia, Hemolytic | Phenacetin | 5.62 | 1949026 17698508 17082564 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 5.62 | 17084956 | |
| MESH:D000755 | Anemia, Sickle Cell | Aspartame | 4.49 | 11372003 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.79 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.21 | 10982225 | |
| MESH:D000855 | Anorexia | Amphetamine | 3.55 | 12183048 16084549 16101753 12005258 | |
| MESH:D000881 | Anthrax | Ciprofloxacin | 5.06 | 20385868 | |
| MESH:D016736 | Antiphospholipid Syndrome | Ciprofloxacin | 5.06 | 9485080 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.31 | 15043669 | |
| MESH:D001005 | Anus Neoplasms | Dacarbazine | 4.65 | 12170190 | |
| MESH:D001008 | Anxiety Disorders | Pentobarbital | 4.61 | 11141031 18313124 | |
| MESH:D001008 | Anxiety Disorders | vinclozolin | 4.61 | 19015723 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.28 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 6.42 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 6.42 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Lidocaine | 6.92 | 513065 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 6.92 | 17460149 | |
| MESH:D001145 | Arrhythmias, Cardiac | Quinidine | 6.92 | 18724381 18057881 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 8.15 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 8.15 | 11256880 | |
| MESH:D001161 | Arteriosclerosis | Reserpine | 8.15 | 10729376 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.52 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 12.57 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 12.57 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 12.57 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 12.57 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | rofecoxib | 12.57 | 16690336 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 12.57 | 16412693 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.12 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Aspartame | 7.22 | 10777254 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 7.22 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 7.22 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 7.22 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 7.22 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 7.22 | 16292516 | |
| MESH:D001249 | Asthma | Ozone | 5.52 | 17854713 16373670 | |
| MESH:D001249 | Asthma | Theophylline | 5.52 | 12113382 9701106 | |
| MESH:D001249 | Asthma | Tretinoin | 5.52 | 16456186 | |
| MESH:D001249 | Asthma | zafirlukast | 5.52 | 14609035 9196086 8087328 10386485 9620945 9377612 10929920 9825082 11596838 15136378 11570617 11393122 19667530 12095178 10064661 12604023 9412547 11991558 10780761 11885876 9620946 19681236 10852428 15572850 12189465 1673495 12742009 12583521 9949315 9027267 11070746 12113382 9847434 9690572 10027429 11061985 8222486 10967152 20332717 12114351 10359889 10817796 8162986 10934090 15170009 11694805 10439636 9701106 18489783 | |
| MESH:D001249 | Asthma | zileuton | 5.52 | 10764316 17944539 20332717 19214143 10181070 8598621 9620945 | |
| MESH:D055963 | Asthma, Aspirin-Induced | zafirlukast | 3.90 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | zafirlukast | 6.83 | 19667531 8389103 11953129 10984370 1554195 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 6.83 | 10984370 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.35 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 7.77 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Mangifera indica extract | 7.77 | 18450471 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 7.77 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Methylcholanthrene | 7.77 | 11922910 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 7.77 | 16873680 17967414 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Dextromethorphan | 4.10 | 17175572 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 3.00 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 3.00 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Choline | 3.00 | 16818868 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 3.00 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Fluvoxamine | 3.00 | 12607287 19232924 18775368 | |
| MESH:D001321 | Autistic Disorder | Linoleic Acid | 3.00 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 3.00 | 16919138 16897403 | |
| MESH:D001321 | Autistic Disorder | olanzapine | 3.00 | 18685284 17069543 | |
| MESH:D001321 | Autistic Disorder | Propranolol | 3.00 | 18766980 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 9.13 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 9.13 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 9.13 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Ciprofloxacin | 4.28 | 11505790 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 2.82 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.38 | 10684365 | |
| MESH:D001480 | Basal Ganglia Diseases | Organophosphorus Compounds | 4.99 | 16804273 | |
| MESH:D001649 | Bile Duct Diseases | bromodichloromethane | 5.58 | 8717228 | |
| MESH:D001714 | Bipolar Disorder | Carbamazepine | 3.07 | 20046352 17594078 | |
| MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 13.15 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Omeprazole | 13.15 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 13.15 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 13.15 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 13.15 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.16 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.52 | 15746008 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 4.72 | 19356626 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 6.63 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 6.63 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 5.83 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | Phenol | 5.83 | 10556009 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 5.26 | 9881647 | |
| MESH:D001862 | Bone Resorption | mangiferin | 5.26 | 9881647 | |
| MESH:D001913 | Bowen's Disease | Phenol | 7.52 | 19293009 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 7.52 | 11207687 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 8.67 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 8.67 | 15306635 | |
| MESH:D001919 | Bradycardia | Propranolol | 8.67 | 6740701 | |
| MESH:D001929 | Brain Edema | Indomethacin | 7.44 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 7.44 | 19309543 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 11.29 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 11.29 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 11.29 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 11.29 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 4.13 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 4.13 | 17150277 | |
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 39.61 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 39.61 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | 2-hydroxyestradiol | 39.61 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | 4-biphenylamine | 39.61 | 17671175 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 39.61 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 39.61 | 18840765 17127718 20435547 15565634 16153821 | |
| MESH:D001943 | Breast Neoplasms | anthracene | 39.61 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Anthracyclines | 39.61 | 19115204 15597849 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 39.61 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bexarotene | 39.61 | 16818667 16344269 | |
| MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 39.61 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 39.61 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 39.61 | 19250217 18462866 18593918 16243823 | |
| MESH:D001943 | Breast Neoplasms | Dacarbazine | 39.61 | 17983394 | |
| MESH:D001943 | Breast Neoplasms | Dieldrin | 39.61 | 11859874 15770527 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 39.61 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 39.61 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 39.61 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 39.61 | 15136595 15634643 15994142 17983394 16826403 16935488 15939500 16595493 18382427 15692762 18695136 17369602 18628466 18234424 16096432 16322301 16264153 17426702 16115903 15668708 19526202 15567936 11325840 15993339 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 39.61 | 19861407 14630087 17018787 17261762 18497071 16675129 12948864 17289903 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 39.61 | 16541309 16873071 17200150 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 39.61 | 12709520 15061365 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 39.61 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 39.61 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 39.61 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 39.61 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Malathion | 39.61 | 12762645 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 39.61 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 39.61 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | ochratoxin A | 39.61 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 39.61 | 18323546 18223236 16244791 18234424 15136595 11325840 16273361 16115903 | |
| MESH:D001943 | Breast Neoplasms | Parathion | 39.61 | 12762645 | |
| MESH:D001943 | Breast Neoplasms | Plant Preparations | 39.61 | 17398067 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 39.61 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Reserpine | 39.61 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 39.61 | 17534123 17651959 16393696 | |
| MESH:D001943 | Breast Neoplasms | Styrene | 39.61 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 39.61 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 39.61 | 19487384 19142967 15668708 19115204 21138602 19155303 17049068 19189210 19011961 15565566 17440819 16202921 19410462 19084267 16873071 20544844 17242785 18629630 20390343 17893378 19066611 18815881 18425577 19221464 18997820 18351453 19103187 19189212 20135344 18855134 19059307 20065188 18821012 20859285 19288272 19289846 18984771 11161223 16818667 16273361 19200415 20005174 19244106 21152245 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 39.61 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tetrachloroethylene | 39.61 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 39.61 | 16443354 16873071 16166294 | |
| MESH:D001982 | Bronchial Diseases | zafirlukast | 5.08 | 11994701 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 4.39 | 15516495 17626835 18315731 16777450 18417511 19059883 14754758 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 4.39 | 12794006 12388339 12654629 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 2.96 | 16813970 | |
| MESH:D002056 | Burns | Indomethacin | 3.12 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.70 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 7.03 | 15141370 15625704 11239499 16537180 | |
| MESH:D002100 | Cachexia | Ozone | 7.03 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 3.89 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 7.80 | 16111702 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | zafirlukast | 7.80 | 15170009 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 15.12 | 15700767 10355542 15721981 16050911 16192424 18705752 15673190 3786805 16227642 16011737 16124888 16097048 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | ferulic acid | 15.12 | 16011737 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 15.12 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Oleanolic Acid | 15.12 | 10355542 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Pentoxifylline | 15.12 | 16227642 | |
| MESH:D002276 | Carcinoid Tumor | Dacarbazine | 12.03 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 12.03 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 12.03 | 16051944 | |
| MESH:D002277 | Carcinoma | 4-dichlorobenzene | 14.59 | 12748734 | |
| MESH:D002277 | Carcinoma | andrographolide | 14.59 | 19426720 | |
| MESH:D002277 | Carcinoma | Curcumin | 14.59 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 14.59 | 19555203 | |
| MESH:D002277 | Carcinoma | Methylcholanthrene | 14.59 | 10545420 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 14.59 | 16835633 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 2.90 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.50 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 39.29 | 6705139 17761372 10737359 3581430 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-aminofluorene | 39.29 | 19052882 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 39.29 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 39.29 | 21507988 12907637 12619106 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 39.29 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 39.29 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 39.29 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | dicyclanil | 39.29 | 17162532 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 39.29 | 16807293 18393292 20101231 17978847 19822196 20007298 18785209 20214788 11831363 3084413 20084675 19208518 17162532 20524982 16779866 16935385 19335982 19171122 19394651 17138121 3581430 16569478 18978308 16288022 19519916 16878318 16698587 16502159 16830150 20727157 18494052 18506893 16540662 17761372 20935162 19539802 20512989 21159647 19107877 18210153 17428255 19701751 19383236 17173139 17055752 16328049 19418558 19052882 18788625 18665156 20432363 10672840 18971187 20514400 19919837 18056438 16681979 10737359 18691550 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 39.29 | 16924424 15948411 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 39.29 | 18059187 17876044 16234567 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 39.29 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 39.29 | 15341023 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 39.29 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 39.29 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 39.29 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 39.29 | 6705139 20007298 20935162 17173139 1701930 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 39.29 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | pyridine | 39.29 | 10696769 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 39.29 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | quinoline | 39.29 | 598648 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 39.29 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 39.29 | 17306315 16507464 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 39.29 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 39.29 | 1917145 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 6.08 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 6.08 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.72 | 11352223 18791128 14736730 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bexarotene | 6.66 | 16247446 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 6.66 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 6.66 | 12023789 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 6.66 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 6.66 | 12391285 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.35 | 17234771 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 6.43 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Dacarbazine | 6.43 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 6.43 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 6.43 | 17341418 | |
| MESH:D002294 | Carcinoma, Squamous Cell | 9,10-Dimethyl-1,2-benzanthracene | 21.89 | 11376689 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 21.89 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 21.89 | 17066447 18337622 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 21.89 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 21.89 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 21.89 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 21.89 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | N-methyl-N-benzylnitrosamine | 21.89 | 12222751 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 21.89 | 17418620 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 21.89 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 21.89 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 21.89 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 21.89 | 16096774 16051514 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Ciprofloxacin | 7.72 | 10741713 15028437 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Nitrofurantoin | 7.72 | 15028437 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 7.72 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 8.88 | 11179087 7544033 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 8.88 | 15728586 11179087 11754973 16170337 17124262 17287366 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 8.88 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 8.88 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 8.88 | 18670907 16120746 18850075 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.32 | 17329180 17131338 16612575 17351982 15811867 17308081 16455267 17519947 17382496 15476868 17928571 16364871 15792986 18627295 16242529 16651473 16952015 15505089 17007740 16731534 16278810 16269455 16109756 17974986 17924179 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.17 | 17334414 16243910 | |
| MESH:D002318 | Cardiovascular Diseases | clopidogrel | 11.53 | 20180610 | |
| MESH:D002318 | Cardiovascular Diseases | Dioxins | 11.53 | 19057694 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 11.53 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 11.53 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 11.53 | 16862667 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 11.53 | 15458977 | |
| MESH:D016893 | Carotid Stenosis | Plant Preparations | 4.51 | 15158307 | |
| MESH:D002386 | Cataract | Acetaminophen | 3.19 | 10977129 | |
| MESH:D002386 | Cataract | Tretinoin | 3.19 | 17460283 | |
| MESH:D002389 | Catatonia | olanzapine | 4.60 | 18071103 16772815 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-biphenylamine | 14.68 | 15746073 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Azoxymethane | 14.68 | 15705887 18075178 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 14.68 | 1399818 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 14.68 | 7505956 2727394 21159647 17174075 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 14.68 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 14.68 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 14.68 | 20056578 19524636 | |
| MESH:D002471 | Cell Transformation, Neoplastic | tobacco tar | 14.68 | 19559774 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 2.66 | 4080065 | |
| MESH:D002543 | Cerebral Hemorrhage | Warfarin | 4.27 | 11061249 | |
| MESH:D002547 | Cerebral Palsy | Toluene | 4.22 | 9294310 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 2.96 | 16129372 | |
| MESH:D002637 | Chest Pain | Omeprazole | 7.14 | 15447763 | |
| MESH:D002637 | Chest Pain | Theophylline | 7.14 | 15238202 | |
| MESH:D002653 | Child Behavior Disorders | Dextromethorphan | 5.58 | 17175572 | |
| MESH:D054506 | Chloracne | Dioxins | 4.05 | 18329192 | |
| MESH:D018281 | Cholangiocarcinoma | 2-aminofluorene | 11.26 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 11.26 | 16628245 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 11.26 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 11.26 | 16835633 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.54 | 12912871 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.52 | 11181007 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 5.67 | 15500046 7624871 15913567 12927374 19486331 18590720 16629650 18164287 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 5.67 | 15861022 16105132 11677210 17681005 17333356 16919318 17110522 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 5.67 | 19176532 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 4.20 | 19407337 10220858 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.50 | 16461808 | |
| MESH:D043171 | Chromosomal Instability | 4-biphenylamine | 5.35 | 17671175 | |
| MESH:D015267 | Churg-Strauss Syndrome | zafirlukast | 4.74 | 9674492 | |
| MESH:D016770 | Ciliophora Infections | Albendazole | 8.52 | 12113305 | |
| MESH:D016770 | Ciliophora Infections | Niclosamide | 8.52 | 12113305 | |
| MESH:D016770 | Ciliophora Infections | Quinine | 8.52 | 12113305 | |
| MESH:D002972 | Cleft Palate | Fluconazole | 4.03 | 16781842 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 4.03 | 8697196 12621046 15340226 15668235 16354765 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 4.03 | 9407595 | |
| MESH:D003072 | Cognition Disorders | Clozapine | 3.38 | 17123785 | |
| MESH:D003092 | Colitis | Curcumin | 7.07 | 16804969 16782535 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 7.07 | 16474422 | |
| MESH:D003092 | Colitis | Tretinoin | 7.07 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 2.87 | 20423518 | |
| MESH:D003103 | Coloboma | Curcumin | 3.03 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 24.25 | 16353153 | |
| MESH:D003110 | Colonic Neoplasms | Azoxymethane | 24.25 | 16818512 15824018 19056647 15705887 12189186 14668109 16293270 | |
| MESH:D003110 | Colonic Neoplasms | bromodichloromethane | 24.25 | 14668109 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 24.25 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 24.25 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 24.25 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 24.25 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Etodolac | 24.25 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 24.25 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 24.25 | 15637740 15786552 11260862 15963497 15936596 15625704 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 24.25 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 24.25 | 19056647 11134977 19440933 17148506 16640504 15741050 17191121 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 24.25 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | rofecoxib | 24.25 | 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 24.25 | 12458338 12902858 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 24.25 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | 4-biphenylamine | 15.87 | 17671175 | |
| MESH:D015179 | Colorectal Neoplasms | andrographolide | 15.87 | 19426720 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 15.87 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Azoxymethane | 15.87 | 10416599 11076880 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 15.87 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 15.87 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Dacarbazine | 15.87 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 15.87 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Etodolac | 15.87 | 11076880 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 15.87 | 18059344 12606626 11197048 17054584 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 15.87 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 15.87 | 15531428 | |
| MESH:D015179 | Colorectal Neoplasms | pterostilbene | 15.87 | 18852136 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 15.87 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 15.87 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 15.87 | 11197048 11076880 18059344 10666051 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 8.16 | 10836866 | |
| MESH:D003128 | Coma | Organophosphorus Compounds | 8.16 | 17098105 | |
| MESH:D000013 | Congenital Abnormalities | 2-amino-4,6-dinitrotoluene | 4.73 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 4.73 | 17141729 14669216 | |
| MESH:D003233 | Conjunctivitis, Allergic | zafirlukast | 4.30 | 15351322 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.30 | 18497527 | |
| MESH:D003324 | Coronary Artery Disease | Plant Preparations | 4.16 | 15158307 | |
| MESH:D003324 | Coronary Artery Disease | Ticlopidine | 4.16 | 19432301 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.51 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | Warfarin | 4.12 | 12872399 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.06 | 17302372 | |
| MESH:D003371 | Cough | Dextromethorphan | 6.65 | 17323712 | |
| MESH:D003371 | Cough | zafirlukast | 6.65 | 12095178 | |
| OMIM:122700 | COUMARIN RESISTANCE | Warfarin | 4.27 | 20579077 20497562 | |
| MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 9.22 | 17686920 | |
| MESH:D019465 | Craniofacial Abnormalities | 6-methyl-2-(phenylethynyl)pyridine | 9.22 | 17065172 | |
| MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 9.22 | 9014606 | |
| MESH:D019465 | Craniofacial Abnormalities | decamethrin | 9.22 | 19861644 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 9.22 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 9.22 | 12039119 9562676 | |
| MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 9.22 | 20036863 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 9.22 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 9.22 | 15322242 10048152 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Toluene | 9.22 | 9294310 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 9.22 | 9211117 17551590 9664655 16925845 8800419 10589399 14991402 9125849 9224671 9142499 | |
| MESH:D016638 | Critical Illness | Estrogens | 4.32 | 16670151 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 6.16 | 16002989 12952375 | |
| MESH:D003456 | Cryptorchidism | vinclozolin | 6.16 | 14966744 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.21 | 16547730 | |
| MESH:D003550 | Cystic Fibrosis | Ciprofloxacin | 8.59 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 8.59 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 8.59 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | zafirlukast | 8.59 | 15463842 | |
| MESH:D003643 | Death | Toluene | 4.02 | 6431079 | |
| MESH:D016757 | Death, Sudden, Cardiac | Thioridazine | 4.31 | 20210726 | |
| MESH:D003665 | Decompression Sickness | zafirlukast | 9.26 | 18309904 | |
| MESH:D003665 | Decompression Sickness | zileuton | 9.26 | 18309904 | |
| MESH:D003704 | Dementia | Polychlorinated Biphenyls | 5.70 | 16140633 | |
| MESH:D003704 | Dementia | Thioridazine | 5.70 | 11575062 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.76 | 19031437 | |
| MESH:D003731 | Dental Caries | Aspartame | 5.27 | 8955999 | |
| MESH:D003866 | Depressive Disorder | Fluvoxamine | 5.80 | 19571598 | |
| MESH:D003866 | Depressive Disorder | Imipramine | 5.80 | 20305041 | |
| MESH:D003866 | Depressive Disorder | tolcapone | 5.80 | 7768276 11224284 | |
| MESH:D003865 | Depressive Disorder, Major | Fluvoxamine | 6.04 | 17474826 | |
| MESH:D003865 | Depressive Disorder, Major | tolcapone | 6.04 | 10440460 | |
| MESH:D003872 | Dermatitis | 3-xylene | 4.30 | 12717741 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | alachlor | 3.66 | 8428444 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Aspartame | 3.66 | 14996049 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 3.66 | 12438553 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 3.53 | 18249437 | |
| MESH:D003876 | Dermatitis, Atopic | zafirlukast | 3.53 | 11901593 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.55 | 20191521 | |
| MESH:D002658 | Developmental Disabilities | 2,3,3',4,4',5-hexachlorobiphenyl | 8.63 | 19647017 | |
| MESH:D002658 | Developmental Disabilities | 2,3',4,4',5-pentachlorobiphenyl | 8.63 | 19647017 | |
| MESH:D002658 | Developmental Disabilities | Choline | 8.63 | 16818868 | |
| MESH:D002658 | Developmental Disabilities | olanzapine | 8.63 | 17069543 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 3.31 | 16285004 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 8.33 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 8.33 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 8.33 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 8.33 | 11055810 18603373 12093613 15862027 6379147 12446591 12644472 17874149 19298542 12083368 19586609 2177838 15298345 11260395 15831366 18715473 17442507 16286809 7637645 19496084 8740154 19960420 1374869 16684804 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 3.55 | 18603373 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Warfarin | 3.55 | 18772604 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 12.40 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 12.40 | 16402076 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 12.40 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 12.40 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 12.40 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 12.40 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 12.40 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 12.40 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 12.40 | 17107852 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.10 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 24.16 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 24.16 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 24.16 | 19960420 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 24.16 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 24.16 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 24.16 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 24.16 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Warfarin | 24.16 | 12644472 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.04 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.04 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 5.08 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 5.08 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Ondansetron | 5.08 | 10867622 | |
| MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 3.90 | 15331141 | |
| OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 3.85 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Warfarin | 4.38 | 14723717 | |
| MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 4.90 | 20216337 16538176 15057820 16538175 | |
| MESH:D004342 | Drug Hypersensitivity | Dacarbazine | 4.90 | 16508601 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1,2,4-trichlorobenzene | 58.29 | 10092053 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1,2-dichloroethylene | 58.29 | 7497910 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 58.29 | 17522070 18289764 7624871 20133375 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2-amino-4,6-dinitrotoluene | 58.29 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 58.29 | 18713872 2444490 11461765 12594235 11739529 12958197 14725611 19420014 16781746 15619225 11743745 14550746 19416960 19370779 16109766 16393943 11834606 12153990 14986274 10663392 10915739 11529661 18071297 16485898 16081117 17522070 16227642 11421492 11287661 10774834 19739265 19923254 17906064 12540782 15968718 12392966 19085960 17562736 16177239 19164858 12705907 | |
| MESH:D056486 | Drug-Induced Liver Injury | allyl alcohol | 58.29 | 7440962 | |
| MESH:D056486 | Drug-Induced Liver Injury | bromobenzene | 58.29 | 12628495 10092053 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 58.29 | 17465707 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 58.29 | 19085960 6884620 10915739 7120509 2869522 10092053 16177239 15027814 7440962 6623471 16227642 7179309 9327722 21278145 15968718 3732212 17522070 3786805 11566570 15998439 4309450 19336974 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 58.29 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorpromazine | 58.29 | 11461765 | |
| MESH:D056486 | Drug-Induced Liver Injury | cyanoginosin LR | 58.29 | 17654400 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 58.29 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylformamide | 58.29 | 3732212 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 58.29 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 58.29 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 58.29 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | gadolinium chloride | 58.29 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ketoconazole | 58.29 | 18289764 | |
| MESH:D056486 | Drug-Induced Liver Injury | Nitrofurantoin | 58.29 | 19789166 8373174 19214031 1551546 | |
| MESH:D056486 | Drug-Induced Liver Injury | Pentoxifylline | 58.29 | 16227642 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 58.29 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Prazosin | 58.29 | 18071297 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ritonavir | 58.29 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tea | 58.29 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 58.29 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | tolcapone | 58.29 | 16604736 19783845 | |
| MESH:D056486 | Drug-Induced Liver Injury | vinylidene chloride | 58.29 | 3697828 | |
| MESH:D056486 | Drug-Induced Liver Injury | zafirlukast | 58.29 | 11119397 12583521 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 58.29 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.45 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Carbamazepine | 11.41 | 20216337 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 11.41 | 12649298 15033597 12231392 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 11.41 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Plant Preparations | 11.41 | 11033412 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 11.41 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.52 | 16326151 18043480 12774134 17190690 16133044 18446180 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 9.37 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 9.37 | 17329845 11595431 17151854 11595415 17045617 10671773 11535926 17351913 11991626 16699067 17202747 | |
| MESH:D004381 | Duodenal Ulcer | lansoprazole | 9.37 | 17151854 | |
| MESH:D004381 | Duodenal Ulcer | Omeprazole | 9.37 | 21218061 15991576 17151854 16613094 | |
| MESH:D004409 | Dyskinesia, Drug-Induced | Levodopa | 7.18 | 15893579 3690436 | |
| MESH:D004409 | Dyskinesia, Drug-Induced | tolcapone | 7.18 | 11455177 | |
| MESH:D050171 | Dyslipidemias | Clofibrate | 9.63 | 16707586 | |
| MESH:D050171 | Dyslipidemias | Clozapine | 9.63 | 16402076 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 9.63 | 18367378 | |
| MESH:D050171 | Dyslipidemias | Fenofibrate | 9.63 | 16707586 | |
| MESH:D004417 | Dyspnea | Diazinon | 3.21 | 16487989 | |
| MESH:D004421 | Dystonia | Phenobarbital | 2.48 | 1851702 | |
| MESH:D020821 | Dystonic Disorders | Nicotine | 4.30 | 17881519 | |
| MESH:D004485 | Eczema | Dexamethasone | 6.21 | 12438553 | |
| MESH:D004485 | Eczema | Methoxsalen | 6.21 | 16259964 | |
| MESH:D004487 | Edema | Arachidonic Acid | 26.60 | 15177302 7990266 16716910 9599246 11698051 9831321 | |
| MESH:D004487 | Edema | Dexamethasone | 26.60 | 19703484 | |
| MESH:D004487 | Edema | Imipramine | 26.60 | 12798668 | |
| MESH:D004487 | Edema | Indomethacin | 26.60 | 7907874 19703484 16100529 8273558 7990266 10653021 8985016 | |
| MESH:D004487 | Edema | Mangifera indica extract | 26.60 | 16716910 16273134 15177302 | |
| MESH:D004487 | Edema | perfluorooctanoic acid | 26.60 | 17259670 12083418 | |
| MESH:D004487 | Edema | pirinixic acid | 26.60 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 26.60 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 26.60 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 26.60 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 26.60 | 11698051 8113982 16716910 9599246 15177302 7812673 8273558 | |
| MESH:D004487 | Edema | zafirlukast | 26.60 | 15351322 | |
| MESH:D004487 | Edema | zileuton | 26.60 | 7990266 7812673 19703484 8273558 9831321 17118201 11698051 | |
| MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 11.70 | 17686920 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 11.70 | 16714409 18230668 15322242 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 11.70 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 9.43 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 9.43 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 9.43 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 9.43 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 3.99 | 19294695 | |
| MESH:D018159 | Endolymphatic Hydrops | Dimethyl Sulfoxide | 4.90 | 20641076 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 6.53 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 6.53 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 15.57 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 15.57 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 15.57 | 18566989 11473722 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 15.57 | 16569247 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 15.57 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 15.57 | 20544844 16202921 19155303 17893378 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 15.57 | 16569247 | |
| MESH:D004715 | Endometriosis | 2,3,4,7,8-pentachlorodibenzofuran | 24.71 | 9294722 | |
| MESH:D004715 | Endometriosis | celecoxib | 24.71 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 24.71 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 24.71 | 16134523 | |
| MESH:D004715 | Endometriosis | rofecoxib | 24.71 | 15652904 | |
| MESH:D004715 | Endometriosis | Sulindac | 24.71 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 24.71 | 9294722 10568697 | |
| MESH:D004715 | Endometriosis | zafirlukast | 24.71 | 15019815 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 8.61 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 8.61 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 8.53 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 8.53 | 15328337 15821434 17637181 | |
| MESH:D019446 | Endotoxemia | zileuton | 8.53 | 15328337 | |
| MESH:D004751 | Enteritis | Indomethacin | 6.67 | 17763956 10567023 16328016 | |
| MESH:D004751 | Enteritis | lansoprazole | 6.67 | 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.07 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.07 | 17923197 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 6.28 | 11298111 | |
| MESH:D004802 | Eosinophilia | zafirlukast | 6.28 | 12689652 12189465 15696079 12742009 15351322 | |
| MESH:D004802 | Eosinophilia | zileuton | 6.28 | 10764316 8621850 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 3.69 | 16538176 16415921 19915237 18855540 20485159 | |
| MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 5.92 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 5.92 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Carbamazepine | 5.02 | 15008574 16628512 17116037 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 5.02 | 11558140 3922381 | |
| MESH:D004827 | Epilepsy | Carbamazepine | 4.65 | 18234410 19620853 7988514 19439326 17178248 19700373 17465707 821787 20417680 9014606 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 4.65 | 20417680 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 4.65 | 19439326 19700373 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.14 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 6.41 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 6.41 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 5.56 | 15276670 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 5.56 | 3659116 | |
| MESH:D004893 | Erythema Nodosum | Aspartame | 5.27 | 9324739 | |
| MESH:D004916 | Erythromelalgia | Carbamazepine | 4.10 | 19549232 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.46 | 16302075 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 10.38 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 10.38 | 16785472 17638652 16481741 15464296 15173087 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 10.38 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 10.38 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | N-methyl-N-benzylnitrosamine | 10.38 | 12222751 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 10.38 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 10.38 | 16510608 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 10.38 | 12235107 | |
| MESH:D005076 | Exanthema | Carbamazepine | 3.85 | 20485159 | |
| MESH:D054908 | Extensively Drug-Resistant Tuberculosis | tolcapone | 4.30 | 19578428 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.25 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.25 | 16938888 9664655 | |
| MESH:D005141 | Eyelid Diseases | Aspartame | 4.73 | 14996049 | |
| MESH:D005221 | Fatigue | Amphetamine | 3.98 | 19890266 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 27.65 | 16239168 16045604 15959796 61145 12795759 19224547 12631006 17595544 | |
| MESH:D005234 | Fatty Liver | Clofibrate | 27.65 | 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 27.65 | 19297423 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 27.65 | 19004024 17967931 18296743 19551842 | |
| MESH:D005234 | Fatty Liver | Dietary Sucrose | 27.65 | 17967931 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 27.65 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 27.65 | 15345470 | |
| MESH:D005234 | Fatty Liver | mangiferin | 27.65 | 15975614 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 27.65 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 27.65 | 15975614 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 27.65 | 19224547 14986274 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.04 | 16002989 16513791 15751030 16534752 16611131 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.04 | 16709447 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 1.89 | 11858732 | |
| MESH:D005317 | Fetal Growth Retardation | 1,2,4-trichlorobenzene | 4.70 | 6884296 | |
| MESH:D005334 | Fever | Arachidonic Acid | 9.75 | 11852909 | |
| MESH:D005334 | Fever | Aspartame | 9.75 | 9630831 | |
| MESH:D005334 | Fever | Indomethacin | 9.75 | 11852909 17627676 10431976 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 9.75 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 7.57 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 7.57 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Dacarbazine | 15.00 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 15.00 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 15.00 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 15.00 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 6.73 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 6.73 | 10962813 14633661 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 18.05 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 18.05 | 18705752 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 18.05 | 18296743 | |
| MESH:D005355 | Fibrosis | Indomethacin | 18.05 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 18.05 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 18.05 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 18.05 | 17994277 | |
| MESH:D005393 | Fish Diseases | Albendazole | 8.31 | 12113305 | |
| MESH:D005393 | Fish Diseases | Niclosamide | 8.31 | 12113305 | |
| MESH:D005393 | Fish Diseases | Quinine | 8.31 | 12113305 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.52 | 11298111 | |
| MESH:D005596 | Fractures, Closed | zileuton | 4.24 | 19544365 | |
| MESH:D005756 | Gastritis | Acetaminophen | 5.74 | 16983495 | |
| MESH:D005756 | Gastritis | Indomethacin | 5.74 | 15046732 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.45 | 11910360 | |
| MESH:D006471 | Gastrointestinal Hemorrhage | Warfarin | 5.06 | 11794436 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.11 | 18462866 | |
| MESH:D005776 | Gaucher Disease | Warfarin | 4.38 | 12359135 | |
| MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 3.30 | 16973722 | |
| MESH:D005832 | Genital Diseases, Male | vinclozolin | 3.64 | 16417039 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 7.43 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 7.43 | 16452187 | |
| MESH:D005909 | Glioblastoma | biochanin A | 20.01 | 16598420 | |
| MESH:D005909 | Glioblastoma | Curcumin | 20.01 | 17596214 | |
| MESH:D005909 | Glioblastoma | Dacarbazine | 20.01 | 12853885 12592361 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 20.01 | 17150277 | |
| MESH:D005909 | Glioblastoma | Genistein | 20.01 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 20.01 | 12870263 | |
| MESH:D005909 | Glioblastoma | Quercetin | 20.01 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 20.01 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 20.01 | 18801729 | |
| MESH:D005910 | Glioma | Indomethacin | 3.07 | 16487511 18371953 | |
| MESH:D005910 | Glioma | Quercetin | 3.07 | 17643826 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 2.88 | 11849393 | |
| MESH:D044882 | Glucose Metabolism Disorders | Mangifera indica extract | 5.10 | 16273134 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 2.94 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.72 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 3.55 | 16518429 | |
| MESH:D006261 | Headache | zafirlukast | 3.99 | 10386485 9377612 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 10.45 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 10.45 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 10.45 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 10.45 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 10.45 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 8.39 | 19898482 | |
| MESH:D034381 | Hearing Loss | Dimethyl Sulfoxide | 8.39 | 20641076 | |
| MESH:D034381 | Hearing Loss | Styrene | 8.39 | 17420221 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.50 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 2.98 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | 2,3,4,7,8-pentachlorodibenzofuran | 11.26 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 11.26 | 17686920 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 11.26 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | polychlorodibenzo-4-dioxin | 11.26 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 11.26 | 11294989 10048152 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 11.26 | 14991402 9664655 | |
| MESH:D006331 | Heart Diseases | 3,4,3',4'-tetrachloroazoxybenzene | 12.65 | 16046796 | |
| MESH:D006331 | Heart Diseases | Ciprofloxacin | 12.65 | 11505790 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 12.65 | 17875725 14766674 16879835 16144979 16244372 16330681 16495754 17888722 18006777 18674790 16707910 12587719 16244371 | |
| MESH:D006331 | Heart Diseases | mangiferin | 12.65 | 12093613 | |
| MESH:D006331 | Heart Diseases | pifithrin | 12.65 | 14766674 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 12.65 | 12093613 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 9.06 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 9.06 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 9.06 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 9.06 | 18097624 | |
| MESH:D006333 | Heart Failure | Propranolol | 9.06 | 20082655 | |
| MESH:D016481 | Helicobacter Infections | Ciprofloxacin | 3.96 | 17643012 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 7.56 | 6705139 | |
| MESH:D006390 | Hemangioendothelioma | quinoline | 7.56 | 598648 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 9.61 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 4-nitroaniline | 9.61 | 15200160 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 9.61 | 15692506 | |
| MESH:D006394 | Hemangiosarcoma | quinoline | 9.61 | 598648 | |
| MESH:D006406 | Hematoma | Warfarin | 5.06 | 17493413 | |
| MESH:D006461 | Hemolysis | allyl alcohol | 4.62 | 2222504 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 2.90 | 16366002 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 5.48 | 11000095 | |
| MESH:D006470 | Hemorrhage | Warfarin | 5.48 | 18429757 | |
| MESH:D006486 | Hemosiderosis | 4-nitroaniline | 5.04 | 3710033 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.06 | 15633222 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 20.68 | 18590720 | |
| MESH:D006505 | Hepatitis | allyl alcohol | 20.68 | 11394713 | |
| MESH:D006505 | Hepatitis | Caffeine | 20.68 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 20.68 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Diazinon | 20.68 | 16487989 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 20.68 | 18339527 | |
| MESH:D006505 | Hepatitis | zafirlukast | 20.68 | 12189465 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.12 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Dantrolene | 7.29 | 14986274 | |
| MESH:D006521 | Hepatitis, Chronic | Nitrofurantoin | 7.29 | 14986274 | |
| MESH:D006529 | Hepatomegaly | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 28.02 | 16109766 | |
| MESH:D006529 | Hepatomegaly | fenarimol | 28.02 | 2387028 | |
| MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 28.02 | 3609246 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 28.02 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 28.02 | 19772884 16221962 18467677 19176532 | |
| MESH:D006529 | Hepatomegaly | propiconazole | 28.02 | 17178689 17178688 | |
| MESH:D006529 | Hepatomegaly | Propranolol | 28.02 | 16371745 | |
| MESH:D006529 | Hepatomegaly | systhane | 28.02 | 17178688 17178689 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 28.02 | 12621046 15340226 16120746 | |
| MESH:D006529 | Hepatomegaly | zileuton | 28.02 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.43 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.29 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.38 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Chlorpromazine | 13.93 | 1682908 | |
| MESH:D006561 | Herpes Simplex | Mangifera indica extract | 13.93 | 10715843 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 13.93 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 13.93 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 13.93 | 16876885 | |
| MESH:D051677 | Histiocytoma, Malignant Fibrous | 1-nitropyrene | 5.55 | 6692400 | |
| MESH:D015658 | HIV Infections | enfuvirtide | 4.82 | 19539522 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 4.82 | 12878215 | |
| MESH:D015658 | HIV Infections | Ritonavir | 4.82 | 17378895 11363243 15388451 11141242 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 6.07 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Dacarbazine | 6.07 | 16170182 18501091 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 6.07 | 18501091 17606976 15147373 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 6.07 | 12676792 | |
| MESH:D006734 | Horse Diseases | Thiabendazole | 4.63 | 16402567 | |
| MESH:D019584 | Hot Flashes | 8-prenylnaringenin | 8.10 | 17088409 | |
| MESH:D019584 | Hot Flashes | Estradiol | 8.10 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 8.10 | 14716179 16566672 17454163 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.40 | 16354765 15340226 18606429 8697196 16959395 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 12.68 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Guanethidine | 12.68 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 12.68 | 12727271 | |
| MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 12.68 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Prazosin | 12.68 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 12.68 | 16870215 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.06 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 2.91 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 3.94 | 18089816 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 6.74 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 6.74 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 6.74 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 3.38 | 12524144 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 2.96 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 7.26 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 7.26 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 7.26 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 7.47 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Levodopa | 7.47 | 16787708 16275827 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 7.47 | 16484555 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 3.57 | 9881663 11315760 | |
| MESH:D006948 | Hyperkinesis | Amphetamine | 10.06 | 1977408 14960337 | |
| MESH:D006948 | Hyperkinesis | Clozapine | 10.06 | 16046005 | |
| MESH:D006948 | Hyperkinesis | Methamphetamine | 10.06 | 17658665 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 16.44 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 16.44 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 16.44 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | Oleanolic Acid | 16.44 | 8847885 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 16.44 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 16.44 | 16873680 | |
| MESH:D006963 | Hyperphagia | olanzapine | 4.60 | 17933447 | |
| MESH:D017495 | Hyperpigmentation | 1-phenylazo-2-naphthol | 5.60 | 1402006 | |
| MESH:D006965 | Hyperplasia | Carbamazepine | 6.04 | 18773962 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 6.04 | 12960047 14722030 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 6.56 | 17604070 | |
| MESH:D006967 | Hypersensitivity | Mangifera indica extract | 6.56 | 16536907 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 6.56 | 16536907 | |
| MESH:D006968 | Hypersensitivity, Delayed | indirubin | 4.30 | 11275354 | |
| MESH:D006973 | Hypertension | Aspartame | 7.75 | 18708962 | |
| MESH:D006973 | Hypertension | Dexamethasone | 7.75 | 17042910 | |
| MESH:D006973 | Hypertension | Nifedipine | 7.75 | 20102058 | |
| MESH:D006973 | Hypertension | Phenylephrine | 7.75 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 7.75 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 7.75 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 6.49 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | ginkgolide B | 6.49 | 16409839 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Hydralazine | 3.04 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | Warfarin | 6.17 | 12359135 | |
| MESH:D006976 | Hypertension, Pulmonary | zafirlukast | 6.17 | 12781059 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 6.17 | 14726295 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 5.96 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 5.96 | 18502941 12791704 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 2.82 | 17488730 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 5.96 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 5.96 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Isoproterenol | 7.03 | 6740701 | |
| MESH:D007022 | Hypotension | Organophosphorus Compounds | 7.03 | 17098105 | |
| MESH:D007022 | Hypotension | Propranolol | 7.03 | 6740701 | |
| MESH:D007035 | Hypothermia | Reserpine | 4.70 | 1977408 | |
| MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 7.28 | 18306037 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 7.28 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.72 | 10651667 16133968 10647630 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 4.21 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 3.72 | 16133044 | |
| MESH:D007238 | Infarction | zolmitriptan | 5.91 | 16615676 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 10.55 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 10.55 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 10.55 | 19309543 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 2.81 | 15036965 | |
| MESH:D007247 | Infertility, Female | Dieldrin | 5.20 | 10630421 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 5.20 | 12013081 | |
| MESH:D007248 | Infertility, Male | 2,4-Dichlorophenoxyacetic Acid | 23.59 | 12948887 | |
| MESH:D007248 | Infertility, Male | alachlor | 23.59 | 17049205 12948887 16466525 | |
| MESH:D007248 | Infertility, Male | Atrazine | 23.59 | 12948887 | |
| MESH:D007248 | Infertility, Male | Diazinon | 23.59 | 16466525 12948887 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 23.59 | 17937319 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 23.59 | 16467254 11955947 | |
| MESH:D007248 | Infertility, Male | metolachlor | 23.59 | 12948887 | |
| MESH:D007248 | Infertility, Male | Parathion | 23.59 | 16029889 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 23.59 | 15346721 12646999 | |
| MESH:D007248 | Infertility, Male | Theophylline | 23.59 | 16988215 | |
| MESH:D007248 | Infertility, Male | vinclozolin | 23.59 | 16467254 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 42.97 | 9831321 15177302 17371808 | |
| MESH:D007249 | Inflammation | Curcumin | 42.97 | 18403477 17151092 16956363 | |
| MESH:D007249 | Inflammation | Dexamethasone | 42.97 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Dietary Fats | 42.97 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 42.97 | 18785209 | |
| MESH:D007249 | Inflammation | ethylisopropylamiloride | 42.97 | 17237260 | |
| MESH:D007249 | Inflammation | Imipramine | 42.97 | 12798668 | |
| MESH:D007249 | Inflammation | Indomethacin | 42.97 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 42.97 | 9205823 17963957 17237260 17255318 12878042 | |
| MESH:D007249 | Inflammation | Mangifera indica extract | 42.97 | 15222974 15177302 | |
| MESH:D007249 | Inflammation | mangiferin | 42.97 | 15222974 | |
| MESH:D007249 | Inflammation | Oleanolic Acid | 42.97 | 8847885 | |
| MESH:D007249 | Inflammation | perfluorooctanoic acid | 42.97 | 12083418 | |
| MESH:D007249 | Inflammation | Plant Extracts | 42.97 | 16366677 12787963 15997105 19332304 | |
| MESH:D007249 | Inflammation | polyphenols | 42.97 | 16366677 | |
| MESH:D007249 | Inflammation | resveratrol | 42.97 | 16366677 | |
| MESH:D007249 | Inflammation | Sulindac | 42.97 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 42.97 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 42.97 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 42.97 | 8273558 15177302 11698051 7812673 7562506 | |
| MESH:D007249 | Inflammation | zafirlukast | 42.97 | 11438310 18309904 | |
| MESH:D007249 | Inflammation | zileuton | 42.97 | 18059327 17118201 18309904 18295198 7812673 9831321 8960868 8621850 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 3.59 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 3.59 | 15339030 | |
| MESH:D007251 | Influenza, Human | Quercetin | 5.80 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 5.80 | 16624496 | |
| MESH:D007299 | Insect Bites and Stings | decamethrin | 4.16 | 15189238 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 7.18 | 18457598 11836018 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 7.18 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 7.18 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 7.18 | 16306350 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 10.77 | 15831440 17994277 17329856 11686837 11713966 15610444 10210152 11855677 18236018 | |
| MESH:D007410 | Intestinal Diseases | N-(3-(aminomethyl)benzyl)acetamidine | 10.77 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | rofecoxib | 10.77 | 15831440 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 10.77 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 11.29 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 11.29 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 11.29 | 12628509 12584176 12351151 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 11.29 | 12351151 12628509 12584176 10213222 10223192 12663524 | |
| MESH:D007417 | Intestinal Polyps | rofecoxib | 6.50 | 11245490 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 6.50 | 11245490 12394442 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 3.55 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 3.72 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.09 | 17255318 | |
| MESH:D007511 | Ischemia | Mangifera indica extract | 6.47 | 16273134 | |
| MESH:D007511 | Ischemia | mangiferin | 6.47 | 16806951 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 4.91 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 4.91 | 17551590 15992940 | |
| MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 7.28 | 18306037 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 7.28 | 18306037 10574470 16133968 | |
| MESH:D007627 | Keloid | Quercetin | 3.35 | 17086741 | |
| MESH:D055623 | Keratosis, Actinic | Phenol | 4.79 | 19293009 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.50 | 15464296 | |
| MESH:D007674 | Kidney Diseases | 2-dichlorobenzene | 32.52 | 8440869 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 32.52 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Aspartame | 32.52 | 11409539 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 32.52 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 32.52 | 12649298 15190930 19839026 18289764 12231392 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 32.52 | 15369732 16775033 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 32.52 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 32.52 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 32.52 | 12093613 | |
| MESH:D007674 | Kidney Diseases | ochratoxin A | 32.52 | 11409539 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 32.52 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 32.52 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 32.52 | 12093613 | |
| MESH:D007674 | Kidney Diseases | vinylidene chloride | 32.52 | 7839370 | |
| MESH:D007674 | Kidney Diseases | zolmitriptan | 32.52 | 16615676 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 2.67 | 16707910 | |
| MESH:D007680 | Kidney Neoplasms | 4-dichlorobenzene | 11.16 | 2471290 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 11.16 | 15003126 16762066 14681315 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 11.16 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | ochratoxin A | 11.16 | 16251485 | |
| MESH:D007680 | Kidney Neoplasms | pyridine | 11.16 | 10696769 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 11.16 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.17 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.55 | 9562676 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 4.88 | 17184923 | |
| MESH:D007859 | Learning Disorders | mangiferin | 4.88 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.03 | 18555241 | |
| MESH:D007896 | Leishmaniasis | fenarimol | 4.04 | 18372651 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.40 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Ketoconazole | 8.40 | 2166429 19744259 8889330 1311351 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Omeprazole | 8.40 | 19248655 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Pentoxifylline | 8.40 | 16863518 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Pentoxifylline | 4.52 | 11508396 | |
| MESH:D007898 | Leishmaniasis, Visceral | artemisinine | 4.50 | 20403680 | |
| MESH:D007898 | Leishmaniasis, Visceral | Ketoconazole | 4.50 | 11332679 | |
| MESH:D007938 | Leukemia | alachlor | 12.45 | 14769641 | |
| MESH:D007938 | Leukemia | Azacitidine | 12.45 | 19148494 | |
| MESH:D007938 | Leukemia | Curcumin | 12.45 | 18462866 | |
| MESH:D007938 | Leukemia | Genistein | 12.45 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | kaempferol | 12.45 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 12.45 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 12.45 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.51 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 3.01 | 15802533 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 11.07 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 11.07 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 11.07 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Ritonavir | 11.07 | 16174765 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 3.76 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 6.51 | 15631656 10785260 16572323 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 6.51 | 15498116 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 6.51 | 19503090 19823023 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 4.81 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 4.81 | 16932348 16482212 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 4.42 | 18720364 17596541 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 4.42 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 4.42 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.42 | 17596541 19850784 16294345 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 4.42 | 18206229 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 3.64 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Anthracyclines | 7.78 | 16823087 17294898 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 7.78 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 7.78 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 7.78 | 17107899 17506722 16788101 16140955 17339181 17217047 19075265 17712046 19035177 16766008 17649720 15748426 19642359 17368321 16823087 9834237 17294898 16331271 16891316 12679006 19225113 19029980 16935935 17301526 17361223 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 3.19 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 8.95 | 16537180 | |
| MESH:D007964 | Leukocytosis | zafirlukast | 8.95 | 18489783 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.06 | 17980183 | |
| MESH:D007970 | Leukopenia | Ciprofloxacin | 6.72 | 17846019 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 6.72 | 15821434 | |
| MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 7.56 | 8812269 | |
| MESH:D007984 | Leydig Cell Tumor | vinclozolin | 7.56 | 16417039 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 2.03 | 9224671 | |
| MESH:D008064 | Lipidoses | Chlorpromazine | 16.55 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Clozapine | 16.55 | 17567588 | |
| MESH:D008064 | Lipidoses | Imipramine | 16.55 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Ketoconazole | 16.55 | 17567588 | |
| MESH:D008064 | Lipidoses | Perhexiline | 16.55 | 15342952 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 16.55 | 15342952 17567588 | |
| MESH:D008064 | Lipidoses | Thioridazine | 16.55 | 15342952 17567588 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.28 | 17353645 | |
| MESH:D054068 | Livedo Reticularis | Warfarin | 5.06 | 18280355 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.06 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 13.19 | 11408273 11903743 17334410 16221502 17174718 16239168 21278145 17157831 16943688 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 13.19 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 13.19 | 19638242 20032147 18665156 18522880 18407596 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 13.19 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 13.19 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 13.19 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 13.19 | 17157831 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 2.99 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 17072980 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | allyl alcohol | 38.09 | 18564211 11063159 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 38.09 | 15362042 18006644 15123356 14512876 17766677 18472094 18166357 17869086 18481824 18251166 18205269 17698563 16027843 15370692 17565644 17823541 18317297 16638106 17944888 17900296 17976157 16015684 14716833 12649538 18705752 15931870 16116963 17481882 18420326 15959796 18279442 18210741 15996030 18395914 18263696 17922224 17631135 18472332 12632512 15818738 16192424 15052691 16011737 17714472 17721639 14716496 18395095 16033810 10355542 12666154 14724832 17708605 12741479 15925388 12586293 18376398 15893842 12445418 15650968 14620537 11481614 17761835 18429990 18054572 20821823 12389079 15057751 16097048 18187930 14748882 18339082 16136751 12609069 18277467 16248980 12667390 12546737 15730626 12898905 18156304 15876570 12445421 17805973 12958196 15338365 18418968 12632514 17640975 17525996 17557913 18412020 15673190 13678700 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 38.09 | 18006644 18705752 17355460 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 38.09 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 38.09 | 14709902 16169303 17640959 14726149 15161499 17203207 15138612 15577212 15864749 18567088 16270385 15369754 15366600 14643895 18210741 15591649 12925901 16603200 18371158 15571005 18237412 17198567 17465448 15744066 16544323 15723089 18672772 15793283 15086199 18637143 15067225 15504291 17881167 18629640 17348192 17724770 12918455 18239293 15298665 16009107 14659978 17201889 17196135 16570917 16042886 16627068 15842777 15763062 15339415 17036385 15479170 15081153 15733078 14568256 17534399 18095165 15942678 17432682 15798949 18364076 17666798 15492853 15099470 15383259 17719030 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethyl Sulfoxide | 38.09 | 11682029 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 38.09 | 16439617 16595196 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 38.09 | 15641146 17629604 15763062 17666798 16610055 18237412 15849816 17036385 15744066 17348192 15383259 17881167 18606216 15864749 18567088 12632512 15339415 18371158 15818738 15754396 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 38.09 | 14659978 14716833 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 38.09 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | ferulic acid | 38.09 | 16011737 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | gadolinium chloride | 38.09 | 12666154 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 38.09 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 38.09 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 38.09 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 38.09 | 15298665 16703270 15925388 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Oleanolic Acid | 38.09 | 10355542 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | oltipraz | 38.09 | 16544323 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Pentoxifylline | 38.09 | 16703270 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Phosphatidylcholines | 38.09 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 38.09 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 38.09 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 38.09 | 17724770 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 38.09 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rofecoxib | 38.09 | 17565644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 38.09 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 38.09 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 38.09 | 16248980 18397230 | |
| MESH:D008107 | Liver Diseases | marker/mechanism | 12969438 | ||
| MESH:D008107 | Liver Diseases | 1,2,4,5-tetrachlorobenzene | 46.90 | 1949037 | |
| MESH:D008107 | Liver Diseases | 1,2,4-trichlorobenzene | 46.90 | 1949037 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 46.90 | 17184895 | |
| MESH:D008107 | Liver Diseases | 2-dichlorobenzene | 46.90 | 8440869 1949037 8661352 1853346 | |
| MESH:D008107 | Liver Diseases | 4-dichlorobenzene | 46.90 | 7801330 1949037 8661352 1715830 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 46.90 | 19784758 16611625 19014921 12969438 11587558 12587719 19460945 16610002 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 46.90 | 15830285 16964402 17285989 16246199 15720792 | |
| MESH:D008107 | Liver Diseases | Chlorpromazine | 46.90 | 14986274 | |
| MESH:D008107 | Liver Diseases | Chlorpyrifos | 46.90 | 15991261 | |
| MESH:D008107 | Liver Diseases | Curcumin | 46.90 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 46.90 | 17034775 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 46.90 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 46.90 | 17207593 | |
| MESH:D008107 | Liver Diseases | Fluconazole | 46.90 | 14966256 | |
| MESH:D008107 | Liver Diseases | Lindane | 46.90 | 1715830 | |
| MESH:D008107 | Liver Diseases | Nitrofurantoin | 46.90 | 14966256 | |
| MESH:D008107 | Liver Diseases | Oleanolic Acid | 46.90 | 8847885 15720792 | |
| MESH:D008107 | Liver Diseases | pentachlorobenzene | 46.90 | 1949037 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 46.90 | 19363144 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 46.90 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 46.90 | 16698588 | |
| MESH:D008107 | Liver Diseases | propiconazole | 46.90 | 19363144 | |
| MESH:D008107 | Liver Diseases | Sulindac | 46.90 | 14986274 16867024 | |
| MESH:D008107 | Liver Diseases | Tetrachloroethylene | 46.90 | 17267091 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Chlormethiazole | 5.04 | 16054987 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.58 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 7.70 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 7.70 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 7.70 | 17457977 | |
| MESH:D008113 | Liver Neoplasms | 1,2,4,5-tetrachlorobenzene | 94.60 | 9714333 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 94.60 | 16835634 18644402 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 94.60 | 18001218 10737359 16273603 10672840 14678523 11376686 | |
| MESH:D008113 | Liver Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 94.60 | 16353153 | |
| MESH:D008113 | Liver Neoplasms | 2-aminofluorene | 94.60 | 19850985 20452335 20492335 19499222 | |
| MESH:D008113 | Liver Neoplasms | 4-biphenylamine | 94.60 | 15761837 | |
| MESH:D008113 | Liver Neoplasms | 4-dichlorobenzene | 94.60 | 12748734 17688981 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 94.60 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 94.60 | 9643874 | |
| MESH:D008113 | Liver Neoplasms | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | 94.60 | 12970073 | |
| MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 94.60 | 15890375 9163691 18177683 2125692 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 94.60 | 20195826 21137059 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 94.60 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 94.60 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 94.60 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | ciprofibrate | 94.60 | 12771043 | |
| MESH:D008113 | Liver Neoplasms | Clofibric Acid | 94.60 | 17602206 | |
| MESH:D008113 | Liver Neoplasms | dicyclanil | 94.60 | 20118626 | |
| MESH:D008113 | Liver Neoplasms | Dieldrin | 94.60 | 9539021 8742319 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 94.60 | 19499222 19833225 12112319 19642983 20137499 21047994 15175105 21167192 20101389 21071580 19427195 20434301 18648771 19073162 19294768 20405173 18644402 2862719 19812893 20492335 16942905 10737359 18977376 20583210 19690152 15885732 19426721 19996281 18754104 19255062 20452335 19850985 12771043 19256749 19638242 9163691 19254457 18978307 21278145 19090486 20501860 19551842 20118626 2422723 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 94.60 | 15890375 16712894 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 94.60 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 94.60 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fenofibrate | 94.60 | 18978307 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 94.60 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | musk xylene | 94.60 | 9441723 9397191 | |
| MESH:D008113 | Liver Neoplasms | oxfendazole | 94.60 | 18754104 | |
| MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 94.60 | 18709148 14757943 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 94.60 | 19073162 19812893 15975961 21047994 8742319 19482888 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 94.60 | 19690152 18648771 20101389 15890375 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 94.60 | 16377806 20007298 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 94.60 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | propiconazole | 94.60 | 19028983 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 94.60 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 94.60 | 19073162 19812893 19321006 20405173 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 94.60 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 94.60 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 94.60 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | marker/mechanism | 11376689 | ||
| MESH:D008114 | Liver Neoplasms, Experimental | 1-phenylazo-2-naphthol | 48.81 | 2563599 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 48.81 | 6150874 1399818 534488 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4-biphenylamine | 48.81 | 11376689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 48.81 | 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 48.81 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 48.81 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 48.81 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 48.81 | 18308698 18164116 3124819 18544905 17854601 18775883 17942915 19539802 16842330 18079962 9362446 18253720 18093689 19126423 18282651 19004024 21159647 16267830 2563599 19009564 17174075 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 48.81 | 15603536 1848544 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 48.81 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 48.81 | 18775883 18253720 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 48.81 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 48.81 | 1399818 598648 | |
| MESH:D008114 | Liver Neoplasms, Experimental | o-Aminoazotoluene | 48.81 | 16267830 15346788 10887293 11398193 12882633 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 48.81 | 1399818 18308698 17172636 6150874 2563599 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 48.81 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | propiconazole | 48.81 | 17178689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 48.81 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | systhane | 48.81 | 17178689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 48.81 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachloroethylene | 48.81 | 7955063 | |
| MESH:D008133 | Long QT Syndrome | olanzapine | 6.22 | 20210726 | |
| MESH:D008133 | Long QT Syndrome | Quinidine | 6.22 | 15350150 11989578 | |
| MESH:D008133 | Long QT Syndrome | Thioridazine | 6.22 | 20210726 | |
| MESH:D008171 | Lung Diseases | Fluconazole | 7.15 | 14966256 | |
| MESH:D008171 | Lung Diseases | Nitrofurantoin | 7.15 | 14966256 9429087 | |
| MESH:D008171 | Lung Diseases | Ozone | 7.15 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 7.15 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 6.69 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Nitrofurantoin | 6.69 | 18516814 | |
| MESH:D008173 | Lung Diseases, Obstructive | zafirlukast | 4.40 | 9847434 | |
| MESH:D055370 | Lung Injury | 4-ipomeanol | 18.72 | 2384072 | |
| MESH:D055370 | Lung Injury | Ciprofloxacin | 18.72 | 18197910 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 18.72 | 21114838 | |
| MESH:D055370 | Lung Injury | naphthalene | 18.72 | 6834280 | |
| MESH:D055370 | Lung Injury | Nitrofurantoin | 18.72 | 1313237 | |
| MESH:D055370 | Lung Injury | Ozone | 18.72 | 20417186 | |
| MESH:D055370 | Lung Injury | vinylidene chloride | 18.72 | 3697828 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 59.00 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 59.00 | 16353153 | |
| MESH:D008175 | Lung Neoplasms | 4-biphenylamine | 59.00 | 17671175 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 59.00 | 9255578 17139156 18813816 12438228 16061637 15172992 19931552 16401635 15893417 18508827 14755239 | |
| MESH:D008175 | Lung Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 59.00 | 11376689 | |
| MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 59.00 | 14755239 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 59.00 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 59.00 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Azoxymethane | 59.00 | 15824018 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 59.00 | 18816296 20869020 6695378 20064080 20135361 17053015 20464547 18520028 18569708 | |
| MESH:D008175 | Lung Neoplasms | bexarotene | 59.00 | 17849452 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 59.00 | 19359593 19925653 16337739 18597497 15390079 11246140 11696405 | |
| MESH:D008175 | Lung Neoplasms | Ciprofloxacin | 59.00 | 20211752 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 59.00 | 11798837 17225452 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 59.00 | 18462866 19359593 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 59.00 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 59.00 | 21163286 20970405 20512841 6695378 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 59.00 | 19555203 11884234 16061637 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 59.00 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 59.00 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 59.00 | 11497255 16537180 11053908 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 59.00 | 18569708 18816296 18520028 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 59.00 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | Methoxsalen | 59.00 | 15893417 | |
| MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 59.00 | 17909032 1399818 11893704 20512841 21163286 10545420 6695378 9230183 16271038 15390079 16337739 20970405 7750092 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 59.00 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 59.00 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 59.00 | 10814675 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 59.00 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | Smoke | 59.00 | 11091918 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 59.00 | 17306315 19931552 17077188 16712894 15276417 | |
| MESH:D008175 | Lung Neoplasms | Styrene | 59.00 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Sulfur Dioxide | 59.00 | 20064080 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 59.00 | 19359593 15713900 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 59.00 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 59.00 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 59.00 | 11807781 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Rifampin | 4.50 | 11422169 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 4.05 | 16628512 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 4.05 | 16373423 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Rifampin | 4.05 | 11422169 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.52 | 15166399 | |
| MESH:D008223 | Lymphoma | 9,10-Dimethyl-1,2-benzanthracene | 12.13 | 11376689 | |
| MESH:D008223 | Lymphoma | bortezomib | 12.13 | 16098063 | |
| MESH:D008223 | Lymphoma | Curcumin | 12.13 | 18462866 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 12.13 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 12.13 | 16098063 | |
| MESH:D008223 | Lymphoma | Methotrexate | 12.13 | 17352296 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 5.65 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 5.65 | 17088997 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | 2,4-Dichlorophenoxyacetic Acid | 9.12 | 16132792 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 9.12 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 9.12 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 9.12 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 6.28 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 6.28 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | bexarotene | 3.55 | 11161223 | |
| MESH:D008288 | Malaria | artemisinine | 4.11 | 16919048 | |
| MESH:D016778 | Malaria, Falciparum | Perhexiline | 6.53 | 16882315 | |
| MESH:D016778 | Malaria, Falciparum | Thioridazine | 6.53 | 16882315 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 3.86 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 7.77 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Styrene | 7.77 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 7.77 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1-nitropyrene | 32.90 | 6692400 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 32.90 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 5,6-dimethylxanthenoneacetic acid | 32.90 | 16944150 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 32.90 | 18840765 1500032 16082771 11807958 8985016 12844480 16153821 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | bexarotene | 32.90 | 19196722 19196723 15591091 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 32.90 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 32.90 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 32.90 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 32.90 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 32.90 | 11408345 11807958 16891317 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 32.90 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 32.90 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Reserpine | 32.90 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 32.90 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 32.90 | 19196723 14580682 16827153 11731420 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 32.90 | 8985016 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 7.20 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 7.20 | 19453300 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 3.57 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 3.57 | 17453147 | |
| MESH:D008545 | Melanoma | Cisplatin | 16.64 | 18332650 18505091 18176117 17761969 16248763 16809738 12374674 15577323 11135225 17023156 12883367 16432458 12393984 | |
| MESH:D008545 | Melanoma | Curcumin | 16.64 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | Dacarbazine | 16.64 | 16760174 12439608 17562445 17508024 16273263 16508601 18332650 16225601 12202904 16034308 12883367 11746506 10623706 15577320 12417787 18445842 12535206 16809738 11712820 17709802 17761969 16928243 17023156 12393984 17623835 17119449 16939954 12556972 18089842 17576460 15020614 15176220 15577323 12640292 15522559 11135225 11254118 16966688 15917704 18505091 17973783 12025231 17334785 18176117 16248763 16098027 17239242 18281670 | |
| MESH:D008545 | Melanoma | Doxorubicin | 16.64 | 16827129 | |
| MESH:D008545 | Melanoma | Melphalan | 16.64 | 18388930 14993021 | |
| MESH:D008545 | Melanoma | Paclitaxel | 16.64 | 16342250 12025231 12040289 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 16.64 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 16.64 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 16.64 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Sulindac | 16.64 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 16.64 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 16.64 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 16.64 | 16505122 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 16.64 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 10.40 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Dacarbazine | 10.40 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 10.40 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 1.99 | 19513568 | |
| MESH:D008569 | Memory Disorders | Curcumin | 4.92 | 17263510 | |
| MESH:D008569 | Memory Disorders | mangiferin | 4.92 | 19182383 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 2.83 | 16940565 | |
| MESH:D001523 | Mental Disorders | Chlorpromazine | 10.65 | 16856516 | |
| MESH:D001523 | Mental Disorders | Clozapine | 10.65 | 16856516 | |
| MESH:D001523 | Mental Disorders | Fluvoxamine | 10.65 | 16856516 | |
| MESH:D001523 | Mental Disorders | Imipramine | 10.65 | 16856516 | |
| MESH:D001523 | Mental Disorders | olanzapine | 10.65 | 16856516 | |
| MESH:D001523 | Mental Disorders | Thioridazine | 10.65 | 16856516 | |
| MESH:D008607 | Mental Retardation | Carbamazepine | 3.51 | 9014606 | |
| MESH:D008607 | Mental Retardation | Toluene | 3.51 | 9294310 | |
| MESH:D008654 | Mesothelioma | Atrazine | 4.45 | 1916698 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 4.45 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 4.45 | 17638057 | |
| MESH:D008659 | Metabolic Diseases | olanzapine | 5.97 | 19142110 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 5.97 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Clozapine | 3.00 | 19142101 | |
| MESH:D008679 | Metaplasia | Ozone | 3.46 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | marker/mechanism | 12030840 | ||
| MESH:D008708 | Methemoglobinemia | 4-biphenylamine | 12.51 | 12030840 | |
| MESH:D008708 | Methemoglobinemia | 4-nitroaniline | 12.51 | 3710033 | |
| MESH:D008708 | Methemoglobinemia | Lidocaine | 12.51 | 3537620 | |
| MESH:D008708 | Methemoglobinemia | Phenacetin | 12.51 | 16296465 4834387 1949026 3537620 | |
| MESH:D008708 | Methemoglobinemia | Primaquine | 12.51 | 3537620 | |
| MESH:D008850 | Microphthalmos | ochratoxin A | 4.22 | 20036863 | |
| MESH:D008881 | Migraine Disorders | Aspartame | 7.30 | 18627677 10792367 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 7.30 | 11903285 | |
| MESH:D008881 | Migraine Disorders | zafirlukast | 7.30 | 10759916 | |
| MESH:D008881 | Migraine Disorders | zolmitriptan | 7.30 | 16615676 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 2.98 | 15792986 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.43 | 19299654 | |
| MESH:D019957 | Motor Skills Disorders | Toluene | 3.69 | 9294310 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 6.55 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 6.55 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Plant Preparations | 6.55 | 17418620 | |
| MESH:D052016 | Mucositis | Doxorubicin | 7.15 | 17415656 | |
| MESH:D052016 | Mucositis | Methotrexate | 7.15 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | alachlor | 19.84 | 14769641 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 19.84 | 18443271 19549372 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 19.84 | 19112201 19372569 19112817 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 19.84 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 19.84 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 19.84 | 16118317 15867202 15744524 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 19.84 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 19.84 | 17049120 14749477 16490592 16267019 17164350 17935668 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 19.84 | 18172295 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 7.04 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 7.04 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 1.94 | 16239165 | |
| MESH:D009164 | Mycobacterium Infections | Ciprofloxacin | 9.15 | 10063276 | |
| MESH:D009164 | Mycobacterium Infections | Rifampin | 9.15 | 18474467 | |
| MESH:D009164 | Mycobacterium Infections | Ritonavir | 9.15 | 21442799 | |
| MESH:D009175 | Mycoplasma Infections | Chlorpromazine | 4.36 | 10773494 | |
| MESH:D009182 | Mycosis Fungoides | Methoxsalen | 4.99 | 16259964 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 10.28 | 18720364 19805378 17596541 17611569 | |
| MESH:D009190 | Myelodysplastic Syndromes | Ciprofloxacin | 10.28 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 10.28 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Pentoxifylline | 10.28 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 10.28 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 18.82 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Anthracyclines | 18.82 | 17284715 | |
| MESH:D009203 | Myocardial Infarction | Contraceptives, Oral | 18.82 | 11752354 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 18.82 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 18.82 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 18.82 | 15740881 16538859 16584858 16697266 19595682 17052832 19172585 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 18.82 | 16584858 17052832 16697266 16538859 19172585 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 18.82 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 18.82 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 18.82 | 17125593 16456233 16317513 16525036 17015251 17188708 | |
| MESH:D017202 | Myocardial Ischemia | Dioxins | 7.34 | 19057694 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 7.34 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 7.34 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 8.95 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 8.95 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 8.95 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 8.95 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.14 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 2.86 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Carbamazepine | 7.42 | 20399394 | |
| MESH:D009224 | Myotonia Congenita | Quinine | 7.42 | 1896199 | |
| MESH:D009298 | Nasal Polyps | zafirlukast | 9.26 | 10665187 12053594 | |
| MESH:D009298 | Nasal Polyps | zileuton | 9.26 | 10665187 | |
| MESH:D009325 | Nausea | zafirlukast | 4.22 | 10386485 | |
| MESH:D009336 | Necrosis | Melatonin | 9.11 | 12195237 | |
| MESH:D009336 | Necrosis | Warfarin | 9.11 | 14723717 | |
| MESH:D009336 | Necrosis | zafirlukast | 9.11 | 15028970 | |
| MESH:D016870 | Neisseriaceae Infections | Ciprofloxacin | 4.72 | 20378725 | |
| MESH:D009349 | Nematode Infections | Thiabendazole | 4.77 | 16402567 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 2.83 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | clopidogrel | 13.94 | 11875746 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 13.94 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 13.94 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 13.94 | 11053908 16537180 11239499 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 13.94 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Pentoxifylline | 13.94 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | quinoline | 13.94 | 598648 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 13.94 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.76 | 19410462 | |
| MESH:D009369 | Neoplasms | marker/mechanism | |||
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 24.35 | 8820588 | |
| MESH:D009369 | Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 24.35 | 11544531 | |
| MESH:D009369 | Neoplasms | Aspartame | 24.35 | 16507461 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 24.35 | 11141357 | |
| MESH:D009369 | Neoplasms | Cisplatin | 24.35 | 16773208 | |
| MESH:D009369 | Neoplasms | Dieldrin | 24.35 | 8820588 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 24.35 | 15313581 | |
| MESH:D009369 | Neoplasms | Lindane | 24.35 | 16818664 12807735 | |
| MESH:D009369 | Neoplasms | Nicotine | 24.35 | 16365874 | |
| MESH:D009369 | Neoplasms | Oleanolic Acid | 24.35 | 8847885 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 24.35 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 24.35 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 24.35 | 11559025 | |
| MESH:D009369 | Neoplasms | Tetrachloroethylene | 24.35 | 11911487 | |
| MESH:D009369 | Neoplasms | Tretinoin | 24.35 | 16946489 16594593 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 6.38 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 6.38 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 6.38 | 20056578 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | bexarotene | 12.96 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 12.96 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 12.96 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 12.96 | 19196722 19200415 19189210 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 5.08 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | Nicotine | 5.08 | 16365874 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 5.83 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Nitrofurantoin | 5.83 | 19214031 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.17 | 16899518 16636307 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 2.57 | 15640375 16889571 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 3.29 | 17433543 | |
| MESH:D009421 | Nervous System Malformations | Carbamazepine | 18.57 | 16990009 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 18.57 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 18.57 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 18.57 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 18.57 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 18.57 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 3.97 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | ochratoxin A | 4.97 | 20036863 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 4.97 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 4.97 | 9142499 | |
| MESH:D019954 | Neurobehavioral Manifestations | 2,3,3',4,4',5-hexachlorobiphenyl | 11.45 | 19647017 | |
| MESH:D019954 | Neurobehavioral Manifestations | 2,3',4,4',5-pentachlorobiphenyl | 11.45 | 19647017 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 11.45 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 3.39 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 3.39 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 14.58 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 14.58 | 15183010 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 14.58 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 14.58 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 14.58 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 14.58 | 16850258 17266991 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 3.10 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 5.59 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 5.59 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.46 | 20387270 | |
| MESH:D020258 | Neurotoxicity Syndromes | 3-xylene | 6.21 | 7820390 8907413 | |
| MESH:D020258 | Neurotoxicity Syndromes | Chlorpyrifos | 6.21 | 15081274 | |
| MESH:D020258 | Neurotoxicity Syndromes | Malathion | 6.21 | 15081274 | |
| MESH:D009503 | Neutropenia | Ciprofloxacin | 5.34 | 17846019 | |
| MESH:D009503 | Neutropenia | Ritonavir | 5.34 | 17378895 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 6.77 | 9802331 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 6.77 | 9802331 | |
| MESH:D009669 | Nose Neoplasms | alachlor | 3.31 | 15580706 16178123 11127290 14563481 16698726 | |
| MESH:D009765 | Obesity | Clozapine | 7.18 | 18515891 19142110 | |
| MESH:D009765 | Obesity | Curcumin | 7.18 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 7.18 | 16723640 20132043 18457598 20518802 17217161 11836018 21332399 19632207 18674790 | |
| MESH:D009765 | Obesity | olanzapine | 7.18 | 18515891 | |
| MESH:D009765 | Obesity | pirinixic acid | 7.18 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 7.18 | 19056576 20132043 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.52 | 6374098 | |
| MESH:D014009 | Onychomycosis | Fluconazole | 4.71 | 14966256 | |
| MESH:D009889 | Opisthorchiasis | Praziquantel | 5.80 | 8896890 | |
| MESH:D010003 | Osteoarthritis | Aspartame | 5.75 | 9630831 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 5.75 | 7009135 | |
| MESH:D010003 | Osteoarthritis | rofecoxib | 5.75 | 16690336 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 3.37 | 15867366 | |
| MESH:D010018 | Osteomalacia | Carbamazepine | 6.73 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 6.73 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 4.92 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 4.92 | 19401787 | |
| MESH:D010024 | Osteoporosis | kaempferol | 4.92 | 16756079 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 11.61 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 11.61 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 11.61 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 11.61 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.70 | 15930896 | |
| MESH:D010051 | Ovarian Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 17.77 | 16891317 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 17.77 | 15464296 19769630 6897625 17225452 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 17.77 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 17.77 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 17.77 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 17.77 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 17.77 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 17.77 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 17.77 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 17.77 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 17.77 | 19331143 | |
| MESH:D010146 | Pain | Acetaminophen | 24.15 | 16870215 | |
| MESH:D010146 | Pain | Aspartame | 24.15 | 9630831 | |
| MESH:D010146 | Pain | Carbamazepine | 24.15 | 15215642 | |
| MESH:D010146 | Pain | Imipramine | 24.15 | 12798668 | |
| MESH:D010146 | Pain | Indomethacin | 24.15 | 17440234 3291741 17627676 13679232 | |
| MESH:D010146 | Pain | Lidocaine | 24.15 | 15215642 | |
| MESH:D010146 | Pain | Mangifera indica extract | 24.15 | 15177302 16273134 | |
| MESH:D010146 | Pain | Phenol | 24.15 | 17610455 | |
| MESH:D010146 | Pain | Sulindac | 24.15 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 24.15 | 16870215 | |
| MESH:D010146 | Pain | zafirlukast | 24.15 | 11438310 15935457 | |
| MESH:D010146 | Pain | zileuton | 24.15 | 15935457 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 6.17 | 12538197 18702446 | |
| MESH:D010149 | Pain, Postoperative | rofecoxib | 6.17 | 18165598 16678543 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 24.98 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 24.98 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 24.98 | 19196508 17440100 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Dacarbazine | 24.98 | 11583197 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 24.98 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 24.98 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 24.98 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 24.98 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 24.98 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 24.98 | 16820089 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 24.98 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 24.98 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 24.98 | 19294695 | |
| MESH:D010195 | Pancreatitis | artemisinine | 5.89 | 17948936 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 5.89 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | zafirlukast | 5.89 | 15028970 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.15 | 11578682 | |
| MESH:D010212 | Papilloma | 9,10-Dimethyl-1,2-benzanthracene | 6.93 | 17234724 15173996 16517061 | |
| MESH:D010212 | Papilloma | Plant Extracts | 6.93 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 6.93 | 18922899 8330346 12065085 18404319 | |
| MESH:D010243 | Paralysis | Zoxazolamine | 5.31 | 16109766 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.06 | 16537180 | |
| MESH:D010267 | Parapsoriasis | Carbamazepine | 4.09 | 16538176 | |
| MESH:D010300 | Parkinson Disease | Atrazine | 11.88 | 17218051 | |
| MESH:D010300 | Parkinson Disease | Dieldrin | 11.88 | 11445065 17291500 11181820 16112328 16809432 | |
| MESH:D010300 | Parkinson Disease | Ditiocarb | 11.88 | 11445065 | |
| MESH:D010300 | Parkinson Disease | Levodopa | 11.88 | 7566641 18328768 19594199 20334432 11432539 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 11.88 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 11.88 | 16702228 | |
| MESH:D010300 | Parkinson Disease | Selegiline | 11.88 | 18328768 | |
| MESH:D010300 | Parkinson Disease | tolcapone | 11.88 | 20216409 19578428 1977408 11746615 8635184 9591521 9708959 7566641 10651109 11586115 8739811 9305320 11793426 20334432 17089403 9754991 9333106 16758261 11432539 19783845 18328768 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 7.17 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Levodopa | 7.17 | 18722529 11246459 8817341 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 7.17 | 15574749 | |
| OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 4.29 | 17679678 17145499 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.06 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 8.33 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 8.33 | 12520081 | |
| MESH:D010392 | Pemphigus | Phenol | 4.79 | 16522979 17163923 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.52 | 11148446 | |
| MESH:D010518 | Periodontitis | etoricoxib | 11.36 | 17225004 | |
| MESH:D010518 | Periodontitis | Indomethacin | 11.36 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 11.36 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.65 | 15464296 | |
| MESH:D010523 | Peripheral Nervous System Diseases | n-hexane | 5.65 | 16484137 | |
| MESH:D010538 | Peritonitis | Melatonin | 8.14 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 8.14 | 16369182 | |
| MESH:D010538 | Peritonitis | zileuton | 8.14 | 17371808 | |
| MESH:D010612 | Pharyngitis | zafirlukast | 5.08 | 9377612 10386485 | |
| MESH:D003557 | Phyllodes Tumor | Dacarbazine | 8.91 | 17983394 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 8.91 | 17983394 | |
| MESH:D010864 | Pilonidal Sinus | Phenol | 4.79 | 15622588 19655223 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 3.52 | 14722030 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.08 | 15687265 16977796 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 8.48 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 8.48 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 9.42 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 9.42 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 9.42 | 18007984 18929643 18381685 | |
| MESH:D011041 | Poisoning | Diazinon | 6.28 | 17603234 | |
| MESH:D011041 | Poisoning | Organophosphorus Compounds | 6.28 | 17098105 | |
| MESH:D011041 | Poisoning | Phenol | 6.28 | 8825745 | |
| MESH:D011115 | Polyneuropathies | Organophosphorus Compounds | 4.67 | 16042503 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 10.02 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 10.02 | 18163543 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Uroporphyrinogens | 10.02 | 17360334 | |
| MESH:D011164 | Porphyrias | 1,2,4-trichlorobenzene | 5.16 | 6636202 | |
| MESH:D011230 | Precancerous Conditions | 1-phenylazo-2-naphthol | 17.18 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Azoxymethane | 17.18 | 14668109 19056647 12458338 | |
| MESH:D011230 | Precancerous Conditions | bromodichloromethane | 17.18 | 14668109 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 17.18 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 17.18 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 17.18 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Daunorubicin | 4.21 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 4.21 | 21297632 | |
| MESH:D011248 | Pregnancy Complications | 2,4-Dichlorophenoxyacetic Acid | 13.15 | 2087686 | |
| MESH:D011248 | Pregnancy Complications | bromodichloromethane | 13.15 | 17344021 14657523 12970577 | |
| MESH:D011248 | Pregnancy Complications | Carbamazepine | 13.15 | 9014606 | |
| MESH:D011248 | Pregnancy Complications | Nitrofurantoin | 13.15 | 19789166 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.52 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 17.64 | 9014606 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 17.64 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 17.64 | 17132714 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 17.64 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 17.64 | 11222880 11118676 11399792 11896295 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 17.64 | 18042343 18220299 19015723 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 3.65 | 17616702 | |
| MESH:D011469 | Prostatic Diseases | vinclozolin | 3.30 | 18220299 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 2.37 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 6.37 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 6.37 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | biochanin A | 6.37 | 12111696 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 6.37 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 6.37 | 18769126 10851300 12497104 18156803 11398177 18226269 15129424 | |
| MESH:D011471 | Prostatic Neoplasms | diallyl disulfide | 6.37 | 16691315 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 6.37 | 17136230 15846301 15046698 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 6.37 | 15749863 15897917 16888761 18437689 16868541 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 6.37 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 6.37 | 15256057 15378649 16925846 | |
| MESH:D011471 | Prostatic Neoplasms | Ketoconazole | 6.37 | 17404083 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 6.37 | 14688026 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | Melphalan | 6.37 | 15749863 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 6.37 | 17136230 17172428 16356831 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 6.37 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 6.37 | 15721890 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 6.37 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 6.37 | 15767336 17804756 16731767 17675339 17718901 17636462 | |
| MESH:D011471 | Prostatic Neoplasms | Simazine | 6.37 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 6.37 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 6.37 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 6.37 | 19789329 18798265 | |
| MESH:D011472 | Prostatitis | vinclozolin | 3.30 | 18629315 | |
| MESH:D020151 | Protein C Deficiency | Warfarin | 4.72 | 18376272 | |
| MESH:D011507 | Proteinuria | Indomethacin | 4.32 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 4.32 | 16636307 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 4.66 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | zileuton | 4.66 | 17827870 19657356 | |
| MESH:D019310 | Pseudolymphoma | Carbamazepine | 7.14 | 9591791 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 7.14 | 12752131 | |
| MESH:D011565 | Psoriasis | Methotrexate | 3.74 | 17410198 | |
| MESH:D011565 | Psoriasis | Methoxsalen | 3.74 | 16259964 | |
| MESH:D011595 | Psychomotor Agitation | olanzapine | 4.00 | 18685284 | |
| MESH:D011618 | Psychotic Disorders | Clozapine | 5.03 | 15331141 | |
| MESH:D011618 | Psychotic Disorders | Thioridazine | 5.03 | 16882315 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.16 | 16723453 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | Theophylline | 5.70 | 18983928 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | zafirlukast | 5.70 | 12877822 12781059 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 12.64 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | Nitrofurantoin | 12.64 | 9429087 | |
| MESH:D011654 | Pulmonary Edema | zafirlukast | 12.64 | 18309904 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 12.64 | 18309904 | |
| MESH:D011655 | Pulmonary Embolism | Warfarin | 4.72 | 19300499 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.03 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 4.35 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 3.58 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | Nitrofurantoin | 3.58 | 1551546 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.75 | 15830843 | |
| MESH:D012003 | Rectal Fistula | Ciprofloxacin | 9.16 | 18371140 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 9.16 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | bromodichloromethane | 4.43 | 17535441 | |
| MESH:D012021 | Reflex, Abnormal | Pentobarbital | 4.39 | 10930210 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 8.17 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 8.17 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 8.17 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 3.93 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 6.48 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 6.48 | 17520802 15827377 16314181 17058453 16317513 | |
| MESH:D015427 | Reperfusion Injury | zafirlukast | 6.48 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 6.48 | 15266012 9865762 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 4.31 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 4.31 | 11700416 18379247 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.50 | 10835634 | |
| MESH:D012131 | Respiratory Insufficiency | Organophosphorus Compounds | 4.72 | 16449848 17098105 | |
| MESH:D012135 | Respiratory Sounds | alachlor | 17.25 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Atrazine | 17.25 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Chlorpyrifos | 17.25 | 16611668 11874814 17119214 | |
| MESH:D012135 | Respiratory Sounds | Fonofos | 17.25 | 16611668 | |
| MESH:D012135 | Respiratory Sounds | Malathion | 17.25 | 17119214 11874814 | |
| MESH:D012135 | Respiratory Sounds | Parathion | 17.25 | 11874814 17119214 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.26 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Chlorpyrifos | 12.25 | 17119214 16611668 | |
| MESH:D012140 | Respiratory Tract Diseases | Fonofos | 12.25 | 16611668 | |
| MESH:D012140 | Respiratory Tract Diseases | Malathion | 12.25 | 17119214 | |
| MESH:D012140 | Respiratory Tract Diseases | Parathion | 12.25 | 17119214 | |
| MESH:D012170 | Retinal Vein Occlusion | clopidogrel | 4.52 | 19371211 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 3.32 | 16849425 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 2.56 | 16116481 16283617 | |
| MESH:D012220 | Rhinitis | zafirlukast | 4.82 | 7767514 20332717 12742009 | |
| MESH:D012220 | Rhinitis | zileuton | 4.82 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 3.66 | 15015336 | |
| MESH:D012509 | Sarcoma | Curcumin | 10.48 | 18462866 | |
| MESH:D012509 | Sarcoma | Dacarbazine | 10.48 | 17898927 18313854 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 10.48 | 15625365 18313854 16767912 17203757 17710206 15675481 | |
| MESH:D012509 | Sarcoma | Polysaccharides | 10.48 | 18753065 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 5.29 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 5.29 | 14601052 16326096 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.17 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 3.89 | 16862918 | |
| MESH:D012559 | Schizophrenia | Clozapine | 2.96 | 11763009 20107430 19369910 20452607 20521320 17726453 17667964 20168265 17123785 20580759 16141801 18855531 18806925 11151749 20521326 | |
| MESH:D012559 | Schizophrenia | norclozapine | 2.96 | 11151749 | |
| MESH:D012559 | Schizophrenia | olanzapine | 2.96 | 20107430 20521326 17726453 | |
| MESH:C537537 | Segawa syndrome, autosomal recessive | Levodopa | 5.07 | 8817341 | |
| MESH:D012640 | Seizures | 3-xylene | 13.09 | 6431079 8907413 | |
| MESH:D012640 | Seizures | Carbamazepine | 13.09 | 15946322 19414003 16180713 16876388 16938433 9844417 9046859 | |
| MESH:D012640 | Seizures | Lindane | 13.09 | 15475178 7539098 12842176 | |
| MESH:D012640 | Seizures | Nicotine | 13.09 | 17873105 | |
| MESH:D012640 | Seizures | Pentobarbital | 13.09 | 10087439 9754883 | |
| MESH:D012640 | Seizures | Phenobarbital | 13.09 | 3137016 4039156 11442880 16876388 | |
| MESH:D012640 | Seizures | Secobarbital | 13.09 | 9806000 | |
| MESH:D012640 | Seizures | stiripentol | 13.09 | 10454489 | |
| MESH:D012640 | Seizures | Toluene | 13.09 | 6431079 9294310 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.19 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 2.67 | 18389075 | |
| MESH:D012729 | Sex Chromosome Aberrations | Chlorpyrifos | 4.43 | 6418539 | |
| MESH:D012772 | Shock, Septic | Mangifera indica extract | 6.30 | 15177305 | |
| MESH:D012772 | Shock, Septic | mangiferin | 6.30 | 15177305 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 9.66 | 7327846 | |
| MESH:D012852 | Sinusitis | zafirlukast | 9.66 | 10386485 10665187 | |
| MESH:D012852 | Sinusitis | zileuton | 9.66 | 10665187 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Warfarin | 4.27 | 12269725 | |
| MESH:D012859 | Sjogren's Syndrome | Aspartame | 4.93 | 16800424 | |
| MESH:D012871 | Skin Diseases | monomethylarsonic acid | 3.45 | 21378128 | |
| MESH:D012878 | Skin Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 17.72 | 15173996 8985016 16517061 11376689 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 17.72 | 10029692 19755658 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 17.72 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Melphalan | 17.72 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 17.72 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 17.72 | 8985016 15837718 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 17.72 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 17.72 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 17.72 | 12065085 8330346 11807781 18404319 8985016 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 17.72 | 16467112 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 4.24 | 19118273 | |
| MESH:D012892 | Sleep Deprivation | Imipramine | 4.57 | 19798453 | |
| MESH:D012893 | Sleep Disorders | Caffeine | 9.02 | 19395429 | |
| MESH:D012893 | Sleep Disorders | Carbamazepine | 9.02 | 19414003 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 9.02 | 16897403 16919138 18182647 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 4.98 | 19452292 18078449 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Caffeine | 7.88 | 17225163 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 7.88 | 18078449 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | ramelteon | 7.88 | 17069551 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.69 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 2.98 | 15625365 17203757 16767912 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 15.99 | 16002989 16709447 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 15.99 | 16709447 | |
| MESH:D013088 | Spermatocele | Phenol | 15.99 | 18646496 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 15.99 | 16709447 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 5.99 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 5.99 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.41 | 12854658 | |
| MESH:D013158 | Splenic Diseases | aniline | 8.18 | 15694462 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 8.18 | 12587719 | |
| MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 4.77 | 1977408 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 3.63 | 16538176 20485159 18855540 16415921 19915237 15057820 19694795 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 7.95 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 7.95 | 18209964 18545984 17160473 16280098 10486359 10192188 10215738 15472012 17207306 16113693 15038085 17638125 16184426 | |
| MESH:D013272 | Stomach Diseases | Omeprazole | 7.95 | 18545984 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 7.73 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | benzofuran | 7.73 | 11397402 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 7.73 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 7.73 | 18396642 15958060 17522103 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 7.73 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 7.73 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 7.73 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 7.73 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 7.73 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 7.73 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 7.73 | 17261132 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 19.86 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 19.86 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 19.86 | 11906479 11523592 16755016 15255614 18299717 11595431 14567935 17657623 17977527 18237397 16397915 18193104 17918041 16169175 11595415 12467913 11729361 16252198 16150113 11145282 10750652 12500499 18431645 12498302 17627676 16934674 18543354 18726076 18087811 10423059 17135157 12787963 17895592 17654042 15104355 18181030 12077510 18209962 15138204 1323529 16631530 10878458 | |
| MESH:D013276 | Stomach Ulcer | lansoprazole | 19.86 | 18726076 18087811 17895592 17918041 11906479 | |
| MESH:D013276 | Stomach Ulcer | Mangifera indica extract | 19.86 | 19305363 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 19.86 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 19.86 | 16150113 11523592 12500499 | |
| MESH:D013276 | Stomach Ulcer | Nifedipine | 19.86 | 14653237 | |
| MESH:D013276 | Stomach Ulcer | Omeprazole | 19.86 | 18237397 10750652 16755016 15991576 17977527 11906479 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 19.86 | 18193104 17135157 12787963 15255614 18237397 | |
| MESH:D020521 | Stroke | Warfarin | 3.63 | 19300499 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 2.98 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 8.23 | 17634840 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 8.23 | 18364113 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 3.52 | 9754883 11529278 | |
| MESH:D013436 | Sulfhemoglobinemia | Phenacetin | 4.90 | 978859 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.47 | 9562676 | |
| MESH:D017180 | Tachycardia, Ventricular | olanzapine | 6.16 | 20210726 | |
| MESH:D017180 | Tachycardia, Ventricular | Thioridazine | 6.16 | 20210726 | |
| MESH:D024801 | Tauopathies | Albendazole | 10.22 | 16930453 | |
| MESH:D024801 | Tauopathies | Daunorubicin | 10.22 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 10.22 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 7.83 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 7.83 | 17997062 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 5.61 | 15864552 | |
| MESH:D013733 | Testicular Diseases | Toluene | 5.61 | 10048760 10514026 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.09 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 7.91 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Aspartame | 7.91 | 17534100 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 7.91 | 15821434 | |
| MESH:D013923 | Thromboembolism | Acenocoumarol | 8.70 | 18698879 | |
| MESH:D013923 | Thromboembolism | Warfarin | 8.70 | 18698879 16960144 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 9.57 | 11994571 | |
| MESH:D019851 | Thrombophilia | Gestodene | 9.57 | 11994571 | |
| MESH:D019851 | Thrombophilia | Warfarin | 9.57 | 17493413 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 10.04 | 15669648 | |
| MESH:D013927 | Thrombosis | Gestodene | 10.04 | 15669648 | |
| MESH:D013927 | Thrombosis | Ticlopidine | 10.04 | 19432301 | |
| MESH:D013927 | Thrombosis | Warfarin | 10.04 | 19300499 17245631 15720958 11307788 17672075 11518727 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.26 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | alachlor | 15.95 | 8812207 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 15.95 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Dacarbazine | 15.95 | 15634649 11815960 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 15.95 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 15.95 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 15.95 | 14736730 18791128 11352223 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 15.95 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 15.95 | 17045167 16026305 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.03 | 19048282 | |
| OMIM:188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | Nicotine | 3.39 | 16785264 16720336 11259349 | |
| MESH:D014029 | Tobacco Use Disorder | Nicotine | 3.85 | 17979512 15735609 18305452 18041664 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 4.98 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 4.98 | 16051514 | |
| MESH:D014123 | Toxoplasmosis | Ciprofloxacin | 4.38 | 20186551 | |
| MESH:D014235 | Trichinellosis | Mangifera indica extract | 9.33 | 14669257 | |
| MESH:D014235 | Trichinellosis | mangiferin | 9.33 | 14669257 | |
| MESH:D014277 | Trigeminal Neuralgia | Phenol | 4.79 | 10223447 16527771 | |
| MESH:D014376 | Tuberculosis | Rifampin | 4.25 | 18397238 15236969 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.25 | 16040207 | |
| MESH:D018088 | Tuberculosis, Multidrug-Resistant | tolcapone | 4.30 | 19578428 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.28 | 10574470 17380554 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 33.63 | 15289314 1399818 15867355 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Naphthylamine | 33.63 | 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-nitroanisole | 33.63 | 14729594 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4-biphenylamine | 33.63 | 11144890 12376482 17671175 6654951 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 33.63 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 33.63 | 15537745 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Ciprofloxacin | 33.63 | 15028437 10741713 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 33.63 | 12973940 15464296 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 33.63 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 33.63 | 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 33.63 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Nitrofurantoin | 33.63 | 15028437 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Phenacetin | 33.63 | 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 33.63 | 11251952 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 33.63 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 33.63 | 16452187 16712894 11723127 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 33.63 | 17572228 16712894 8653321 | |
| MESH:D014552 | Urinary Tract Infections | Nitrofurantoin | 4.94 | 1551546 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.63 | 18462866 | |
| MESH:D014570 | Urologic Diseases | Diazinon | 3.64 | 16487989 | |
| MESH:D014581 | Urticaria | Acetaminophen | 4.17 | 10982225 | |
| MESH:D014581 | Urticaria | zafirlukast | 4.17 | 14512923 14713918 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 18.04 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 18.04 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 18.04 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 18.04 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 18.04 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 18.04 | 16129372 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 3.52 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 17.63 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 17.63 | 16690809 15809267 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 17.63 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 17.63 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 17.63 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 17.63 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 2.97 | 16752155 | |
| MESH:D014605 | Uveitis | Dexamethasone | 3.18 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 9.52 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Dacarbazine | 9.52 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 9.52 | 16002989 16513791 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 2.81 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 2.94 | 12125929 | |
| MESH:D014657 | Vasculitis | Warfarin | 7.46 | 20337814 | |
| MESH:D014657 | Vasculitis | zafirlukast | 7.46 | 12189465 | |
| MESH:D020301 | Vasospasm, Intracranial | Nicardipine | 10.41 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | Papaverine | 10.41 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 10.41 | 18364113 | |
| MESH:D014689 | Venous Insufficiency | coumarin | 4.13 | 12708602 | |
| MESH:D054556 | Venous Thromboembolism | Warfarin | 4.72 | 18776969 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 5.71 | 14671159 15869587 | |
| MESH:D020246 | Venous Thrombosis | Warfarin | 5.71 | 14723717 15733061 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Dietary Sucrose | 15.55 | 18551017 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 15.55 | 17334414 17638931 17678736 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 15.55 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 15.55 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 15.55 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 7.49 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 7.49 | 18097624 | |
| MESH:D014820 | Vitiligo | Methoxsalen | 9.59 | 16259964 | |
| MESH:D014820 | Vitiligo | tolcapone | 9.59 | 10573327 | |
| MESH:D014820 | Vitiligo | Tretinoin | 9.59 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 6.12 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 6.12 | 11897121 | |
| MESH:D014860 | Warts | Phenol | 4.45 | 19122958 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.60 | 15886252 | |
| MESH:D015430 | Weight Gain | Clozapine | 7.97 | 20107430 17502770 16141801 16402076 20564506 20521320 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 7.97 | 16723640 | |
| MESH:D015430 | Weight Gain | olanzapine | 7.97 | 19434072 17933447 20107430 | |
| MESH:D015431 | Weight Loss | Clozapine | 3.46 | 17933447 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.50 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 6.32 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Estrogens | 6.32 | 11172683 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 6.32 | 19894650 20213670 |
| Pathway ID | Pathway Name |
|---|---|
| REACT:13433 | Biological oxidations |
| KEGG:00232 | Caffeine metabolism |
| KEGG:00982 | Drug metabolism - cytochrome P450 |
| KEGG:00591 | Linoleic acid metabolism |
| KEGG:01100 | Metabolic pathways |
| KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 |
| KEGG:00830 | Retinol metabolism |
| KEGG:00380 | Tryptophan metabolism |
| Releated gene ID | Related gene Name |
|---|---|
| PA27093 | CYP1A2 |
| PA378 | NR1I2 |
| Releated disease ID | Related disease Name |
|---|---|
| PA447300 | Acquired Long QT Syndrome (aLQTS) |
| PA444807 | Long QT Syndrome |
| PA446852 | Hot Flashes |
| PA446411 | Endometrial Neoplasms |
| PA447196 | Anxiety Disorders |
| PA443434 | Arthritis, Rheumatoid |
| PA443635 | Cardiovascular Diseases |
| PA446876 | Substance-Related Disorders |
| PA444065 | Epilepsy |
| PA445876 | Tobacco Use Disorder |
| PA443430 | Arthritis |
| PA445451 | Psoriasis |
| PA447321 | Depressive Disorder, Major |
| PA445019 | Myocardial Infarction |
| PA443450 | Asthma |
| PA446863 | Hepatitis C, Chronic |
| PA445062 | Neoplasms |
| PA447278 | Depression |
| PA444447 | Carcinoma, Hepatocellular |
| PA445204 | Ovarian Neoplasms |
| PA447268 | tardive dyskinesia |
| PA445254 | Parkinson Disease |
| PA447216 | Schizophrenia |
| PA443890 | Diabetes Mellitus, Type 2 |
| PA443560 | Breast Neoplasms |
| PA445629 | Seizures |
| PA443937 | Drug Toxicity |
| PA446108 | Colorectal Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA449319 | digoxin |
| PA451260 | ritonavir |
| PA163522473 | tipranavir |
| PA448964 | chlorpromazine |
| PA451666 | thioridazine |
| PA451771 | trifluoperazine |
| PA164754789 | conjugated estrogens |
| PA449509 | estrogens |
| PA451752 | triamterene |
| PA450897 | phenacetin |
| PA450947 | phenytoin |
| PA10035 | bromazepam |
| PA10816 | ezetimibe |
| PA451976 | zolpidem |
| PA449349 | diphenhydramine |
| PA450522 | mirtazapine |
| PA449527 | ethinyl estradiol |
| PA450475 | metoclopramide |
| PA10804 | imatinib |
| PA10066 | duloxetine |
| PA164712507 | Anxiolytics |
| PA450626 | nicotine |
| PA450192 | leflunomide |
| PA451250 | rifampin |
| PA450214 | levofloxacin |
| PA448710 | caffeine |
| PA448015 | acetaminophen |
| PA165820585 | 1,7-dimethylxanthine |
| PA452229 | antidepressants |
| PA164713257 | Selective serotonin reuptake inhibitors |
| PA452614 | furafylline |
| PA448073 | ethanol |
| PA451646 | theobromine |
| PA165109660 | genistein |
| PA450801 | paroxetine |
| PA452347 | glucocorticoids |
| PA451999 | interferons |
| PA451241 | ribavirin |
| PA449247 | dexamethasone |
| PA449552 | etoposide |
| PA450496 | midazolam |
| PA451611 | teniposide |
| PA450401 | methadone |
| PA452616 | debrisoquine |
| PA450373 | mephenytoin |
| PA451718 | tolbutamide |
| PA452604 | xenobiotics |
| PA449165 | cyclophosphamide |
| PA450761 | paclitaxel |
| PA451581 | tamoxifen |
| PA452620 | tegafur |
| PA449048 | clomipramine |
| PA449676 | fluphenazine |
| PA451333 | sertraline |
| PA450226 | lidocaine |
| PA131550706 | echinacea |
| PA448333 | alprazolam |
| PA449167 | cyclosporine |
| PA449233 | desipramine |
| PA450266 | loratadine |
| PA154410481 | prasugrel |
| PA451701 | tizanidine |
| PA451906 | warfarin |
| PA448785 | carbamazepine |
| PA449053 | clopidogrel |
| PA452606 | zoxazolamine |
| PA448710 | caffeine |
| PA449015 | citalopram |
| PA449061 | clozapine |
| PA449160 | cyclobenzaprine |
| PA449503 | estradiol |
| PA449690 | fluvoxamine |
| PA449841 | haloperidol |
| PA449969 | imipramine |
| PA450595 | naproxen |
| PA450705 | ondansetron |
| PA451145 | propranolol |
| PA451251 | riluzole |
| PA451271 | ropivacaine |
| PA451576 | tacrine |
| PA451647 | theophylline |
| PA451868 | verapamil |
| PA451975 | zolmitriptan |
| PA448383 | amiodarone |
| PA450492 | mibefradil |
| PA451686 | ticlopidine |
| PA450530 | modafinil |
| PA451668 | thiotepa |
| PA452233 | antipsychotics |
| PA450688 | olanzapine |
| PA449273 | dextromethorphan |
| PA450268 | losartan |
| PA450704 | omeprazole |
| PA451089 | pravastatin |
| PA450911 | phenobarbital |
| PA450970 | pioglitazone |
| PA449563 | exemestane |
| PA449001 | cimetidine |
| PA449394 | donepezil |
| PA451103 | primaquine |
| PA452609 | aflatoxin b1 |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB07453 | - | 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00030 | inducer | Insulin recombinant | Hypoglycemic Agents |
| DB00046 | inducer | Humalog Mix75/25 | Hypoglycemic Agents;Antidiabetic |
| DB00047 | inducer | Insulin Glargine | Hypoglycemic Agents;Antidiabetic |
| DB00071 | inducer | Insulin, porcine | Hypoglycemic Agents |
| DB00170 | substrate | Menadione | Dietary supplement;Micronutrient;Antifibrinolytic Agents;Vitamins/minerals;Vitamins |
| DB00176 | inhibitor | Fluvoxamine | Anti-anxiety Agents;Selective Serotonin Reuptake Inhibitors (SSRIs);Antidepressive Agents;Serotonin Uptake Inhibitors;Antidepressive Agents, Second-Generation |
| DB00184 | inducer | Nicotine | Anti-craving Agents;Central Nervous System Agents;Autonomic drugs;Nicotinic Agonists;Ganglionic Stimulants |
| DB00188 | substrate | Bortezomib | Antineoplastic Agents;Protease Inhibitors |
| DB00191 | inhibitor | Fen-phen | Adrenergic Agents;Central Nervous System Stimulants;Sympathomimetics;Central Nervous System Agents;Appetite Depressants;Anorexigenic Agents;Stimulants |
| DB00195 | substrate | Betaxolol | Antihypertensive Agents;Adrenergic beta-Antagonists;Sympatholytics;EENT Drugs |
| DB00199 | inhibitor | T-Stat Pad-Lot | Anti-Bacterial Agents;Macrolides |
| DB00201 | inhibitor | Wigraine Tab | Central Nervous System Stimulants;Anorexigenic Agents;Phosphodiesterase Inhibitors |
| DB00208 | inhibitor | Ticlopidine | Platelet Aggregation Inhibitors;Fibrinolytic Agents |
| DB00213 | inducer | Pantoprazole | Anti-Ulcer Agents;Proton-pump Inhibitors |
| DB00215 | inhibitor | Citalopram | Antidepressants;Selective Serotonin Reuptake Inhibitors (SSRIs);Serotonin Uptake Inhibitors;Antidepressive Agents, Second-Generation |
| DB00220 | inhibitor | Nelfinavir | Anti-HIV Agents;HIV Protease Inhibitors |
| DB00238 | inhibitor | Nevirapine | Anti-HIV Agents;Nonnucleoside Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
| DB00246 | substrate | Ziprasidone | Antipsychotics;Dopamine Antagonists;Serotonin Antagonists;Antipsychotic Agents |
| DB00257 | inhibitor | Lotrisone | Antifungal Agents;Anti-Infective Agents, Local;Growth Inhibitors |
| DB00261 | substrate | Anagrelide | Antithrombotic Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents |
| DB00262 | substrate | Carmustine | Antineoplastic Agents;Antineoplastic Agents, Alkylating |
| DB00268 | inhibitor | Ropinirole | Central Nervous System Agents;Antiparkinson Agents;Antidyskinetics;Dopamine Agonists |
| DB00277 | inhibitor | Theophylline rougier elixir | Vasodilator Agents;Phosphodiesterase Inhibitors;Bronchodilator Agents;Respiratory Smooth Muscle Relaxants |
| DB00281 | inhibitor | Xylonor Spray | Antiarrhythmic Agents;Anesthetics;Anesthetics, Local;Anti-Arrhythmia Agents |
| DB00286 | substrate | Prempro | Estrogens |
| DB00296 | substrate | Ropivacaine | Anesthetics;Local Anesthetics;Anesthetics, Local |
| DB00297 | substrate | Sensorcaine Forte | Anesthetics, Local |
| DB00300 | inhibitor | Truvada | Anti-HIV Agents;Nucleoside and Nucleotide Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
| DB00313 | inhibitor | Valproic Acid | Anticonvulsants;Enzyme Inhibitors;Antimanic Agents;GABA Agents |
| DB00315 | substrate | Zolmitriptan | Vasoconstrictor Agents;Anti-inflammatory Agents;Anti-migraine Agents;Selective Serotonin Agonists;Serotonin Agonists |
| DB00316 | substrate | Zydone | Analgesics, Non-Narcotic;Antipyretics |
| DB00321 | substrate | Triavil Tab | Adrenergic Uptake Inhibitors;Analgesics, Non-Narcotic;Antidepressive Agents, Tricyclic |
| DB00325 | inhibitor | Cora-Bosan B43 | Antihypertensive Agents;Vasodilator Agents;Nitric Oxide Donors;Indicators and Reagents |
| DB00333 | substrate | Methadone | Narcotics;Analgesics;Opiate Agonists;Antitussives;Analgesics, Opioid;Antitussive Agents |
| DB00334 | substrate | Olanzapine | Antiemetics;Antipsychotics;Antipsychotic Agents;Serotonin Uptake Inhibitors |
| DB00338 | inducer | Omeprazole | Anti-Ulcer Agents;Enzyme Inhibitors;Proton-pump Inhibitors |
| DB00339 | substrate | Rifater - Tab | Antitubercular Agents |
| DB00342 | - | Terfenadine | Antiarrhythmic Agents;Anti-Allergic Agents;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
| DB00356 | substrate | Parafon Forte Tablets | Muscle Relaxants, Central |
| DB00357 | inducer | Aminoglutethimide | Antineoplastic Agents;Adrenergic Agents;Antineoplastic Agents, Hormonal;Aromatase Inhibitors |
| DB00363 | inhibitor | Clozapine | Antipsychotics;Serotonin Antagonists;Antipsychotic Agents;GABA Antagonists |
| DB00365 | substrate | Grepafloxacin | Anti-Infectives;Anti-Bacterial Agents;Quinolones;Antibiotics |
| DB00368 | inhibitor | Norepinephrine | Vasoconstrictor Agents;Sympathomimetics;Adrenergic alpha-Agonists |
| DB00370 | substrate | Mirtazapine | Histamine H1 Antagonists;Adrenergic alpha-Antagonists;Antidepressive Agents, Tricyclic |
| DB00377 | substrate | Palonosetron | Antiemetics;Serotonin Antagonists |
| DB00379 | inhibitor | Mexiletine | Anti-Arrhythmia Agents |
| DB00381 | inhibitor | Lotrel | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers;Antianginals |
| DB00382 | substrate | Tacrine | Parasympathomimetics;Cholinesterase Inhibitors;Nootropic Agents |
| DB00384 | inhibitor | Riva-Zide 50/25mg Tablets | Diuretics;Potassium-sparing Diuretics |
| DB00388 | inducer | Vasosulf Oph Soln | Vasoconstrictor Agents;Sympathomimetics;Adrenergic alpha-Agonists;Mydriatics;Cardiotonic Agents;Nasal Decongestants |
| DB00396 | substrate | Synovex S | Contraceptives;Progestins |
| DB00397 | inhibitor | Tussaminic DH Pediatric Syrup | Sympathomimetics;Appetite Depressants;Adrenergic alpha-Agonists;Nasal Decongestants |
| DB00398 | inhibitor | Sorafenib | Antineoplastic Agents;Protein Kinase Inhibitors;Anticancer Agents |
| DB00400 | substrate | Griseofulvin | Antibiotics, Antifungal;Antibacterial Agents |
| DB00401 | inhibitor | Nisoldipine | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
| DB00412 | inhibitor | Avandaryl | Hypoglycemic Agents;Vasodilator Agents;Fibrinolytic Agents;Thazolidinediones |
| DB00418 | inducer | Secobarbital | Hypnotics and Sedatives;Adjuvants, Anesthesia;GABA Modulators;Barbiturates;Adjuvants |
| DB00420 | substrate | Promazine | Antiemetics;Antipsychotics;Dopamine Antagonists;Neuroleptics;Phenothiazines;Antipsychotic Agents |
| DB00425 | substrate | Zolpidem | GABA Agonists;Hypnotics and Sedatives |
| DB00448 | inducer | Lansoprazole | Anti-Infective Agents;Anti-Infectives;Anti-Ulcer Agents;Enzyme Inhibitors;Proton-pump Inhibitors |
| DB00458 | inhibitor | Imipramine | Adrenergic Uptake Inhibitors;Antidepressive Agents, Tricyclic;Norepinephrine-Reuptake Inhibitors |
| DB00467 | inhibitor | Enoxacin | Anti-Infective Agents;Nucleic Acid Synthesis Inhibitors |
| DB00468 | inducer | Triogene for | Antimalarials;Analgesics, Non-Narcotic;Muscle Relaxants, Central |
| DB00472 | inhibitor | Fluoxetine | Selective Serotonin Reuptake Inhibitors (SSRIs);Antidepressants, Second-Generation;Serotonin Uptake Inhibitors;Antidepressive Agents, Second-Generation |
| DB00476 | substrate | Duloxetine | Dopamine Uptake Inhibitors;Adrenergic Uptake Inhibitors;Antidepressive Agents;Serotonin Uptake Inhibitors |
| DB00477 | substrate | Chlorpromazine | Antiemetics;Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
| DB00487 | inhibitor | Pefloxacin | Anti-Infective Agents;Nucleic Acid Synthesis Inhibitors |
| DB00499 | inhibitor | Flutamide | Antineoplastic Agents, Hormonal;Androgen Antagonists |
| DB00501 | inhibitor | Cimetidine | Anti-Ulcer Agents;Analgesics;Enzyme Inhibitors;Adjuvants;Histamine Antagonists;Histamine H2 Antagonists |
| DB00502 | substrate | Haloperidol | Antiemetics;Antidyskinetics;Antipsychotics;Dopamine Antagonists;Antipsychotic Agents;Butyrophenones;Anti-Dyskinesia Agents |
| DB00503 | inducer | Kaletra | Anti-HIV Agents;HIV Protease Inhibitors |
| DB00518 | inducer | Albendazole | Anthelmintics;Anticestodal Agents;Antiprotozoal Agents;Tubulin Modulators |
| DB00523 | inhibitor | Alitretinoin | Antineoplastic Agents;Keratolytic Agents |
| DB00526 | substrate | Oxaliplatin | Antineoplastic Agents |
| DB00530 | - | Erlotinib | Protein Kinase Inhibitors |
| DB00532 | - | Mephenytoin | Anticonvulsants |
| DB00533 | inhibitor | Rofecoxib | Cyclooxygenase Inhibitors;Cyclooxygenase 2 Inhibitors |
| DB00537 | inhibitor | Ciprodex | Anti-Infective Agents;Anti-Infectives;Quinolones;Nucleic Acid Synthesis Inhibitors |
| DB00539 | substrate | Toremifene | Antineoplastic Agents;Antineoplastic Agents, Hormonal;Selective Estrogen Receptor Modulators;Bone Density Conservation Agents |
| DB00540 | substrate | Nortriptyline | Antidepressants;Adrenergic Uptake Inhibitors;Antidepressive Agents, Tricyclic;Norepinephrine-Reuptake Inhibitors |
| DB00544 | substrate | Fluorouracil | Antineoplastic Agents;Antimetabolites;Immunosuppressive Agents;Antimetabolites, Antineoplastic |
| DB00549 | inhibitor | Zafirlukast | Anti-Asthmatic Agents;Leukotriene Antagonists |
| DB00553 | inhibitor | Methoxsalen | Antineoplastic Agents;Cross-Linking Reagents;Photosensitizing Agents;Pigmenting Agents |
| DB00564 | inducer | Carbamazepine | Anticonvulsants;Analgesics;Antimanic Agents;Analgesics, Non-Narcotic |
| DB00568 | substrate | Cinnarizine | Calcium Channel Blockers;Anti-Allergic Agents;Histamine H1 Antagonists |
| DB00571 | inhibitor | Propranolol | Anti-anxiety Agents;Antihypertensive Agents;Adrenergic Agents;Adrenergic beta-Antagonists;Vasodilator Agents;Antiarrhythmic Agents;Anti-Arrhythmia Agents |
| DB00572 | inhibitor | Spascupreel Tablets | Mydriatics;Bronchodilator Agents;Adjuvants, Anesthesia;Muscarinic Antagonists;Anti-Arrhythmia Agents;Parasympatholytics |
| DB00586 | inhibitor | Diclofenac | Cyclooxygenase Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00604 | substrate | Cisapride | Anti-Ulcer Agents;Gastrointestinal Agents;Serotonin Agonists;Prokinetic Agents |
| DB00605 | inhibitor | Sulindac | Antineoplastic Agents;Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00607 | inducer | Nafcillin | Anti-Bacterial Agents;Penicillins |
| DB00615 | substrate | Rifabutin | Anti-Bacterial Agents;Antibiotics, Antitubercular |
| DB00619 | substrate | Imatinib | Antineoplastic Agents;Protein Kinase Inhibitors |
| DB00623 | inhibitor | Fluphenazine | Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
| DB00625 | inhibitor | Efavirenz | Anti-HIV Agents;Nonnucleoside Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
| DB00629 | substrate | Guanabenz | Antihypertensive Agents;Sympatholytics;Adrenergic alpha-Agonists |
| DB00655 | substrate | Holis 98 | Antineoplastic Agents;Estrogens;Osteoporosis Prophylactic;Anti-menopausal Agents |
| DB00661 | substrate | Tarka | Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
| DB00668 | inhibitor | Zorcaine | Vasoconstrictor Agents;Sympathomimetics;Adrenergic alpha-Agonists;Mydriatics;Bronchodilator Agents;Adrenergic beta-Agonists;Adrenergic Agonists |
| DB00673 | substrate | Aprepitant | Antiemetics |
| DB00675 | substrate | Tamoxifen | Antineoplastic Agents, Hormonal;Selective Estrogen Receptor Modulators;Estrogen Antagonists;Bone Density Conservation Agents |
| DB00678 | inhibitor | Hyzaar | Antihypertensive Agents;Angiotensin II Receptor Antagonists;Antiarrhythmic Agents;Angiotensin II Type 1 Receptor Blockers;Anti-Arrhythmia Agents |
| DB00679 | inhibitor | Thioridazine | Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
| DB00682 | substrate | Warfarin | Anticoagulants;Rodenticides;Coumarin and Indandione Derivatives |
| DB00694 | substrate | Daunorubicin | Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic |
| DB00696 | substrate | Wigraine Tab | Vasoconstrictor Agents;Sympatholytics;Adrenergic alpha-Agonists;Analgesics, Non-Narcotic |
| DB00697 | substrate | Tizanidine | Muscle Relaxants;Skeletal Muscle Relaxants;Anticonvulsants;Analgesics;Adrenergic alpha-Agonists;Muscle Relaxants, Central;Parasympatholytics |
| DB00705 | inhibitor | Delavirdine | Anti-HIV Agents;Nonnucleoside Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
| DB00724 | substrate | Imiquimod | Antineoplastic Agents;Antiviral Agents;Adjuvants, Immunologic;Interferon Inducers |
| DB00730 | inhibitor | Tresaderm Dermatologic Solution | Anthelmintics;Antinematodal Agents |
| DB00737 | inhibitor | Antivert Tab | Antiemetics;Anti-Allergic Agents;Histamine H1 Antagonists;Antihistamines |
| DB00738 | substrate | Pentamidine | Antifungal Agents;Trypanocidal Agents;Antiprotozoal Agents |
| DB00740 | substrate | Riluzole | Anticonvulsants;Neuroprotective Agents;Anesthetics;Excitatory Amino Acid Antagonists |
| DB00744 | inhibitor | Zileuton | Lipoxygenase Inhibitors;Leukotriene Antagonists |
| DB00745 | inducer | Modafinil | Central Nervous System Stimulants;Central Nervous System Agents;Anorexigenic Agents;Stimulants;Neuroprotective Agents |
| DB00752 | inhibitor | Tranylcypromine | Antidepressants;Anti-anxiety Agents;Antidepressive Agents;Monoamine Oxidase Inhibitors |
| DB00758 | substrate | Clopidogrel | Antiplatelet Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents |
| DB00763 | inhibitor | Methimazole | Antithyroid Agents |
| DB00772 | substrate | Malathion | Cholinesterase Inhibitors;Insecticides |
| DB00773 | substrate | Etoposide | Nucleic Acid Synthesis Inhibitors;Antineoplastic Agents, Phytogenic |
| DB00778 | inhibitor | Roxithromycin | Anti-Bacterial Agents;Macrolides |
| DB00783 | substrate | Triquilar 21 | Anticholesteremic Agents;Estrogens;Anti-menopausal Agents |
| DB00787 | - | Zovirax Injection | Antiviral Agents;Nucleosides and Nucleotides |
| DB00788 | substrate | Naproxen | Cyclooxygenase Inhibitors;Gout Suppressants |
| DB00794 | inducer | Primidone | Anticonvulsants;Barbiturates |
| DB00806 | substrate | Pentoxifylline | Free Radical Scavengers;Vasodilator Agents;Platelet Aggregation Inhibitors;Phosphodiesterase Inhibitors;Radiation-Protective Agents;Hematologic Agents;Hemorrheologic Agents |
| DB00818 | inhibitor | Propofol | Free Radical Scavengers;Hypnotics and Sedatives;Antiemetics;Anticonvulsants;Anesthetics, Intravenous |
| DB00829 | inhibitor | Diazepam | Anti-anxiety Agents;Hypnotics and Sedatives;Antiemetics;Anticonvulsants;Adjuvants, Anesthesia;GABA Modulators;Anesthetics, Intravenous;Muscle Relaxants, Central |
| DB00831 | substrate | Stelabid No 2 | Antiemetics;Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
| DB00850 | inhibitor | Triavil Tab | Antipsychotics;Dopamine Antagonists;Phenothiazines;Antipsychotic Agents |
| DB00851 | substrate | Dacarbazine | Antineoplastic Agents;Antineoplastic Agents, Alkylating |
| DB00857 | substrate | Terbinafine | Antifungals;Enzyme Inhibitors;Antifungal Agents;Trypanocidal Agents;Allylamines |
| DB00863 | inhibitor | Tritec | Anti-Ulcer Agents;Histamine H2 Antagonists |
| DB00882 | inhibitor | Clomifene | Selective Estrogen Receptor Modulators;Estrogen Antagonists;Fertility Agents, Female |
| DB00898 | substrate | Ethanol | Anti-Infective Agents, Local;Solvents;Central Nervous System Depressants;Disinfectants |
| DB00904 | inhibitor | Ondansetron | Anti-anxiety Agents;Antiemetics;Antipsychotics;Serotonin Antagonists;Antipruritics;Antipsychotic Agents |
| DB00908 | inhibitor | Quinidine | Enzyme Inhibitors;Antiarrhythmic Agents;Antimalarials;Muscarinic Antagonists;Adrenergic alpha-Antagonists;Anti-Arrhythmia Agents |
| DB00917 | substrate | Dinoprostone | Oxytocics;Prostaglandins |
| DB00921 | inhibitor | Buprenorphine | Narcotics;Analgesics, Opioid;Narcotic Antagonists |
| DB00924 | substrate | Cyclobenzaprine | Muscle Relaxants;Skeletal Muscle Relaxants;Antidepressive Agents, Tricyclic;Muscle Relaxants, Central;Tranquilizing Agents |
| DB00934 | substrate | Maprotiline | Antidepressants;Adrenergic Uptake Inhibitors;Antidepressive Agents, Second-Generation |
| DB00951 | inhibitor | Rifater | Antitubercular Agents;Fatty Acid Synthesis Inhibitors |
| DB00967 | inhibitor | Clarinex-D 12 Hour Extended Release Tablets | Cholinergic Antagonists;Antihistamines;Histamine H1 Antagonists, Non-Sedating |
| DB00969 | substrate | Alosetron | Serotonin Antagonists;Gastrointestinal Agents |
| DB00972 | substrate | Azelastine | Lipoxygenase Inhibitors;Platelet Aggregation Inhibitors;Bronchodilator Agents;Anti-Allergic Agents;Histamine H1 Antagonists;Histamine H1 Antagonists, Non-Sedating |
| DB00976 | substrate | Telithromycin | Anti-Bacterial Agents;Ketolides |
| DB00978 | inhibitor | Lomefloxacin | Anti-Infective Agents;Antitubercular Agents;Photosensitizing Agents;Anti-Infective Agents, Urinary |
| DB00980 | substrate | Ramelteon | Hypnotics and Sedatives |
| DB00988 | inhibitor | Dopamine | Dopamine Agents;Sympathomimetics;Cardiotonic Agents;Sympathomimetic |
| DB00998 | substrate | Frovatriptan | Vasoconstrictor Agents;Anti-inflammatory Agents;Anti-migraine Agents;Serotonin Agonists |
| DB01002 | substrate | Levobupivacaine | Anesthetics;Anesthetics, Local |
| DB01007 | inhibitor | GyneCure Vaginal Ovules Tandempak | Antifungal Agents |
| DB01012 | substrate | Cinacalcet | Calcimimetics |
| DB01013 | inhibitor | Clobetasol | Anti-inflammatory Agents;Corticosteroids, topical;Glucocorticoids |
| DB01026 | inhibitor | Ketoconazole | Antifungals;Antifungal Agents |
| DB01028 | substrate | Methoxyflurane | Anesthetics, Inhalation |
| DB01029 | inhibitor | Avalide 300/12.5 mg | Antihypertensive Agents;Angiotensin II Receptor Antagonists;Angiotensin II Type 1 Receptor Blockers |
| DB01037 | inhibitor | Selegiline | Central Nervous System Agents;Antiparkinson Agents;Antidyskinetics;Neuroprotective Agents;Monoamine Oxidase Inhibitors;Dopaminergics |
| DB01041 | substrate | Thalidomide | Immunosuppressive Agents;Leprostatic Agents;Teratogens;Angiogenesis Inhibitors |
| DB01045 | inducer | Rifater | Enzyme Inhibitors;Antituberculosis Agents;Nucleic Acid Synthesis Inhibitors;Leprostatic Agents;Antibiotics;Antibiotics, Antitubercular |
| DB01056 | inhibitor | Tocainide | Sodium channel blockers;Anti-Arrhythmia Agents |
| DB01058 | substrate | Drontal Tab | Anthelmintics |
| DB01059 | inhibitor | Norfloxacin | Anti-Infectives;Anti-Bacterial Agents;Enzyme Inhibitors;Quinolones;Nucleic Acid Synthesis Inhibitors |
| DB01065 | inhibitor | Plenovit Melatonina | Antioxidants;Free Radical Scavengers;Anticonvulsants;Adjuvants, Immunologic;Central Nervous System Depressants |
| DB01075 | substrate | Suppress Cough Syr W.Cod.Diphen.Hcl Amm.Chl. | Hypnotics and Sedatives;Antiemetics;Antiparkinson Agents;Antidyskinetics;Antipruritics;Anesthetics;Anti-Allergic Agents;Histamine H1 Antagonists;Anesthetics, Local;Antitussives;Ethanolamine Derivatives |
| DB01079 | inhibitor | Tegaserod | Gastrointestinal Agents;Serotonin Agonists |
| DB01087 | inducer | Primaquine | Antimalarials;Antiprotozoal Agents;Antimalarial Agents |
| DB01094 | substrate | Hesperetin | Anticholesteremic Agents |
| DB01095 | inhibitor | Fluvastatin | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| DB01097 | substrate | Leflunomide | Antineoplastic Agents;Antirheumatic Agents;Antiviral Agents;Anti-inflammatory Agents;Enzyme Inhibitors;Immunosuppressive Agents;Antiparasitic Agents;Adjuvants |
| DB01100 | substrate | Pimozide | Dopamine Antagonists;Antipsychotic Agents;Anti-Dyskinesia Agents |
| DB01104 | substrate | Sertraline | Antidepressants;Selective Serotonin Reuptake Inhibitors (SSRIs);Antidepressive Agents;Serotonin Uptake Inhibitors |
| DB01110 | inhibitor | Miconazole | Antifungal Agents |
| DB01115 | inhibitor | Nifedipine | Vasodilator Agents;Calcium Channel Blockers;Tocolytic Agents;Dihydropyridines |
| DB01118 | inhibitor | Amiodarone | Vasodilator Agents;Enzyme Inhibitors;Anti-Arrhythmia Agents |
| DB01124 | - | Tolbutamide | Hypoglycemic Agents;Sulfonylureas |
| DB01129 | inducer | Rabeprazole | Anti-Ulcer Agents;Enzyme Inhibitors |
| DB01131 | substrate | Proguanil | Antimetabolites;Antimalarials |
| DB01136 | substrate | Carvedilol | Antihypertensive Agents;Adrenergic Agents;Adrenergic beta-Antagonists;Vasodilator Agents;Adrenergic alpha-Antagonists |
| DB01137 | inhibitor | Levofloxacin | Anti-Bacterial Agents;Quinolones;Nucleic Acid Synthesis Inhibitors;Anti-Infective Agents, Urinary |
| DB01142 | substrate | Doxepin | Antidepressants;Anti-anxiety Agents;Antipruritics;Antidepressive Agents, Tricyclic;Norepinephrine-Reuptake Inhibitors;Histamine Antagonists |
| DB01151 | substrate | Desipramine | Antidepressants;Adrenergic Uptake Inhibitors;Enzyme Inhibitors;Antidepressive Agents, Tricyclic;Norepinephrine-Reuptake Inhibitors |
| DB01156 | substrate | Bupropion | Dopamine Uptake Inhibitors;Antidepressive Agents;Antidepressive Agents, Second-Generation |
| DB01165 | inhibitor | Ofloxacin | Anti-Infectives;Anti-Bacterial Agents;Quinolones;Nucleic Acid Synthesis Inhibitors;Anti-Infective Agents, Urinary |
| DB01166 | substrate | Cilostazol | Vasodilator Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents;Phosphodiesterase Inhibitors;Bronchodilator Agents;Neuroprotective Agents |
| DB01171 | inhibitor | Moclobemide | Antidepressive Agents;Monoamine Oxidase Inhibitors |
| DB01174 | inducer | Phenobarbital | Hypnotics and Sedatives;Anticonvulsants;GABA Modulators;Excitatory Amino Acid Antagonists |
| DB01182 | inhibitor | Propafenone | Anti-Arrhythmia Agents |
| DB01184 | substrate | Domperidone | Antiemetics;Dopamine Antagonists |
| DB01191 | inhibitor | Dexfenfluramine | Appetite Depressants;Serotonin Agonists;Serotonin reuptake inhibitor;Antiobesity Agents |
| DB01200 | inhibitor | Bromocriptine | Antiparkinson Agents;Antidyskinetics;Dopamine Agonists;Hormone Antagonists |
| DB01211 | inhibitor | Clarithromycin | Anti-Bacterial Agents;Other Macrolides;Protein Synthesis Inhibitors;Macrolides |
| DB01217 | inhibitor | Anastrozole | Antineoplastic Agents;Antineoplastic Agents, Hormonal;Aromatase Inhibitors |
| DB01223 | substrate | Quiex-Pred Sus | Phosphodiesterase Inhibitors;Bronchodilator Agents;Cardiotonic Agents;Respiratory Smooth Muscle Relaxants |
| DB01241 | inhibitor | Gemfibrozil | Antilipemic Agents;Fribic Acid Derivatives |
| DB01242 | substrate | Clomipramine | Antidepressive Agents, Tricyclic;Serotonin Uptake Inhibitors |
| DB01254 | substrate | Dasatinib | Protein Kinase Inhibitors |
| DB01283 | substrate | Lumiracoxib | Cyclooxygenase Inhibitors;Cyclooxygenase 2 Inhibitors |
| DB01303 | substrate | Oxtriphylline | Bronchodilator Agents |
| DB01306 | inducer | NovoMix 30 | Hypoglycemic Agents;Antidiabetic |
| DB01307 | inducer | Insulin Detemir | Hypoglycemic Agents;Antidiabetic |
| DB01309 | inducer | Insulin Glulisine | Hypoglycemic Agents;Antidiabetic |
| DB01355 | substrate | Hexobarbital | Hypnotics and Sedatives;GABA Modulators;Barbiturates;Adjuvants |
| DB01367 | substrate | Rasagiline | Neuroprotective Agents;Monoamine Oxidase Inhibitors |
| DB01388 | inhibitor | Mibefradil | Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
| DB01403 | inhibitor | Methotrimeprazine | Dopamine Antagonists;Analgesics, Non-Narcotic;Antipsychotic Agents |
| DB01405 | inhibitor | Temafloxacin | Anti-Bacterial Agents |
| DB01407 | substrate | Clenbuterol | Sympathomimetics;Bronchodilator Agents;Adrenergic beta-Agonists |
| DB01412 | substrate | Theobromine | Vasodilator Agents;Bronchodilator Agents |
| DB01418 | substrate | Acenocoumarol | Anticoagulants;Coumarin and Indandione Derivatives |
| DB01424 | substrate | Aminophenazone | Analgesics;Pyrazolones |
| DB01435 | substrate | Formule L2 | |
| DB01544 | substrate | Flunitrazepam | Anti-anxiety Agents;Hypnotics and Sedatives;Benzodiazepines;GABA Modulators |
| DB01558 | substrate | Bromazepam | Anti-anxiety Agents;Hypnotics and Sedatives;Benzodiazepines;GABA Modulators |
| DB01601 | inhibitor | Kaletra | Anti-HIV Agents;HIV Protease Inhibitors |
| DB01621 | substrate | Pipotiazine | Phenothiazines;Antipsychotic Agents |
| DB01623 | substrate | Thiothixene | Dopamine Antagonists;Antipsychotic Agents;Thioxanthenes |
| DB01628 | inhibitor | Etoricoxib | Cyclooxygenase Inhibitors |
| DB01645 | substrate | Genistein | Antineoplastic Agents;Enzyme Inhibitors;Growth Inhibitors;Anticarcinogenic Agents;Protein Kinase Inhibitors;Phytoestrogens |
| DB02709 | inducer | Resveratrol | Antioxidants;Platelet Aggregation Inhibitors;Enzyme Inhibitors;Anticarcinogenic Agents;Antineoplastic Agents, Phytogenic;Antimutagenic Agents |
| DB03783 | substrate | Phenacetin | Analgesics;Analgesics, Non-Narcotic |
| DB04574 | substrate | Estropipate | Hormone Replacement Agents;Estrogens |
| DB04841 | substrate | Flunarizine | Anticonvulsants;Vasodilator Agents;Calcium Channel Blockers;Histamine H1 Antagonists |
| DB05271 | inhibitor | Rotigotine Transdermal Patch | Antiparkinson Agents;Antidyskinetics;Dopamine Agonists |
| DB06148 | substrate | Mianserin | Serotonin Antagonists;Histamine H1 Antagonists;Adrenergic alpha-Antagonists;Antidepressive Agents, Second-Generation |
| DB06712 | inhibitor | Nilvadipine | Antihypertensive Agents;Calcium Channel Blockers |
| DB06716 | inhibitor | Fospropofol | Hypnotics and Sedatives;Anesthetics, Intravenous |
| DB06717 | substrate | Fosaprepitant | Antiemetics |
| DB06732 | inducer | beta-Naphthoflavone |
| No data |
| No data |